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Abstract 
 
Many patients who present with symptoms of heart failure are found to have a normal 
left ventricular ejection fraction and therefore were labelled as having “diastolic heart 
failure” implying that the underlying pathophysiology is due to diastolic dysfunction 
alone.  However, using a combination of echocardiographical techniques, a variety of 
abnormalities were found including reduced longitudinal function, impaired left 
ventricular twist and torsional dyssynchrony in systole leading to reduced and 
delayed untwisting, impaired suction and reduced early diastolic left ventricular filling 
not fully compensated for in late diastole due to left atrial dysfunction.  Furthermore in 
a group of subjects with treated hypertension, the most common risk factor for this 
form of heart failure, despite a normal resting echocardiogram, there were already 
substantial abnormalities of both systolic and diastolic function which were only 
apparent on exercise.  Thus these studies have demonstrated that in heart failure 
with a normal ejection fraction, there are major abnormalities of systolic function 
especially torsion or twist, which impact on diastolic filling and that the condition is 
not due to diastolic dysfunction alone.  In addition, these findings emphasise the 
importance of exercise echocardiography for diagnosis and detecting early left 
ventricular dysfunction before patients progress to developing heart failure.     
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CHAPTER 1 
INTRODUCTION 
 
 
 
 
 
 
Contributory publications: 
Yip GW, Fung JW, Tan YT, Sanderson JE. Hypertension and heart failure: a 
dysfunction of systole, diastole or both? J Hum Hypertens 2009;23(5):295-306. 
 
Sanderson JE, Tan YT, Heart Failure with Normal Ejection Fraction.  In: Henein MY, 
editor. Heart Failure in Clinical Practice. London: Springer;2010.p.123-137. 
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1. INTRODUCTION 
1.1 DEFINING HEART FAILURE WITH NORMAL EJECTION FRACTION 
It has been known for over 70 years that heart failure can occur in patients in whom 
left ventricular systolic contractile function appears to be normal when measured by 
the ejection fraction.  Since systolic function was presumed to be normal in these 
patients, this form of heart failure was thought to be due to diastolic dysfunction or 
abnormal filling and hence was labelled as diastolic heart failure (DHF).  However, 
there has been increasing evidence that systolic function is not entirely normal in 
these patients and therefore the terms ‘heart failure with a normal ejection fraction’ 
(HFNEF) and ‘heart failure with a preserved ejection fraction’ (HFPEF) have been 
used as the preferred terms to diastolic heart failure, as they are more descriptive 
terms which do not make assumptions about the causation of the condition, nor imply 
that the primary abnormality lies solely in diastole.  For these reasons, the term 
HFNEF is used throughout this thesis.  
 
The term HFNEF is descriptive of a syndrome which has been shown to involve a 
collection of cardiovascular abnormalities each contributing to the genesis of 
symptoms.  These include vascular and ventricular stiffening (1;2), diastolic 
dysfunction requiring elevated filling pressure to enable adequate left ventricular 
filling, increased heart volume and epicardial constraints (2). 
 
2 
 
Over the past decade, there has been an apparently steady rise in the prevalence of  
HFNEF (3).  Despite this, there has been considerable controversy with regards to 
the existence of the condition, its terminology, the characteristics of the condition and 
the diagnostic criteria for HFNEF.  The confusion has arisen as some authors 
suggested that systolic function is normal in HFNEF patients (4;5), while others 
questioned if the two entities exist as a continuum of heart failure or whether they are 
distinct entities (6).  
 
In view of the unimodal distribution of left ventricular ejection fraction illustrated by 
observational studies (7-9) (Figure 1.1), it was thought that chronic heart failure is a 
pathophysiological identity which encompasses a continuous spectrum of related 
phenotypes and should not be dichotomised into two separate entities based on the 
left ventricular ejection fraction (LVEF) alone (10).  
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Figure 1.1 Illustrating the unimodular distribution of left ventricular ejection 
fraction in patients with heart failure 
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1.1a, the CHARM study (7).  1.1b, the Euro Heart Survey (8).  1.1c, the SENIOR 
study (7-9).    
Adapted from Brutsaert DL (10). 
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Furthermore, several studies have shown that left ventricular systolic function is not 
entirely normal despite a seemingly normal global systolic performance, hence 
suggesting that diastolic heart failure and systolic heart failure reflect two ends of the 
spectrum of heart failure syndrome, and that diastolic heart failure progresses to 
systolic heart failure with time (11-16).  In contrary, there are studies which showed 
that there are significant structural, functional and molecular differences between 
those patients with diastolic heart failure and those patients with systolic heart failure, 
and it has been suggested therefore that these two conditions are different entities 
and exist as two separate syndromes (17).   
 
For example, van Heerebeek et al. found morphological differences between systolic 
and diastolic heart failure (18), but this study did not reflect a true comparison 
between HFNEF and heart failure with a reduced ejection fraction (HFREF) as it 
compared hypertensive patients with a normal ejection fraction and non-hypertensive 
non-ischaemic cardiomyopathy patients.  There are differences in microscopic and 
neuroendocrine features which consequently lead to differences in left ventricular 
structure and echocardiographic characteristics between HFNEF and HFREF.  These 
differences are attributed by underlying or contributing factors such as ageing, 
diabetes and hypertension.  Yip et al. comprehensively summarised the phenotypic 
differences between HFNEF and HFREF and the close similarities of exercise 
response in both conditions (Table 1.1) (19).  However, diastolic dysfunction which 
has been shown to be a strong predictor of exercise intolerance (20), is present in 
both conditions and is not unique to HFNEF.       
5 
 
Table 1.1 Summary of the similarities and differences between HFNEF and HFREF  
Parameters HFNEF HFREF 
Microscopic and neuroendocrine features   
  Cardiac cell hypertrophy Increased Minimal 
  Cardiomyocytes resting tension Increased Decreased 
  Myofilament density Preserved Decreased 
  Titin N2B/N2BA ratio Increased Decreased 
  Interstitial collagen Increased Decreased 
  MMP-1 / TIMP-1 ratio Minimal change Decreased 
  Β-receptor down regulation  Present Present 
  Myocardial β-adrenergic receptor desensitisation Present Present 
  Norepinephrine Increased Increased 
  B-type natriuretic peptide Increased More increased 
Resting echocardiographic parameters   
  LV cavity size Normal/decreased Increased 
  LV shape and geometry Minimal change Spherical 
  LV mass index Increased Increased 
  LV mass to cavity ratio Increased Normal/decreased 
  Relative wall thickness Increased Normal 
  End-diastolic volume / wall stress Normal/decreased Increased 
  End-systolic volume / wall stress Normal Increased 
  LV ejection fraction Normal Decreased 
  Longitudinal velocity / strain Decreased More decreased 
  Radial strain Decreased More decreased 
  LV twist / torsion Normal/decreased Decreased 
  LV twist / untwist rate Normal/decreased Decreased 
Exercise response   
  Peak oxygen consumption Reduced Reduced 
  Ventilatory anaerobic thresholds Reduced Reduced 
  Heart rate response Blunted Blunted 
  Stroke volume / cardiac output Decreased More decreased 
  Contractile reserve Decreased Decreased 
  Systemic vascular resistance Normal/increased Increased 
  Longitudinal velocity / strain Decreased More decreased 
  Radial strain Decreased More decreased 
  Circumferential strain Decreased More decreased 
  LV twist / torsion Decreased More decreased 
  LV untwisting Delayed Delayed 
 
Adapted from Yip G et al. (19). 
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The neuroendocrine, gross and microscopic structural differences between the two 
conditions (18;21;22) are likely a reflection of the aetiology of the conditions and this 
determines the phenotype and the progression of the disease.  Ultimately, the 
primary difference is whether left ventricular remodelling has occurred or not 
(Figure 1.2) (21).  
 
In HFREF, myocardial infarction is the more usual cause and this is a powerful 
stimulus of ventricular remodelling and there is rapid progression of systolic 
dysfunction with ventricular dilatation, the more typical and recognisable form of heart 
failure.  Patients who develop HFREF following a myocardial ischaemic event usually 
pass through an early or initial HFNEF phase (Figure 1.2).  In contrast, hypertension 
in conjunction with diabetes and ageing are the more common causes of HFNEF, is 
commonly associated with left ventricular hypertrophy (LVH) in the absence of left 
ventricular dilatation.  It appears that HFNEF does progress to HFREF with time (21).  
Table 1.2 summarises the comparison of clinical features of HFNEF and HFREF. 
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Figure 1.2   Phenotype of heart failure relates to degree of remodelling and 
aetiology 
 
Adapted from Sanderson JE (21). 
 
LVEF, left ventricular ejection fraction; Sm, peak systolic myocardial mitral annular velocity by colour 
tissue Doppler; LV, left ventricular; HFREF, heart failure with a reduced ejection fraction; HFNEF, 
heart failure with a normal ejection fraction. 
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Table 1.2   Comparison of clinical features of HFNEF and HFREF  
Clinical features HFNEF HFREF 
Gender 
 
Females > Males Males > Females 
Age 
 
60-80 50-70 
Aetiology  Hypertension 
Diabetes 
Atrial fibrillation 
Transient ischaemia 
Myocardial infarction 
Idiopathic dilated 
cardiomyopathy 
 
Clinical progress Often episodic heart 
failure  
Persistent heart 
failure  
 
Ventricular 
remodelling 
(increased volume) 
 
None Present 
LV hypertrophy 
 
Increased Increased / decreased 
Peak mitral inflow 
velocity pattern 
 
Abnormal relaxation 
pattern (ARP) 
Restrictive filling 
pattern (RFP) 
Peak mitral annular 
velocity 
 
Moderately reduced Markedly reduced 
LA volume index 
 
Increased Increased  
 
Adapted from Sanderson JE (21). 
HFNEF, heart failure with a normal ejection; HFREF, heart failure with a reduced ejection fraction; LV, 
left ventricular; LA, left atrial. 
 
9 
 
The exact pathophysiology of HFNEF is still debated.  There is unlikely to be one 
pathophysiology common to all HFNEF subjects.  The challenge of studying and 
understanding HFNEF arises from the heterogenous aetiologies (ageing, 
hypertension, diabetes, renal dysfunction, obesity and atrial fibrillation) (23), which 
are all confounders of diagnosis and are known disease modifiers with direct causal 
effect in the prevalence of HFNEF, and the complex mechanisms related to the 
condition, some of which have been demonstrated in the following chapters of this 
thesis, such as left ventricular systolic and diastolic impairment, left ventricular 
torsional abnormality, left ventricular dyssynchrony, ventricular-arterial coupling (2) 
and impaired chronotropic response (24).   
 
Traditional measurements of global systolic function such as left ventricular ejection 
fraction, stroke work and peak dP/dt (left ventricular pressure change) do not account 
for the non-uniformity of regional myocardial function as global compensation is likely 
to mask regional impairment.  A common example is radial compensation for 
longitudinal or long axis dysfunction seen particularly in many patients with HFNEF.  
In addition, there is currently no robust and accurate method to discriminate between 
pure systolic and diastolic dysfunction.  This is not surprising as systolic and diastolic 
functions are intimately linked.   
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1.2 EPIDEMIOLOGY OF HFNEF 
Patients with HFNEF are typically older females and frequently have a history of 
hypertension and other comorbidities such as atrial fibrillation, diabetes mellitus, 
obesity, renal impairment, anaemia and mild coronary artery disease (23).  Clinically, 
the presenting symptoms and signs of patients with HFNEF are similar to those with 
HFREF (25).  While it is much easier to recognise patients with HFREF given their 
classic history and presentation, patients with HFNEF do not always present with 
typical diagnostic history, symptoms and signs.  Patients with HFNEF often complain 
of breathlessness on exertion or reduced exercise tolerance, which is confounded by 
many other common factors such as underlying pulmonary disease, anaemia or 
obesity.  Hence, they are often not referred for further investigations due to the non-
specific symptom of breathlessness.  Consequently, the prevalence of HFNEF could 
be under-estimated and may lead to adverse clinical consequence, as the prognosis 
of HFNEF has been shown to be comparable to that of HFREF (3;25;26).   
 
The mortality of HFNEF one year post hospital discharge was  22-29%, similar to that 
of HFREF, and the five year mortality was as high as 65% (3;25).  The poor 
prognosis of HFNEF was also reflected in another follow up study which found 
comparable five year survival rates between HFNEF (43%) and HFREF (46%) (26).   
 
A cross-sectional echocardiographic survey of randomly selected subjects over the 
age of 60 years found 35% of the study population had diastolic dysfunction which 
was associated with poorer quality of life despite the absence of signs of heart 
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failure (27).  This study assessed diastolic function by Doppler evaluation of the 
mitral and pulmonary venous inflow and tissue Doppler imaging.  The abnormal 
relaxation pattern (ARP) of the mitral inflow velocity is very common in the elderly 
and therefore it is difficult to assess the true prevalence of diastolic dysfunction in the 
elderly population over and above that due to ageing (28).  Similarly, diastolic 
dysfunction is associated with obesity (29), which is commonly seen in patients with 
HFNEF.  A study of patients with HFNEF with similar symptoms and 6-minute walk 
test (6-MWT) performance as patients with HFREF, has found normal levels of N-
terminal pro B-type natriuretic peptide (NT-proBNP) at rest in HFNEF patients 
implying that these patients did not have heart failure (30).  Ultimately, the diagnosis 
challenge of HFNEF could lie in the fact that patients with HFNEF are mainly 
symptomatic on exertion and thus abnormalities are only apparent when tests are 
performed on exercise. 
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1.3 GUIDELINES FOR DIAGNOSING HFNEF  
A recent report (2007) from the European Society of Cardiology (ESC) attempted to 
provide some guidelines for the diagnosis of HFNEF based on the presence of four 
conditions (Figure 1.3) (31):  
 the presence of clinical symptoms or signs of heart failure; 
 left ventricular ejection fraction of more than 50%; 
 a non-dilated left ventricle; and  
 the demonstration of abnormalities in left ventricular diastolic function.    
 
13 
 
Figure 1.3 European Society of Cardiology recommendation for diagnosing 
HFNEF 
 
Adapted from Paulus W.J. et al. (31). 
HFNEF, heart failure with a normal ejection; LV, left ventricular; LVEF, left ventricular ejection fraction; 
LVEDVI, left ventricular end diastolic volume index; mPCW, mean pulmonary capillary wedge 
pressure; LVEDP, left ventricular end diastolic pressure; E/e’, ratio of early mitral diastolic inflow 
velocity to early diastolic mitral annular velocity; NT-proBNP, N-terminal pro B-type natriuretic peptide; 
BNP, B-type natriuretic peptide; E/A, ratio of early to late diastolic mitral inflow velocity; DT, 
deceleration time of early mitral inflow velocity; Ard - Ad, difference between duration of reversed 
pulmonary vein atrial systolic flow (Ard) and duration of late diastole mitral inflow (Ad); LAVI, left atrial 
volume index; LVMI, left ventricular mass index. 
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The assessment of diastolic function is not easy and has been a subject of much 
debate as it cannot be done by a single method and there is no obvious ‘gold 
standard’.  The latest recommendation published by the American Society of 
Echocardiography (ASE) for the evaluation of diastolic function uses similar 
parameters as the European Society of Cardiology and outlined an approach to 
grade diastolic dysfunction (32) (Figures 1.4 and 1.5).  
 
Based on both these updated guidelines and recommendations, it appears that 
imaging, particularly echocardiography, is the cornerstone of diagnosis and remains 
the most widely available and versatile assessment tool for the evaluation of left 
ventricular function and the diagnosis of HFNEF.   
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Figure 1.4 Scheme for diagnosing diastolic dysfunction  
 
 
Adapted from American Society of Echocardiography recommendation (32). 
EF, ejection fraction; E/e’, ratio of early mitral diastolic inflow velocity to early diastolic mitral annular 
velocity; Sep, septal wall ; Lat, lateral wall ; Av, average of septal and lateral walls; LAP, left atrial 
pressure; LA vol, left atrial volume; Ard - Ad, difference between duration of reversed pulmonary vein 
atrial systolic flow (Ard) and duration of late diastole mitral inflow (Ad); Δ, change in (delta); E/A, ratio 
of early to late diastolic mitral inflow velocity; PAS, pulmonary arterial systolic pressure; IVRT, 
isovolumic relaxation time; T, time; E-e’, early mitral diastolic inflow velocity less early diastolic mitral 
annular velocity.   
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Figure 1.5 Scheme for grading diastolic dysfunction  
 
 
Adapted from American Society of Echocardiography recommendation (32). 
LA, left atrial; e’, peak early diastolic myocardial mitral annular velocity by pulse wave Doppler 
imaging; E/A, ratio of early to late diastolic mitral inflow velocity; DT, deceleration time of early mitral 
inflow velocity; AV, average; E/e’, ratio of early mitral diastolic inflow velocity to early diastolic mitral 
annular velocity; Ard - Ad, difference between duration of reversed pulmonary vein atrial systolic flow 
(Ard) and duration of late diastole mitral inflow (Ad); Δ, change (delta); E/A, ratio of early to late 
diastolic mitral inflow velocity; Val, Valsalva.   
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Prior to these guidelines, Vasan and Levy proposed the criteria for diagnosing 
“Diastolic Heart Failure”.  The proposed criteria for definite, probable and possible 
diagnosis of diastolic heart failure were based on clinical, echocardiographical and 
cardiac catheterisation findings (Table 1.3) (33).  The short coming of this is the 
requirement of invasive measurement and confirmation of a raised left ventricular 
end diastolic pressure (LVEDP) which is not always feasible in daily clinical practice. 
 
Table 1.3 Vasan and Levy criteria for definite diastolic heart failure  
Criteria for definite diastolic heart failure 
1.   Evidence of congestive heart failure (Framingham or Boston Criteria). 
2.   Objective evidence of normal left ventricular ejection fraction (ejection fraction 
more than 50% more than 72 hours after presentation with congestive heart 
failure). 
3.   Evidence of left ventricular diastolic dysfunction by cardiac catheterisation. 
 
Adapted from Vasan and Levy (33). 
 Framingham Criteria for congestive heart failure requires at least two major or one major and two 
minor criteria.  
 Boston Criteria for congestive heart failure involves scoring system of which the composite score 
has a maximum of 12 points.  A diagnosis of definite heart failure requires a score of eight or 
more points.  
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Yturralde and Gaasch suggested that the diagnosis of definite diastolic heart failure 
should fulfill two major criteria and one item of the confirmatory evidences; and a 
probable diagnosis of diastolic heart failure could be made in those without 
confirmatory evidence (Table 1.4) (34). 
 
Table 1.4 Yturralde and Gaasch criteria for diagnosing diastolic heart failure 
Major criteria: 
1.   Clinical evidence of heart failure (Framingham or Boston criteria), plasma B-
type natriuretic peptide or chest x-ray, cardiopulmonary exercise testing. 
2.   Normal left ventricular ejection fraction and chamber size. 
Confirmatory evidence: 
1.   Left ventricular hypertrophy or concentric remodelling. 
2.   Left atrial enlargement (in absence of atrial fibrillation). 
3. Echocardiographic or catheterisation evidence of diastolic dysfunction. 
 
Adapted from Yturralde and Gaasch (34). 
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The measurement of left ventricular ejection fraction remains one of the crucial 
criteria for the diagnosis of HFNEF in all the guidelines and this is not without 
problems.  The guidelines do not include tissue Doppler imaging and speckle 
tracking imaging measurements of left ventricular twist, strain or strain rate which 
may give further insight into the mechanics of HFNEF.  The guidelines also include 
invasive measurement of left ventricular diastolic function which is not without its 
pitfalls and is not routinely performed.  More importantly, none of the current 
available guidelines include exercise measurement of left ventricular function which 
is when patients are most symptomatic.  All these guidelines for diagnosis are based 
on measurements made at rest while HFNEF is essentially an exercise related 
condition.   
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1.3.1 MEASUREMENT OF LEFT VENTRICULAR EJECTION FRACTION  
It is difficult to define a “normal” range of left ventricular ejection fraction.  Left 
ventricular ejection fraction of more than 45-50% has been considered to reflect 
normal systolic function in many studies on HFNEF.  The measurement of ejection 
fraction has been widely used as a convenient and readily available index in clinical 
practice even though it is recognised as a poor and non-specific measurement of left 
ventricular function, as it merely reflects the change in left ventricular volume and 
therefore only provides a crude guide to distinguish good and poor overall pump 
function.  The measurement of left ventricular ejection fraction does not provide any 
information about myocardial contractile function, and fails to account for any 
compensatory mechanisms. 
 
All the guidelines involve measurement of left ventricular ejection fraction which 
requires measurement of left ventricular end-diastolic and end-systolic volumes by 
echocardiography.  There are two commonly used methods of measuring left 
ventricular ejection fraction by echocardiography.  Firstly, using Simpson’s biplane 
technique by applying the method of discs, the left ventricular volumes and ejection 
fraction are calculated after measuring the left ventricular end-diastolic and end-
systolic contours by planimetry of the apical images.  This method relies on clear 
delineation of endocardial edges for accurate measurements with acceptable 
reproducibility.  The measurements should be averaged from both four-chamber and 
two-chamber views which are not significantly foreshortened, preferably from two or 
three beats.    
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Secondly, the estimation of left ventricular ejection fraction can also be made from 
radial end-diastolic and end-systolic diameter measurements obtained by M-mode 
echocardiography from a parasternal window.  There are several pitfalls of using this 
method.  Firstly, measurements of the left ventricular diameter are made along a 
single scan line which involves assumptions about the left ventricular cavity size and 
shape.  Secondly, this method is dependent on measurements taken at the correct 
time points (end diastole and systole), on-axis images and correct identification of the 
endocardium as applied in the Simpson’s biplane method.  Although commonly used 
in clinical practice, it is not an accurate method for the measurement of left ventricular 
ejection fraction (35).  Furthermore, although ejection fraction has some prognostic 
value it is affected by preload, afterload, heart rate and dyssynchrony as well as 
myocardial contractility.  It reflects radial function more than longitudinal function, and 
is not, therefore, to be a true measure of systolic function (36).   
   
For example, Maciver and Townsend have demonstrated that the left ventricular 
ejection fraction is mathematically increased in the presence of left ventricular 
hypertrophy and a normal left ventricular volume (37).  This creates a false 
impression of normal systolic function.  Using a model, they illustrated that there may 
be a reduction in stroke volume and impaired left ventricular long axis function 
despite a normal left ventricular ejection fraction.  The preservation of ejection 
fraction is directly related to the presence of increased left ventricular mass.  
Myocardial radial thickening occurs when the myocardial long-axis shortens, 
therefore an increase in myocardial mass leads to an additional increase in 
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endocardial displacement radially.  Consequently, an increase in ejection fraction is 
observed if myocardial shortening remains unchanged.  This explains the 
preservation of ejection fraction in the presence of left ventricular hypertrophy which 
is present in many patients with HFNEF, even when there is a significant reduction in 
long-axis function and stroke volume. 
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1.3.2 ASSESSMENT OF DIASTOLIC FUNCTION AND LEFT 
VENTRICULAR FILLING PRESSURES 
Classically, diastolic dysfunction is assessed from pressure-volume loops measured 
at cardiac catheterisation (38).  The end diastolic pressure-volume relationship 
(EDPVR) is thought to represent the passive mechanical properties of the left 
ventricle.  Changes in the left ventricular pressure-volume relationship reflect 
changes in ventricular elastance and compliance.  Compliance is the slope of the end 
diastolic pressure-volume relationship, while the slope of end systolic pressure-
volume relationship (ESPVR) is a measure of end systolic elastance (Ees) (38) 
(Figure 1.6). 
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Figure 1.6 Left ventricular pressure-volume relationship  
 
 
 
ESPVR, end systolic pressure-volume relationship; EDPVR, end diastolic pressure-volume 
relationship; LV, left ventricular. 
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Classically, in systolic heart failure, the end systolic pressure-volume relationship is 
displaced to the right and downwards associated with reduced left ventricular ejection 
capacity while end diastolic pressure remains normal.  In diastolic dysfunction, the 
end-diastolic pressure-volume relationship is displaced to the left and upwards 
associated with reduced left ventricular capacity to fill and raised end diastolic 
pressure (39) (Figure 1.7). 
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Figure 1.7   Left ventricular pressure-volume loops in systolic and diastolic 
dysfunction 
 
 
 
Adapted from Maeder T. et al.  (23). 
LV, left ventricular. 
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Data from patients with HFNEF has shown that end diastolic pressure-volume 
relationship curves are highly variable and may be shifted towards lower, normal and 
higher volumes.  The heterogeneous results of pressure-volume analysis in patients 
with HFNEF highlighted by Maurer et al. suggest that different pathophysiological 
mechanisms exist in individual patients (38) (Figure 1.8). 
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Figure 1.8 Variations of end diastolic pressure-volume relationship of 
patients with HFNEF 
 
 
 Adapted from Maurer M.S. et al. (38). 
LV, left ventricular.  
 
29 
 
A normal left ventricle will become less compliant consequent to an abnormal 
increase in left ventricular volume such as in renal failure.  Therefore, the end 
diastolic pressure-volume relationship is actually not a measure of stiffness but the 
extent to which stiffness depends on volume (40).  Consequently, the measurement 
of end diastolic pressure-volume relationship is not particularly useful in daily practice 
and cannot be considered a ‘gold’ standard as is commonly claimed. 
 
Mitral inflow velocities in contrast are easy to obtain and represents the overall 
diastolic filling characteristics of the heart and thus provide a rough assessment of 
diastolic function and left ventricular filling pressures.  The limitations of this 
measurement include age, heart rate, preload and afterload dependency.  
Measurements have to be adjusted for age (31;41;42).  However, the preload 
dependence of the peak early diastolic mitral inflow velocity (E) can be useful given 
that it reflects the driving force across the mitral valve. 
 
When pulse wave sample is placed at the tip of the mitral valve leaflets when the 
valve is opened, the peak velocity measured represents the change in pressure 
between the left atrium and the left ventricle.  In normal subjects, the left ventricular 
pressure decreases rapidly during left ventricular relaxation, soon after the 
completion of left ventricular contraction.  A driving force is created when the left 
ventricular pressure becomes lower than the left atrial pressure.  The blood flow 
velocity from the left atrium to the left ventricle across the mitral valve is measured as 
the mitral inflow velocity.  The peak velocity is measured as the early diastolic mitral 
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inflow velocity E wave (Figure 1.9).  In late diastole, left atrial pressure exceeds left 
ventricular pressure during atrial contraction, creating the late diastolic mitral inflow 
velocity (A) wave.   
 
Diastolic function can be graded into four broad categories, namely normal, mild, 
moderate and severe diastolic dysfunction based on mitral inflow Doppler patterns. 
Mild diastolic dysfunction is associated with abnormal left ventricular relaxation 
leading to reduced driving force to fill the left ventricle, hence a reduced velocity 
across the mitral valve.  This is reflected as a smaller early diastolic mitral inflow 
velocity E wave.  Reduced early diastolic filling is compensated by increased late 
diastolic filling during atrial contraction and hence a bigger late diastolic mitral inflow 
velocity A wave, resulting in a lower ratio of early to late diastolic mitral inflow velocity 
(E/A).  As disease progresses from mild to moderate diastolic dysfunction, left atrial 
pressure is raised leading to an increase in driving pressure in early diastole resulting 
in pseudonormalisation when the E wave and E/A ratio are similar to the normal 
pattern.  In more advanced disease associated with abnormal left ventricle 
compliance (severe diastolic dysfunction), the left atrial pressure becomes even 
higher resulting in higher transmitral pressure gradient, hence a marked increase in 
early diastolic mitral inflow velocity.  This results in a restrictive mitral Doppler inflow 
pattern (Figure 1.9).   
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Figure 1.9 Doppler echocardiographic left ventricular diastolic filling patterns 
 
 
 
E, early diastolic mitral inflow velocity; A, late diastolic mitral inflow velocity; e’, early diastolic mitral 
annular velocity; TDI, tissue Doppler imaging. 
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Tissue Doppler imaging has introduced new indices which can give additional help in 
the assessment of left ventricular function.  Given that the apex is relatively fixed, the 
movement of the mitral valve annulus is a direct measure of left ventricular 
longitudinal function also known as the long axis movement or the mitral annular 
motion or the atrioventricular plane displacement.  The same holds true for the 
tricuspid valve annulus and the right ventricle.  Therefore, the application of tissue 
Doppler to the mitral annulus is used as a measure of long axis function. 
 
Rushmer et al. showed that long axis shortening was greater than that of the short 
axis during early systole, causing a geometrical change in the left ventricle to 
become more spherical in shape (43).  They also showed that there was a greater 
change in volume per unit change in the short axis fibre length during systole when 
the left ventricle is more spherical.   As pointed out by Henein and Gibson, this 
change occurs due to the motion of discreet long axis fibres separate from fibres 
supporting the short axis, and not due to a homogenous set of oblique fibres (44).   
 
During ejection, the two axes are effectively in phase with one another although peak 
long axis shortening occurs at aortic valve closure, while the short axis continues to 
reduce reaching its minimum at the time of mitral valve opening.  In diastole, the 
mitral annular motion starts at the same time as mitral inflow when the left ventricular 
pressure has fallen.  Therefore, the mitral annular motion can be considered primarily 
as a measure of left ventricular recoil and has been shown to correlate with tau, the 
exponential decay of left ventricular pressure, during isovolumic relaxation (45).      
33 
 
In the literature, Em is also represented as E’ or e’, all of which are abbreviations used 
to describe early diastolic mitral annular velocity.  Usually now the term e’ refers to the 
measurement by pulse wave Doppler (PWD) while Em is by continuous wave Doppler 
(CWD), detailed in Chapter 4. 
 
Myocardial velocity is a relatively load independent measure.  In an experimental 
model of heart failure in dogs, the early diastolic mitral annular velocity (Em) was 
impaired early, and progressive decline of Em with worsening heart failure was 
associated with increased left atrial pressures (46).  Furthermore, early diastolic (Em) 
and systolic mitral annular velocities (Sm) are powerful predictors of prognosis in a 
variety of cardiac conditions including heart failure (47-49), and add incremental 
value to standard clinical and echocardiographical measures.   
 
Wang et al. found that Em <3 cm/s was the best prognostic index in long-term follow-
up of heart failure patients (48).  Taking into account of measurements of Sm, E/e’ 
and deceleration time (DT), they showed that Em is the strongest predictor of cardiac 
mortality in patients with heart failure.  In addition to DT≤140ms and E/e’>15, Em 
<3cm/s improved the power of heart failure survival prediction.  Similar results were 
found by the same investigators in a group of hypertensive subjects with left 
ventricular hypertrophy, where again a low Em (<3.5cm/s) was the strongest 
prognostic indicator after adjusting for increased septal thickness and moderate to 
severe diastolic dysfunction assessed by mitral inflow patterns (pseudonormalisation 
and restrictive filling pattern) (49).  In a group of patients with idiopathic dilated 
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cardiomyopathy, Em was significantly lower in those who had pulmonary oedema 
compared to those who were clinically stable (17).  These studies confirmed that 
decreased Em is one of the earliest markers for diastolic dysfunction and is present in 
all stages of diastolic dysfunction (Figure 1.9). 
 
Since Em or e’ remains reduced and early diastolic mitral inflow velocity E increases 
with higher filling pressure (Figure 1.9), the ratio between transmitral E and e’, E/e’, is 
considered a good surrogate marker for left ventricular filling pressure and has been 
shown to correlate with pulmonary capillary wedge pressure (45;50).  Ommen et al. 
demonstrated that E/e’>15 predicts an elevated left ventricular filling pressure of more 
than 15mmHg, while E/e’ <8 is associated with normal left ventricular filling 
pressure (45).  Thus the preload dependence of the mitral inflow velocities can be put 
to good use as a clinical guide, even more so when used in combination with e’.  
 
An increased left atrial volume is a marker of a chronically elevated left atrial 
pressure.  In a population based study, left atrial volume indexed to body surface 
area (LAVI) is strongly associated with cardiovascular disease including 
hypertension, atrial fibrillation and congestive heart failure (51).  In another study, 
LAVI was shown to be a strong predictor of diastolic dysfunction in a group of 
suspected heart failure patients with normal left ventricular ejection fraction, given 
that parameters which predict raised left atrial pressure used for assessing diastolic 
function such as left ventricular wall thickness, left ventricular mass index, 
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deceleration time of E wave, and age are all predictors of left atrial volume 
index (52). 
 
Therefore, using a combination of e’ and the ratio E/e’ with left atrial volume index, a 
reasonable diagnosis of increased left ventricular filling pressure or raised left atrial 
pressure and probable diastolic dysfunction can be reliably made (53).  However, 
early diastolic filling is very dependent on the previous systole.  Any reduction in 
systolic function, co-ordination or dyssynchrony (discussed later) will have a profound 
impact on the ability of the left ventricle to fill adequately at normal pressures during 
diastole.  But in practice, the presence of left ventricular hypertrophy and an 
increased left atrial volume index on echocardiography in the absence of valvular 
heart disease in a breathless patient, strongly supports a clinical diagnosis of 
HFNEF. 
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1.4 PATHOPHYSIOLOGY OF HFNEF 
The classical explanations for HFNEF include the following, all of which were based 
on measurements acquired at rest. 
 An increase in intrinsic myocardial stiffness and impaired relaxation in diastole 
requires higher left atrial pressures for filling in late diastole, predisposing these 
patients to pulmonary venous congestion and dyspnoea especially on 
exertion (4). 
 Deranged ventricular-arterial coupling secondary to systolic ventricular and 
arterial stiffening which exaggerates hypertensive response when systolic 
pressure load is increased during exercise or stress, consequently inducing load-
dependent diastolic dysfunction (2). 
 Enhanced sensitivity to volume overload in relation to volume-dependent 
elevation of filling pressures seen in renal impairment.  This was observed in a 
subgroup of hypertensive HFNEF patients who had renal impairment and 
increased left ventricular volumes but normal systolic ventricular and vascular 
stiffness (54).   
 
These concepts underestimate the impact of the previous systole on early diastolic 
filling, particularly inco-ordination or dyssynchrony, reduced longitudinal function and 
left ventricular torsion.  Furthermore, heart failure is essentially a disease on 
exercise, therefore studies performed at rest might not unmask the underlying 
abnormalities. 
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1.4.1 SYSTOLIC FUNCTION IN HFNEF 
In an early study Yip et al. studied 68 patients with heart failure, 29 with a LVEF>45% 
and 39 with a LVEF<45% compared to age-matched controls (12).  They found that 
systolic mitral annular velocity (Sm) was significantly lower in those with HFNEF 
(4.81 ± 0.23 cm/s) compared to controls (6.10 ± 0.14 cm/s), but was higher than 
those with HFREF.  A similar finding was seen using early diastolic mitral annular 
velocity (Em).  In this study, the left ventricular ejection fraction in the HFNEF group 
was statistically lower than age-matched controls although still within the accepted 
normal limits.  They concluded that there was evidence of abnormal systolic function 
in many patients with HFNEF and that true ‘isolated’ diastolic dysfunction is probably 
rare.  These findings have now been confirmed by several other studies (11;13-
16;55).  
 
In a thorough assessment of regional myocardial function, Yu et al. studied 339 
subjects, 92 with systolic heart failure or HFREF (ejection fraction <50%), 73 with 
diastolic heart failure or HFNEF (ejection fraction >50% with diastolic abnormalities 
on Doppler echocardiography), 68 had isolated diastolic dysfunction (DD) without 
symptoms of heart failure and 106 were normal subjects (11).  They assessed 
myocardial velocities of 12 segments (6 basal and 6 mid segments) and found 
significantly lower Sm and Em in patients with systolic heart failure, diastolic heart 
failure and diastolic dysfunction, compared to control subjects (systolic heart failure < 
diastolic heart failure < diastolic dysfunction < controls).  This concluded that despite 
a normal ejection fraction, systolic function is not normal in HFNEF.  This is not 
38 
 
surprising as systolic function is probably affected by left ventricular hypertrophy and 
the accompanying fibrosis as much as diastolic function.   
 
Shan et al. found that Sm and Em are related to the percentage of interstitial fibrosis 
within the myocardium as both measurements are reduced with increased 
fibrosis (56).  In another study involving a large number of subjects with a wide range 
of left ventricular ejection fraction, a close relationship between systolic and diastolic 
velocities was demonstrated (57).  Vinereau et al. similarly found a strong correlation 
between the Sm and Em (16).  These studies suggest that left ventricular systole and 
diastole are closely intertwined.   
 
In reality, systole and diastole constitute one cycle and the major determinant of 
diastolic filling is the strength and coordination of the previous systole.  Early diastolic 
suction is dependent on the force of the previous systolic contraction (58).  In 
addition, incoordinated systolic contraction, as seen in left ventricular dyssynchrony,  
will prolong isovolumic relaxation and impair diastolic function (59).  The motion of 
the ventricular base (mitral annulus) during early diastole reflects both systolic and 
diastolic function of the subendocardial fibres which because of their position, are 
more susceptible to the effects of fibrosis, hypertrophy and ischaemia.  This may 
explain why the measurement of mitral annular velocities is a powerful predictor of 
prognosis in a variety of cardiac diseases including heart failure (48).  Furthermore, 
all the precursors of HFNEF such as hypertension, left ventricular hypertrophy, 
ageing and diabetes alter global myocardial architecture and fibre orientation which 
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have important effects on left ventricular torsion in systole and left ventricular 
untwisting in diastole (60). 
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1.4.2 DIASTOLIC FUNCTION IN HFNEF 
Diastolic function is known as the ability of the heart to fill while maintaining normal 
pressure to enable subsequent systolic ejection applying the Frank-Starling 
mechanism.  Diastole consists of four phases as outlined below. 
 
 Phase 1 is the onset of left ventricular relaxation which begins before aortic valve 
closure.  This is associated with a rapid fall in intraventricular pressure during 
isovolumic relaxation period.  This process is influenced by both active 
(adenosine triphosphate hydrolysis to facilitate calcium reuptake and to release 
actin-myosin bonds) and passive (elastic recoil derived from the release of stored 
elastic energy during systole) components.  
 
 Phase 2 starts at the opening of the mitral valve when rapid filling takes place.  
This process is dependent on the generation of atrial-ventricular pressure 
gradient which is driven by the ability of the left ventricle to relax in order to create 
and maintain a low intraventricular pressure.  This transmitral pressure gradient 
acts as a suction mechanism to draw blood into the ventricle for early rapid filling 
which contributes approximately 80% of normal ventricular filling. 
 
 Phase 3 is diastasis when the atrial-ventricular pressure equilibrates.  When this 
phase is studied using pressure-volume loops, it represents the passive 
mechanical properties of the left ventricle and left ventricular compliance can be 
derived (discussed in section 1.3.2). 
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 Phase 4 is atrial contraction or late diastolic filling which contributes approximately 
20% of normal ventricular filling.  This process is dependent on the left ventricular 
end diastolic pressure and left atrial function (detailed in section 1.4.3). 
 
Many studies of diastolic dysfunction in HFNEF were performed using pressure-
volume analysis focusing on the EDPVR (phase 1-3).  Zile et al. showed increased 
diastolic stiffness and abnormal left ventricular relaxation in patients with diastolic 
dysfunction by pressure-volume analysis (5).  They demonstrated a shift in the 
EDPVR upwards and to the left suggesting increased left ventricular stiffness or 
reduced compliance (Figure 1.10).  The same group of investigators also found a 
prolonged time constant of relaxation in a majority of HFNEF patients, implying 
reduced left ventricular relaxation rate (61).   
 
In the contrary, Kawaguchi et al. found an upward parallel shift of the EDPVR in 
HFNEF compared to controls, suggesting that systolic ventricular and arterial 
stiffness, but not left ventricular diastolic stiffness, are raised in HFNEF (2) 
(Figure 1.10).  Nevertheless, these studies showed that there is an increase in left 
ventricular end diastolic pressure in HFNEF.  
 
42 
 
Figure 1.10 End diastolic pressure-volume relationships in diastolic 
dysfunction  
 
 
Adapted from Borlaug & Kass (62). 
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1.4.3 LEFT ATRIAL FUNCTION IN HFNEF 
Left atrial contraction constitutes to late diastolic filling in phase 4 of diastole.  The left 
atrium plays three main mechanical roles throughout the different phases of the 
cardiac cycle.  It acts as a reservoir from pulmonary venous filling during ventricular 
systole and then as a conduit during early diastole before it contracts in late 
diastole (63).  It has been shown that atrial contraction contributes 29% of total left 
ventricular stroke volume and thus plays a significant role in heart failure (64).  Active 
atrial contraction acts as a booster to augment left ventricular filling particularly in 
compensation of decreased early diastolic filling due to diastolic dysfunction, for 
example in left ventricular hypertrophy seen in hypertensive heart disease which is 
one of the common precursors of HFNEF.   
 
The loss of atrial contraction in atrial fibrillation (AF), also a common condition 
associated with HFNEF, results in up to 20% of cardiac output reduction which can 
lead to presentation of heart failure symptoms (63).  Fung et al. reported that HFNEF 
patients with AF had a dilated left atrium and reported poorer quality of life and 
reduced exercise capacity (65).  It is recognised that an increase in left atrial size is a 
strong predictor of adverse cardiovascular outcome and is associated with worse 
diastolic dysfunction (66;67).   Increase in left ventricular filling pressure causes left 
atrial pressure overload leading to left atrial dilatation hence increase in left atrial 
volume as discussed in section 1.3.2.  This is considered an adaptive response to 
maintain left ventricular stroke volume and cardiac output.  Sustained and prolonged 
increase in left ventricular filling pressure causes further left atrial dilatation 
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exceeding the limits of Frank-Starling relationship resulting in left atrial dysfunction 
(68), as illustrated in Figure 1.11.   
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Figure 1.11 Mechanisms of left atrial dysfunction 
 
 
 
CO, cardiac output; LA, left atrium; LV, left ventricle; SV, stroke volume.
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Using tissue Doppler imaging, Wang et al. found that the hazard ratio of cardiac 
death was significantly increased when late diastolic myocardial velocity, Am was 
≤4cm/s (47).  Measurements of left atrial function were found to be predictive of 
exercise capacity in chronic heart failure in two other studies (69;70).  Melenovsky et 
al. found that left atrial volume was higher in HFNEF patients compared to 
hypertensive subjects with left ventricular hypertrophy, and that left atrial total, 
passive and active emptying fractions were reduced in HFNEF subjects (71).  They 
also demonstrated that the Am rose in the hypertensive subjects with handgrip 
exercise but remained unchanged in HFNEF patients.  It has been shown in another 
study that left atrial dilatation and dysfunction are present in systolic heart failure or 
HFREF and can predict outcome (72).  This finding was also supported by Kurt et al. 
in addition to their finding of impaired left atrial function in subjects with diastolic 
dysfunction and those with “diastolic heart failure” (73).   
 
Most of these studies were performed at rest or during isometric handgrip exercise 
when patients were asymptomatic but demonstrated a wider abnormality in the 
pathophysiology of HFNEF.  
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1.4.4 DYSSYNCHRONY IN HFNEF  
The contraction and relaxation of a normal left ventricle are synchronous.  The 
movement of the ventricular walls are coordinated in systole to enable maximum 
systolic ejection, while coordinated relaxation in diastole allows optimal filling.  The 
loss of coordinated cardiac movement results in cardiac dyssynchrony.  Essentially, 
the term dyssynchrony describes the abnormal and discoordinated timing of cardiac 
motions, particularly the timing of contraction or relaxation of different myocardial 
segments known as systolic or diastolic dyssynchrony respectively.  Disturbances of 
regional myocardial function have been recognised to occur in a variety of cardiac 
diseases (74;75).  The relationship between electrical activation of the left ventricle 
and the mechanical contraction of the left ventricle is known as the electro-
mechanical synchrony.  The disturbance of electrical propagation such as those seen 
in bundle brunch block, leads to delayed activation of affected myocardial segments, 
hence a change in activation sequence of various left ventricular segments.  This is 
known as electro-mechanical dyssynchrony or intraventricular dyssynchrony, which is 
recognised to be an important contributing factor of left ventricular remodelling and 
systolic dysfunction (76).  Recently, it has been shown that electro-mechanical 
dyssynchrony is present in patients with heart failure even with narrow QRS 
complexes (77).  
  
Tissue Doppler imaging provides good temporal resolution and is most commonly 
used to detect dyssynchronous contraction and relaxation.  The myocardial velocity-
time curve provides information about the magnitude and the timing of left ventricular 
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segmental contraction and relaxation.  Two recent studies applying tissue Doppler 
imaging technique have demonstrated that dyssynchrony can occur in both systole 
and diastole in patients with HFNEF (78;79).  Wang et al. compared 60 patients with 
DHF (LVEF>50%), 60 with SHF and 35 controls (78).  Systolic dyssynchrony was 
taken as the maximum time difference between 4 basal segments of the time to 
either peak or onset of the systolic myocardial velocity.  The maximum time 
difference to the onset of the peak early diastolic velocity was used as a 
measurement for diastolic dyssynchrony.  Left ventricular intraventricular delay was 
abnormal in patients with DHF, 58% in diastole and 33% also in systole.  These 
results were very similar to those with SHF (60% with diastolic dyssynchrony and 
40% with systolic dyssynchrony).  In a second study by Yu et al., by applying the 
technique of standard deviation of time to peak systolic and early diastolic velocities 
derived from 12 segments, they found the prevalence of diastolic and systolic 
dyssynchrony in 92 patients with HFNEF was 36% and 39% respectively, and 43% 
and 57% respectively in 281 patients with SHF (79).  Despite the close relationship 
between peak systolic and early diastolic myocardial velocities shown by Yip et al. 
(57), the correlation between systolic and diastolic dyssynchrony was weak although 
statistically significant.  Yu et al. found 57% of SHF patients had systolic 
dyssynchrony but reported that only 26% of SHF patients had co-existing systolic 
and diastolic dyssynchrony.  Only 14% of DHF patients had co-existing systolic and 
diastolic dyssynchrony.   
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In contrast to the well described systolic dyssynchrony commonly seen in patients 
with systolic heart failure or HFREF which is associated with wide QRS complexes, 
the presence of diastolic and / or systolic dyssynchrony in HFNEF patients was 
associated with narrow QRS complexes.  This suggests that electro-mechanical 
dissociation is not the main explanation of left ventricular dyssynchrony seen in 
HFNEF.  The nature of dyssynchrony in HFNEF is likely to be different from that in 
HFREF and this abnormality could arise from the myocardium itself, given that the 
geometrical difference between the two conditions, which is regional wall motion 
abnormalities in the presence of left ventricular dilatation and the presence of electro-
mechanical discoordination seen in HFREF, compared to left ventricular hypertrophy 
in the absence of left ventricular dilatation and lack of apparent electro-mechanical 
discoordination in HFNEF.  
   
Of note, these studies assessed dyssynchrony in a single myocardial plane 
(longitudinal plane) using tissue Doppler imaging which reflects segmental 
dyssynchrony.  However, myocardial mechanics involve a combination of radial, 
circumferential and oblique motions in addition to longitudinal motion.  Assessing 
multi-plane motion coordination or left ventricular torsional synchrony may provide 
more insight into these complex left ventricular mechanics and may be more 
applicable in HFNEF.  In addition, these studies were performed at rest and the 
impact of left ventricular dyssynchrony on exercise remains unknown.   
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2. LEFT VENTRICULAR TWIST AND TORSION 
2.1 LEFT VENTRICULAR MUSCLE FIBRE 
Left ventricular twist and torsion has intrigued many since its first description by 
William Harvey in 1628 when the twisting motion of the left ventricle was observed 
and described.  The anatomical arrangement and the architecture of the myocardium 
underlying this motion have caused much fascination amongst anatomists and 
physiologists.  Knowledge of the myocardial fibre orientation helps in the 
understanding of the function of the heart and its efficiency as a pumping chamber.  
The knowledge of myofibre geometry of the left ventricle is important in the 
understanding of torsion mechanics which contribute significantly to the overall 
atrioventricular plane displacement or long axis function. 
   
There is still ongoing debate amongst cardiac anatomists with regards to the true left 
ventricular architecture.  Descriptions of the myocardial architecture range from 
layered myofibre sheets, aggregated myocyte mesh to myocardial band (80-82).  The 
proposal of the myocardial band theory by Torrent-Guasp et al. which described a 
continuum of myocardial band wrapping around itself to form the helical structure 
containing two distinct arms of the left ventricle (Figure 2.1), has been a subject of 
much debate, but explains the overall left ventricular mechanics, particularly torsion 
mechanics (82). 
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Figure 2.1 The myocardial band theory  
 
Extracted from Buckberg GD et al. (83). 
 
Histological studies established that there is a transmural transition of fibre direction 
from the endocardium to the epicardium (80;84).  Streeter et al. used a rapid fixation 
method to analyse canine hearts set in various stages of the cardiac cycle, and found 
that fibre angles, in relation to the circumferential fibres, increase during systole 
compared to diastole and concluded the presence of ventricular twist motion (80).  
The predominantly longitudinal endocardial fibre becomes circumferentially 
orientated in the midwall which then orientates longitudinally again in the epicardium.  
These different planes of myofibres have been described as myocardial sheets which 
contribute to the different plane of motion of the myocardium.  In addition to the 
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longitudinal and circumferential fibres, the left ventricle also has a helical muscle fibre 
arrangement which contributes significantly in the efficiency of left ventricular 
ejection, storage and release of potential energy leading to relaxation and left 
ventricular suction in diastole. 
   
The helical myofibre consists of subendocardial and subepicardial fibres orientated in 
an opposing oblique fashion.  The subendocardium is orientated in an ascending 
direction and has been described to adopt a right-handed helix similar to the finger 
orientation of a superimposed human hand.  Conversely, the subepicardium is 
orientated in a descending direction and has been described to adopt a left-handed 
helix (85)(Figure 2.2). 
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Figure 2.2 The opposing helixes of subendocardium and subepicardium 
 
 
 Modified from Sengupta PP et al. (85). 
 
This transition of the helical myofibre from the right-handed helix in the 
subendocardium to the left-handed helix in the subepicardium (86;87) results in a 
significant increase in myocardial thickening and structural rearrangement throughout 
the cardiac cycle (88).  This finding fits the description of myocardial band by Torrent-
Guasp (82;86) and was further elaborated in the study by Buckberg et al. (83) as 
illustrated in Figure 2.3. 
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Figure 2.3 Illustration of left ventricular torsion due to opposing helical 
myocardium 
 
 
Modified from Buckberg GD et al. (83). 
 
Left  
Helix 
Right  
Helix 
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2.2 LEFT VENTRICULAR TORSION MECHANICS 
The helical geometry of the ventricle and the oblique fibre orientation of the 
myocardial fibre in opposing direction results in rotational movement of the ventricle.  
During isovolumic contraction, the electrical activation starts in the subendocardium 
from the apex towards the base leading to the shortening of the subendocardial 
fibres while the subepicardial fibres lengthen, resulting in a biphasic deformation 
between the two muscle layers (87).  The opposing muscle deformation allows 
muscular force adjustment to maintain isovolumic mechanics.  The contraction of the 
subepicardium and all other muscles occurs during systolic ejection, resulting in 
maximum myocardial shortening in the apex compared to the base (89).  The apical-
basal strain gradient allows the mitral annulus to be pulled towards the apex to 
produce the longitudinal mitral annular systolic motion.   
 
In addition, contraction of the subepicardial fibres results in a predominant 
counterclockwise rotation of the left ventricular apex in view of the longer arm and 
hence a bigger lever of the subepicardial fibre.  At the same time, the opposing 
direction of myocardial fibre orientation, results in the clockwise rotation of the left 
ventricular base to produce a wringing motion in aid of systolic ejection and left 
ventricular emptying.  This wringing mechanism of the left ventricle enables potential 
energy to be stored during systole and later released to aid diastolic filling. 
   
In early diastole, the left ventricular pressure starts to decline even before the mitral 
valve opens and this is associated with the change of shape of the ventricle also 
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known as the ellipticalisation of the ventricle (90;91).  Early diastole encompasses 
the period of isovolumic relaxation and pressure decay extending into the period of 
rapid ventricular filling.  The twisted subendocardial and subepicardial fibres behave 
like fully compressed springs which uncoil with the release of stored potential energy 
turning the left ventricle in the opposite direction (92).   
 
Diastolic untwist starts in the subendocardium in the apical-basal direction and in the 
subepicardium in the basal-apical direction.  Subendocardial fibres start to relax 
before the subepicardial fibres and the direction of relaxation is of an opposite 
direction.  This results in a transmural apical-basal gradient of relaxation to produce a 
lower ventricular pressure in the apex compared to the base to facilitate base-to-apex 
diastolic suction (83;93), contributing to rapid early diastolic filling (94;95).   
 
In normal hearts, about 40% of the left ventricular untwisting is completed during the 
isovolumic relaxation period (96).  Further untwisting continues beyond mitral valve 
opening to facilitate additional left ventricular filling.   Notomi et al. demonstrated that 
left ventricular untwist occurs at the beginning of left ventricular relaxation and 
preceded the generation of intraventricular pressure gradient (IVPG) which reflects 
ventricular suction and showed a close correlation between the left ventricular 
untwisting rate with tau, the time constant of left ventricular pressure decay, and 
IVPG (96).  They also found a strong correlation between peak left ventricular twist 
and peak left ventricular untwisting rate, illustrating the inseparable mechanism 
connecting systole to diastole.   
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In another study involving healthy subjects and patients with hypertrophic 
cardiomyopathy, Notomi et al. demonstrated the temporal link between torsion and 
cardiac events at rest and on exercise (97).  In resting normal subjects, left 
ventricular torsion starts soon after mitral valve closure and peak torsion takes place 
just before aortic valve closure.  The left ventricle starts to untwist just before aortic 
valve closure and maximum untwisting occurs after mitral valve opening.  This is 
followed by the generation of peak intraventricular pressure gradient which precedes 
the peak E wave detected on pulse wave Doppler of the mitral inflow.  On exercise, 
the sequence of events is similar, albeit the magnitude of twist and untwisting are 
increased (97) (Figure 2.4).   
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Figure 2.4 Left ventricular torsion at rest and on exercise in normal subjects 
 
 
          
Adapted from Notomi Y et al. (97). 
mc, mitral valve closure; ao,aortic valve opening; ej, left ventricular ejection; ac,aortic valve closure; 
mo, mitral valve opening; Peak IVPG, peak intraventricular pressure gradient; Pk E, peak mitral inflow 
E wave; End E, end of mitral inflow E wave.
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Notomi et al. also showed that longitudinal fibres contract simultaneously during left 
ventricular twisting in systole but peak untwisting precedes peak longitudinal fibre 
relaxation in diastole.  This temporal sequence of events is maintained on 
exercise (97) (Figure 2.5).  
 
61 
 
Figure 2.5 Myocardial velocity of two left ventricular components at rest and 
on exercise in normal subjects 
 
 
          
Adapted from Notomi Y et al. (97). 
Annotations as per Figure 2.4.  
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In addition to the apex-to-base gradient, there is also a transmural subepicardial-
subendocardial gradient (93).  Sengupta et al. has found evidence of delayed 
subepicardial circumferential apex-to-base lengthening which correlated with the 
isovolumic relaxation time and duration required for the left ventricle to reach the 
lowest pressure (93).  They explained that this is due to the late repolarisation of the 
apical subepicardium.  Their study also showed that the subepicardial circumferential 
fibres continued to shorten beyond aortic valve closure and isovolumic relaxation.     
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2.3 MEASUREMENT OF TORSION 
The study of left ventricular torsion had been most challenging until the development 
of sophisticated imaging techniques and analytical software such as cardiac 
magnetic resonance imaging (CMRI) and 2D speckle tracking. 
 
Using an invasive technique, Ingels et al. studied the motion of the heart by 
implanting tantalum wire clippings and found the left ventricular base and apex rotate 
in an opposing direction in systole creating a wringing effect (98).  Such invasive 
studies were limited by the surgical accessibility of the epicardium and results may be 
affected by tissue inflammation, fibrosis and haemorrhage.   
 
Mirro et al. explored the use of 2D echocardiography in the assessment of left 
ventricular torsion (99).  The study was limited as the technique was dependent on 
identifying papillary muscles as landmarks, which were presumed to be relatively 
consistent in position for motion study.  Their technique limited the study of the 
overall left ventricular torsion as they were unable to reliably locate landmarks at the 
left ventricular base and apex to study the opposing rotational motions which result in 
the overall torsion.  It was not until 1990 that cardiac magnetic resonance imaging 
(MRI) was first used to study left ventricular torsion.  Tagging technique was used to 
mark a specific area of the myocardium prior to image acquisition.  This technique 
allowed detailed assessment of the myocardial motion (100).  While the availability 
and accessibility of cardiac MRI with tagging is sparse, the advancement of 2D 
echocardiography continued.  
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In 2002, Garot et al. used tissue Doppler imaging (TDI) to assess left ventricular 
torsion (101).  This method was validated against standard cardiac MRI and was 
found to correlate well.  However, the angular-dependency of TDI limits the study of 
multiplane movement of the left ventricle (102).  The breakthrough came from the 
development and application of speckle tracking imaging (STI) which allowed 
accurate tracking of the left ventricular motion without the limitation of angle-
dependency (103).  The use of STI to assess left ventricular torsion was validated 
against TDI and cardiac MRI tagging by Notomi et al. (104).  With these modern non-
invasive techniques, measurements of myocardial movement can be undertaken 
reliably and results are reproducible.   
 
The ellipsoid shape of the left ventricle has a long axis which is directed from apex to 
base.  The left ventricular rotation, twist and torsion are terms frequently used 
interchangeably in published literature to describe the wringing motion of the left 
ventricle.  The more accurate and concise definition of these terms are outlined as 
below. 
 
The left ventricular rotation is referred to as the two dimensional rotational motion of 
a section of the left ventricular short axis as viewed from the apex.  The base and 
apex of the left ventricle rotate in opposite directions throughout the cardiac cycle.  
During systole, the apex rotates in a counter-clockwise direction while the base 
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rotates in a clockwise direction when viewed from the apex, and vice versa during 
diastole.   
 
Left ventricular twist is the net difference between the rotational angles from apex to 
base along the central long axis, or simply the difference between the opposite 
rotational motions.  Rotation and twist are measured in degrees.   
 
Torsion is the difference in apical rotation and basal rotation with respect to left 
ventricular length and is a measurement of gradient of the rotational angle from the 
base to the apex of the left ventricle along the long axis.  It is also regarded as left 
ventricular twist corrected to left ventricular length and is expressed as degrees per 
centimetre (Figure 2.6). 
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Figure 2.6 Definitions of left ventricular rotation, twist and torsion 
 
 
Adapted from van Dalen BM et al. (105). 
LV, left ventricular. 
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3. HYPOTHESIS  
We hypothesised that there are combined complex abnormalities in both systolic and 
diastolic left ventricular function in HFNEF.  These abnormalities are more apparent 
on exercise and contribute to the generation of exertional symptoms in patients.   
 
We hypothesised that abnormalities in systole, such as impaired long axis function 
and reduced left ventricular twist, lead to impaired diastolic function particularly on 
exercise when left ventricular filling time is shortened.  There is a delay in left 
ventricular untwisting and mitral annular recoil, leading to reduced left ventricular 
suction causing impaired early diastolic filling. 
 
We hypothesised that left atrial function is also impaired, hence the reduced 
compensatory late diastolic filling further contributes to the genesis of symptoms in 
HFNEF. 
 
Furthermore, we hypothesised that there is systolic and diastolic dyssynchrony 
attributed by the lack of cohesive movements of different myocardial planes, 
particularly on exercise, which further impacts on the left ventricular mechanics.  
Impaired mitral annular motion is caused by the uncoupling of longitudinal motion 
and twist during systole and the separation of longitudinal lengthening and untwist in 
diastole. 
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We hypothesised that left ventricular assessment performed on exercise which is 
when patients are symptomatic, is key to elucidate mechanism. 
 
Aim of study: 
 To assess the overall left ventricular systolic and diastolic function at rest and on 
exercise in patients with HFNEF. 
 To assess the role of left ventricular twist and torsion on exercise in patients with 
HFNEF. 
 To assess the coordination of left ventricular twist and longitudinal motion on 
exercise in patients with HFNEF. 
 To assess left ventricular torsional dyssynchrony on exercise in patients with 
HFNEF. 
 To assess left atrial function in patients with HFNEF. 
 To study the overall left ventricular systolic and diastolic function in patients with 
and without symptoms of heart failure. 
 To provide a coherent explanation and schema of the mechanisms involved in the 
genesis of symptoms on exercise in patients with HFNEF and patients with 
hypertension without overt heart failure. 
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4. METHODS 
4.1 PATIENTS 
A total of 90 patients were recruited from the two university hospital heart failure 
specialist clinics (University Hospital of North Staffordshire and University Hospital 
Birmingham).  A full medical history was taken from all patients and a complete 
clinical examination was performed, including 12-lead electrocardiogram (ECG), 
initial screening echocardiogram to rule out significant structural abnormalities, 
pulmonary function test and cardiopulmonary exercise testing.  These patients had: 
 signs or symptoms of heart failure;  
 normal left ventricular ejection fraction and chamber size; 
 objective evidence of exercise limitation on cardiopulmonary exercise testing; and 
 absence of pulmonary disease on pulmonary function test.   
 
All patients had symptoms of heart failure with New York Heart Association (NYHA) 
class II or more and met the criteria of Vasan and Levy for probable diastolic heart 
failure (33). 
 
Thirty had previous coronary angiography which did not find any obstructive coronary 
lesions and there were no ECG changes on cardiopulmonary exercise on reaching a 
respiratory exchange ratio (RER) >1 to suggest ischaemia in any of the study 
subjects. 
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Exclusion criteria were moderate to severe pulmonary disease, significant congenital 
or valvular heart disease, electrical pacemakers or implantable cardiac defibrillators, 
and established history of ischaemic heart disease.  Exclusion criteria specific to 
each study are outlined in each chapter. 
 
Overall, eighteen patients were excluded (seven had evidence of respiratory 
restriction, one had significant coronary artery disease, two were unable to exercise, 
one had normal peak oxygen consumption on cardiopulmonary exercise testing,  two 
failed to increase their heart rate on exercise and five did not have adequate images 
for analysis).  The remaining 72 patients subsequently underwent detailed resting 
and exercise echocardiography studies. 
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4.2 HEALTHY CONTROLS 
A total of 58 healthy subjects with comparable mean age to the patients were 
recruited.  These healthy subjects were volunteers from local general practitioner 
surgeries.  They had no past medical history and were not on any medications.  All 
healthy subjects had a full clinical examination, 12-lead electrocardiogram, initial 
screening echocardiogram when they participated in a community screening 
programme at the surgery, pulmonary function test and cardiopulmonary exercise 
testing.   
 
Overall, three healthy subjects were excluded from the study (one was tachycardic at 
rest due to anxiety, one had reduced peak oxygen consumption on cardiopulmonary 
exercise testing and one had echocardiographic findings fulfilling some of the criteria 
for diagnosing HFNEF).  Seventeen completely asymptomatic volunteers were found 
to have elevated blood pressure which had not been previously diagnosed.  Two of 
these subjects did not have adequate images for analysis therefore were excluded.  
The remaining 15 asymptomatic hypertensive volunteers underwent similar 
investigations and assessments as the healthy controls, and their data was used for 
a substudy (see Chapter 6).   
 
Thirty eight remaining healthy subjects who were found to have no abnormal findings 
in the initial assessment were regarded as age-matched healthy controls and 
underwent detailed resting and exercise echocardiography study.  Data of these 
healthy controls was used as comparison for all the studies in this thesis. 
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All patients and healthy subjects (including the asymptomatic hypertensive 
volunteers) gave written informed consent prior to their participation and the study 
was approved by the National Research Ethics Service (Research Ethics Committee 
reference: 06/Q2706/69). 
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4.3 CARDIOPULMONARY EXERCISE TEST 
The age, height, weight and calculated body mass index (BMI) of all subjects were 
recorded.  Subjects had standard spirometry (forced expiratory volume in one second 
and forced vital capacity) before they underwent incremental treadmill exercise 
testing using a modified Bruce protocol (106;107) with metabolic gas exchange and 
simultaneous heart rate and rhythm, systolic and diastolic blood pressure and oxygen 
saturation by pulse oximetry monitoring.  The exercise testing was performed using a 
Schiller CS-200 Ergo-Spiro exercise machine which was calibrated by a trained 
physiologist prior to every study.  Exercise data was collected continuously and 
expressed as 30-second means and analysed by the physiologist who was blinded to 
the clinical details of each subject.  Peak oxygen consumption (peak VO2) was 
defined as the highest value of oxygen consumption during exercise and expressed 
as ml/min/kg.  A respiratory exchange ratio (RER) of >1 was taken to indicate 
maximal effort (108).   All subjects achieved a RER >1.  The tests were performed 
and results interpreted by two qualified physiologists, blinded to subject groups. 
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4.4 IMAGE ACQUISITION AND ANALYSIS 
4.4.1 TWO-DIMENSIONAL ECHOCARDIOGRAPHY 
All subjects underwent full echocardiography examination using a GE Vingmed Vivid 
Seven scanner (Horton, Norway) at rest and on exercise.  All echocardiographic 
measurements and analyses were done in duplicate by two independent observers 
blinded to each other’s results.   
 
Exercise echocardiography was performed on a semi-recumbent and tilting bicycle 
ergometer (Lode BV, Netherlands).  The position of the subjects on the bicycle 
ergometer was adjusted to enable optimal image acquisition.  All subjects paddled at 
a constant speed of 60 revolutions per minute (rpm) starting at a workload of five 
watts.  The load of the ergometer was increased by five watts every three minutes.  
At the onset of symptoms of breathlessness, patients were advised to continue 
paddling while the load of the ergometer was fixed and image acquisitions made.  
Image acquisition was made when healthy controls reached a maximum heart rate of 
100bpm while paddling (sub-maximal exercise to maximise frame rates).  
 
The heart rate, symptom status, brachial blood pressure and heart rhythm were 
monitored continuously during exercise.  Image acquisition was performed with the 
same pre-determined protocol for all subjects. 
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Two-dimensional (2D) images and colour-coded tissue Doppler images (TDI) from 
the parasternal (long axis and short axis at basal, mid ventricular and apical levels) 
and apex (two, three and four chamber views) were obtained and stored digitally.  
The sector width and depth were optimised to maintain a frame rate of >50 
frames/second for the 2D images which were later used for speckle tracking.  At least 
three sets of images with loops consisting of at least three consecutive cardiac cycles 
each were stored.  Three sets of images with loops consisting of five consecutive 
cardiac cycles each were stored if the patient was in atrial fibrillation.  Cardiac cycles 
before and after ectopic beat were excluded.  Images were analysed offline using a 
customised software package (EchoPac, GE). 
 
Left ventricular (LV) dimensions and wall thickness were measured according to the 
recommendation of the American Society of Echocardiography (109).  LV volume 
and ejection fraction (EF) were measured using the modified biplane Simpson’s 
method from the apical four and two chamber views.  Left ventricular mass was 
calculated according to the Devereux formula (110).  Left atrial (LA) volume was 
calculated using the biplane area-length method from the apical four and two 
chamber views, and was indexed to body surface area to derive the LA volume index 
(LAVI) (52).  The early filling (E) and atrial filling (A) peak velocities, E/A ratio, 
deceleration time (DT) of early filling and isovolumic relaxation time (IVRT) were 
measured from transmitral flow. 
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4.4.2 COLOUR DOPPLER M-MODE PROPAGATION VELOCITY 
Courtois et al showed that the intraventricular pressure gradient generated during 
early left ventricular relaxation contributes to left ventricular suction (111).  Colour 
Doppler M-mode propagation velocity ,Vp, has been shown to relate closely to the 
intraventricular pressure gradient (58) and can be used as an index of left ventricular 
filling due to its relative preload-independence (112). Vp has also been shown to be 
decreased in myocardial ischaemia (113) and  heart failure (114). 
 
There has been no agreement in the method of measuring Vp and each method is 
associated with pitfalls and advantages.  The major limitation is a large variation in 
Vp values with small deviation of slope measurement.  Sessoms et al. compared Vp 
measured by difference methods and found that the measurement of Vp can vary up 
to 250% using different methods (115).  They concluded that the method of Vp 
measurement applied by Garcia et al. (112) had the lowest variability and hence 
more reliable. 
 
The Garcia method of Vp measurement (112) was adopted in the studies in this 
thesis as it produces a more consistent measurement particularly in the analyses of 
exercise images. 
   
Colour M-mode Doppler was obtained by positioning the scan line through the mitral 
valve in the four chamber view using colour flow imaging with the Nyquist limit and 
the colour baseline adjusted to obtain the best spatial resolution.  The colour M-Mode 
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signal was recorded using a narrow sector with minimum depth to include only the 
annulus and 4cm into the ventricular cavity with an aliasing velocity of 0.5-0.7 m/s.  
The colour M-mode profile was recorded at a sweep speed of 100mm/s.  The slope 
of the line along the edge of the colour Doppler flow as it moves from the mitral 
annulus to the ventricular apex in early diastole, was taken as the propagation 
velocity (Vp).  Vp was measured by the slope of the first aliasing isovelocity line 
(along the yellow or blue isovelocity line) in early diastole as described by Garcia et 
al.  (112) (Figure 4.1).  The average of five measurements was taken in view of the 
large variability in numerical value with slight change of the slope even when 
measurements were made on the same image.   
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Figure 4.1 Measurement of mitral flow propagation velocity 
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4.4.3 TISSUE DOPPLER IMAGING 
Tissue Doppler imaging (TDI) provides excellent temporal resolution and enables 
measurement of instantaneous quantitative information on myocardial velocity along 
an image line.  Pulse wave TDI provides Doppler frequency at a given time whereby 
the peak of each frequency is linearly related to tissue velocity therefore representing 
the tissue velocity at the given time and position.  This enables accurate timing and 
velocity measurements.   
 
On the other hand, colour TDI provides the mean Doppler frequency estimated from 
several Doppler frequencies per time unit, with each pixel colour coded according to 
its velocity.  The added advantage of colour TDI is that it allows analysis of tissue 
velocity from various regions at a given time.  Displacement is the integration of 
velocity over time.  Strain describes the deformation or the change in length of an 
object from one state to another and is commonly expressed as a percentage.  Strain 
rate is the rate of deformation and is derived from the differentiation of strain with 
time, expressed sec-1.   
 
The derivatives of tissue velocity provide information on tissue displacement, strain 
and strain rate which are incorporated into most of the commercially available 
analysis software, such as Echopac by GE, and are calculated automatically.  The 
main limitation of TDI is its angle dependency but it has the advantage of feasibility, 
high reproducibility and is relatively pre-load independent.   
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The peak mitral annular myocardial velocity of all the four walls of the left ventricle 
(septal, lateral, inferior and anterior) was recorded with real time pulse wave tissue 
Doppler method as previously described (116).  At least three consecutive beats of 
Doppler tissue images of each ventricular wall were stored digitally.  The sample 
volume and gain were optimised and the Nyquist limit was set to 15-20 cm/s.  The 
peak systolic (S’), early diastolic (e’) and late diastolic (A’) velocities were measured 
(Figure 4.2) and E/e’, an index of left ventricular filling pressure, was calculated (50).   
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Figure 4.2 Measurement of mitral annular myocardial velocities using pulse 
wave Doppler 
 
 
Example of measurement of mitral annular velocities of left ventricular septal wall 
using pulse wave Doppler.  
S’, peak systolic myocardial mitral annular velocity; e’, early diastolic myocardial mitral annular 
velocity; A’, late diastolic myocardial mitral annular velocity. 
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Colour coded tissue Doppler images were also acquired over three consecutive 
cardiac cycles for each of the four myocardial walls and analysed offline as 
previously described (47;48).  Mean systolic (Sm), early diastolic (Em) and late 
diastolic (Am) velocities were measured by placing a 4×4 mm region of interest in the 
midmyocardial area of each wall (Figure 4.3).  Measurements were performed 
manually by post-processing of data using Echopac software.  All data was 
transferred to spreadsheets for further calculations and analyses.   
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Figure 4.3 Measurement of mitral annular myocardial velocities using colour 
tissue Doppler 
 
 
 
Example of measurement of mitral annular velocities of left ventricular septal wall 
using colour coded tissue Doppler.  
Sm, systolic myocardial mitral annular velocity; Em, early diastolic myocardial mitral annular velocity; 
Am, late diastolic myocardial mitral annular velocity; AVO, aortic valve opening; AVC, aortic valve 
closure; MVO, mitral valve opening; MVC, mitral valve closure. 
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4.4.4 SPECKLE TRACKING 
The use of speckle tracking imaging (STI) overcomes the issue of angle dependency 
in TDI.  The fundamental principle of STI is based on the spatial distribution of 
characteristic myocardial tissue acoustic assumed to be unique for each myocardial 
segment, known as speckle pattern, attributed by the constructive and destructive 
interference of radiofrequency reflections from the myocardium.  Tracking of the 
speckle pattern throughout the cardiac cycle allows one to follow the movement of 
the myocardium (117).  Two-dimensional deformation can be measured with each 
plane of image as illustrated in Figure 4.4. 
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Figure 4.4 Two-dimensional left ventricular deformation 
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2D images of the apical long axis views (apical four chamber and two chamber) and 
parasternal short axis views at three levels (base, papillary and apex) were obtained 
at a frame rate of >60 Hz.  Left ventricular longitudinal strain, radial strain, 
circumferential strain and rotation were assessed using the speckle tracking method 
using offline analysis of the long and short axis images as illustrated in Figure 4.4, by 
tracing the endocardium on end-diastolic frame and the thickness of the region of 
interest adjusted to include the entire myocardium.  Each R-R internal was taken as a 
cardiac cycle and was used to correct for differences in heart rate (Figures 4.5 
and 4.6).  
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Figure 4.5 Example of longitudinal strain analysis by speckle tracking 
 
 
Colour of each longitudinal strain curve corresponds to each colour-coded 
myocardial segment.  White curve represents average longitudinal strain of the six 
segments. 
AVC, aortic valve closure. 
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Figure 4.6 Example of rotation analysis by speckle tracking 
 
 
Colour of each rotation curve corresponds to each colour-coded myocardial segment.  
White curve represents average rotation of the six segments. 
AVC, aortic valve closure. 
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In this study, the thickness of the region of interest (ROI) was adjusted so that the 
tracking border traces the endocardium and the outer border of the region of interest 
traces the inner edge of the epicardium.  This is particularly crucial when applying 
speckle tracking in the short axis views for the analysis of left ventricular rotation, 
radial and circumflex strain. 
 
The setting of the ROI affects the magnitude of these results significantly.  If the ROI 
extends beyond the epicardium, the magnitude of measurement is significantly lower. 
Conversely, if the ROI is set too small the magnitude of measurement is significantly 
higher as illustrated in Figure 4.7.  Once the ROI is set, the EchoPac software 
automatically tracks the myocardial motion on the subsequent frame and results are 
displayed graphically.  
 
In view of the significant difference in measurement, particularly when analysing 
short axis images, the observers agreed to select the thickness of the region of 
interest described above in all speckle tracking analyses.   
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Figure 4.7 Region of interest selection using speckle tracking analysis 
 
 
 
Annotations as per Figure 4.6. 
a 
b 
c 
Maximum thickness 
of region of interest 
resulting in radial 
strain < 41%  
Moderate thickness 
of region of interest 
resulting in radial 
strain = 41% 
Minimum thickness 
of region of interest 
resulting in radial 
strain > 41%  
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Rotation and strain in the radial, longitudinal and circumferential planes were 
measured as previously described (103;104;118).  The thickness of the region of 
interest was adjusted as detailed above.  Three sets of strain values for each 
segment (six segments from both apical long axis views and six segments from each 
short axis views at three levels) were measured manually and recorded.  The 
average longitudinal, radial and circumferential strain was manually calculated from 
the three data sets.  The global longitudinal, radial and circumferential strain data 
automatically generated by the Echopac software was also recorded.   
 
Takeuchi et al. defined left ventricular untwist as a percentage of systolic twist and 
normalised untwist rate with isovolumic relaxation time (119).  This only assesses 
early untwist mechanism albeit this is the significant proportion of the entire event.  In 
this thesis, the left ventricular untwisting and untwisting rate were assessed by using 
data from speckle tracking.  The degree of untwisting was taken as the reverse 
direction of twist in diastole.  The time of peak twist and peak untwist were recorded 
and the duration between the two events was noted as the total duration of 
untwisting.  The total duration of untwist was taken as 100%.  Early untwist was 
taken as the magnitude of untwist at 25% of the total untwisting duration.  The left 
ventricular untwisting at 50% (mid untwisting) and 75% (late untwisting) of the total 
duration of untwisting were also calculated (Figure 4.8).    
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Figure 4.8 Measurement of left ventricular untwist 
 
 
Annotations as per Figure 4.6. 
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4.5 STATISTICAL METHODS 
SPSS version 16 software (SPSS Inc,Chicago, Illinois, USA) was used for statistical 
analyses.  The following methods were applied to examine data in all chapters.  
Additional statistical analyses specific to individual studies are outlined in each 
chapter. 
  
Power analysis was performed for the first study in this thesis (Chapter 5).  Sample 
size was estimated using pilot data.  For systolic longitudinal function with anticipated 
difference in mean of 1.5 and standard deviation (SD) of 2, the achieved sample 
sizes of 56 patients and 27 controls provide 89% power for an unpaired t-test with 
α=0.05 (two tail).  For rotation an anticipated difference in mean of 3 degrees and SD 
of 4, the achieved sample sizes of 56 patients and 27 controls provide 89% power for 
an unpaired t-test with α=0.05 (two tail). 
 
Continuous variables were expressed as mean ± standard deviation (SD).    Fisher’s 
exact test was conducted for nominal variables.  Normality was assessed by 
visualising P-P plot and Q-Q plots.   
 
Comparisons of normally distributed data between HFNEF patients and controls 
were performed using an unpaired t-test and Mann-Whitney U test was used for non-
normally distributed data.  Comparisons of rest and exercise data for HFNEF patients 
and controls were performed using a paired t-test.  The paired and unpaired t-tests 
were applied in all chapters except Chapter 6. 
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The Pearson correlation coefficient, r, was used to examine the association and the 
strength of the relationship between variables.  Scatterplots were generated and 
linear regressions were performed to assess the relationship between two continuous 
variables. 
 
Inter-observer and intra-observer agreements were performed using readings of 10 
randomly selected subjects and calculated using alpha model reliability analysis and 
reported as interclass correlation coefficient (ICC) with 95% confidence interval (CI).  
 
A p value of <0.05 was considered statistically significant.   
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CHAPTER 5 
SYSTOLIC AND DIASTOLIC 
DYSFUNCTION ON EXERCISE 
 
 
 
 
 
Contributory publication: 
Tan YT, Wenzelburger F, Lee E, Heatlie G, Leyva F, Patel K, Frenneaux M, 
Sanderson JE.  The pathophysiology of heart failure with normal ejection fraction: 
exercise echocardiography reveals complex abnormalities of both systolic and 
diastolic ventricular function involving torsion, untwist and longitudinal motion.  J Am 
Coll Cardiol 2009;54(1):36-46. 
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5. SYSTOLIC AND DIASTOLIC DYSFUNCTION ON 
EXERCISE 
5.1 SUMMARY 
This study was to test the hypothesis that in HFNEF, exercise limitation is due to 
combined systolic and diastolic abnormalities particularly involving ventricular twist 
and deformation leading to reduced left ventricular suction, delayed untwisting and 
impaired early diastolic filling. 
 
Fifty six patients and 27 age-matched healthy controls had rest and exercise images 
of sufficient quality for analysis.  At rest, systolic longitudinal and radial strain, systolic 
mitral annular velocities and apical rotation were lower in patients and all failed to rise 
normally on exercise.  Systolic longitudinal functional reserve was also significantly 
lower in patients .  In diastole, patients had reduced and delayed untwisting, reduced 
left ventricular suction at rest and on exercise, and higher end-diastolic pressures.  
Mean mitral annular systolic and diastolic velocities, systolic left ventricular rotation 
and early diastolic untwist on exercise all correlated with peak VO2. 
  
This study concluded that in HFNEF, there are widespread abnormalities of both 
systolic and diastolic function which become more apparent on exercise and hence 
HFNEF is not an isolated disorder of diastole. 
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5.2 INTRODUCTION 
Some studies suggested that systolic function is normal in HFNEF(4;5).  This study 
was to test the hypotheses that systolic function is not normal in HFNEF and that 
complex abnormalities in systolic and diastolic left ventricular function are more 
apparent on exercise and contribute to the generation of exertional symptoms in 
HFNEF patients.  These abnormalities include impaired long axis function and 
reduced left ventricular twist in systole, leading to delayed left ventricular untwist and 
mitral annular recoil, reduced left ventricular suction and impaired early diastolic 
filling.  
 
New developments in echocardiography particularly speckle-tracking imaging enable 
a much fuller assessment of left ventricular systolic and diastolic functions including 
the measurement of myocardial deformation or strain in three planes, ventricular twist 
and untwist, and left ventricular suction which is a vital mechanism in early diastolic 
ventricular filling.  As outlined earlier in Chapter 4, these advanced echocardiography 
techniques were applied to assess global and regional left ventricular function at rest 
and more importantly on exercise.  This study forms the major part of this thesis. 
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5.3 METHODS 
Patients and age-matched controls were recruited as described in Chapter 4.  All 
patients had symptoms of heart failure with New York Heart Association (NYHA) 
class II or more and met the criteria of Vasan and Levy for probable diastolic heart 
failure (33).   
   
All study subjects underwent cardiopulmonary exercise testing and full 
echocardiography at rest and on semi-recumbent exercise on a tilting bicycle 
ergometer as described in Chapter 4.  
  
Two-dimensional echocardiography, tissue Doppler and speckle tracking imaging 
and analyses were performed as described in Chapter 4. 
 
In addition, derived parameters for assessing systolic and diastolic function were 
calculated.  Stroke volume was calculated using the aortic valve pulse wave Doppler 
method, whereby the velocity time integral of aortic annular flow was obtained by 
tracing the pulsed Doppler profile and multiplied by the area of the aortic annulus as 
previously described (120).  Preload recruitable stroke work index, peak power index, 
single beat estimated end-systolic elastance, arterial elastance (121;122), chamber 
stiffness (123), pressure volume ratio (124) and longitudinal reserve indices (125) 
were calculated. 
 
 
101 
 
Calculation of derived parameters: 
Stroke work index   =  mean blood pressure (BP) * stroke volume (SV) /  
   end diastolic volume (EDV) 
Mean blood pressure (BP) =  BP diastole + 1/3 (BP systole-BP diastole) 
Cardiac output (CO)  =  heart rate (HR) * stroke volume (SV) 
Arterial elastance (Ea)  =  0.9 * BP systole / stroke volume 
End systolic elastance (Ees) =  0.9 * BP systole / end systolic volume (ESV) 
Peak power index (PPI) =  peak ejection rate (LVOT peak velocity) *  
BP systole / EDV 
Pressure / volume ratio  =  (E/e’) / EDV 
Chamber stiffness (K)  =  70 / (DT-20)2 
Systolic longitudinal function reserve index  =  Δ S’ * [ 1 - (1/S’rest) ] 
Diastolic longitudinal function reserve index  =  Δ E’ * [ 1 - (1/E’rest) ] 
 
 
LVOT, left ventricular outflow tract; DT, deceleration time. 
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5.4 STATISTICS  
Statistical analyses were performed as described in Chapter 4. 
 
Comparisons between HFNEF patients and controls were performed using an 
unpaired t-test for normally distributed data and the Mann-Whitney U-test for non-
normally distributed data.  Comparisons within HFNEF patients and controls were 
performed using a paired t-test only as all data was normally distributed.  Linear 
regression was performed to test correlations. 
 
Inter-observer and intra-observer agreements were performed using readings of 10 
randomly selected subjects.  Variability of tissue Doppler analysis, speckle tracking 
analysis and mitral flow propagation velocity were assessed at rest and on exercise. 
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5.5 RESULTS 
In this study, a total of 121 subjects (74 patients and 47 controls) were recruited.  
Eighteen patients were excluded (seven were found to have respiratory limitation on 
cardiopulmonary exercise test and did not achieve a respiratory exchange ratio of >1, 
six were unable to exercise and had poor picture quality for analysis, two had no 
increase in heart rate on exercise, one was found to have evidence of ischaemia on 
cardiopulmonary exercise test, one had normal peak VO2 on cardiopulmonary 
exercise testing, and one had entirely normal echocardiography).  Only 27 
completely healthy controls without past medical history and on no medications were 
included.  Twenty subjects were excluded (seventeen of the control subjects had 
evidence of hypertension at rest which was not previously diagnosed, one had a 
reduced peak VO2 on cardiopulmonary exercise test, one had echocardiographic 
findings which fulfilled the criteria for HFNEF although completely asymptomatic, and 
one had sinus tachycardia at rest due to anxiety). 
 
The mean age of the patients was 72 ± 7 years and 70% were female.  Control 
subjects were of comparable age (70 ± 7 years, p= not significant) and also 70% 
were female.  The past medical history and drug history of patients are summarised 
in Table 5.1.  All patients were on treatment and had symptoms of heart failure with 
New York Heart Association (NYHA) class II or III.  Patients had a significantly higher 
body mass index (BMI) compared to controls but peak VO2, which was indexed to 
BMI and age, was significantly lower in patients compared to controls (Table 5.1).  
The left ventricular ejection fraction and left ventricular dimensions were comparable 
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between patients and controls.  Left atrial volume index (LAVI), mitral inflow E and A 
waves, and E/e’ were significantly higher in patients (Table 5.2). 
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Table 5.1   Clinical characteristics – left ventricular function study     
                                                                                                                                                                                      Patients Controls p-value
Number of subjects 56 27  
Age  72±7 70±7 0.195 
Gender 39♀ / 17♂ 19♀ / 8♂  0.579 * 
BMI  30±5 24±4 <0.001 
NYHA  class II = 41 
class III = 15 
n/a  
NT-proBNP (pg/ml) 131±153 46±23.4  
Peak VO2 (ml/min/kg) 
(percent of predicted)  
17.9±4.0 
(78±16%) 
30.9±.4.3 
(135±18%) 
<0.001 
Hypertension 45/56 (80%) 0 (0%)  
Years of hypertension  8.3±10.0 0 <0.001 ‡ 
Diabetes mellitus 12 (21%) 0 (0%)  
Atrial fibrillation 3 (5%) 0 (0%)  
Coronary artery disease 6 (11%) 0 (0%)  
ACE-inhibitor 18 (32%) 0 (0%)  
AR1-blocker 16 (29%) 0 (0%)  
α-blocker 11 (20%) 0 (0%)  
β-blocker 20 (36%) 0 (0%)  
Calcium-channel-blocker 13 (23%) 0 (0%)  
Diuretic 28 (50%) 0 (0%)  
Statin 19 (34%) 0 (0%)  
 
Data is presented as number (and %) or mean ± standard deviation. 
p-value: unpaired t-test between patients and controls except * Fisher exact test between patients and 
controls and ‡ Mann-Whitney U test between patients and controls. 
BMI, body mass index; NYHA, New York Heart Association classification for heart failure; Peak VO2, 
peak oxygen consumption; ACE, angiotension-converting enzyme; AR1, angiotensin 1 receptor; NT-
proBNP,N-terminal pro B-type natriuretic peptide. 
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Table 5.2  Standard echocardiographic parameters – left ventricular function 
study     
                                                                                                                                                                                      Patients Controls p-value 
LVEDD (cm) 4.7±0.7 4.6±0.5 0.275 
Biplane LVEF (%) 61±6 62±8 0.306 
FS (%) 40±10 39±7 0.558 
IVSd (cm) 1.1±0.3 1.0±0.2 0.092 
LVMI (g/m2) 96±34 82±22 0.081 
LAVI (ml/m2) 32±11 24±9 0.002 
E-Wave (cm/s) 0.69±0.19 0.57±0.11 0.003 
A-Wave (cm/s) 0.85±0.19 0.70±0.14 0.001 
E/A 0.83±0.26 0.84±0.19 0.877 
DT (ms) 250±58 258±46 0.515 
IVRT (ms) 96±27 100±22 0.569 
E/e’ 11.4±4.3 8.2±2.0 0.001 
 
Data is presented as mean ± standard deviation. 
p-value: unpaired t-test between patients and controls. 
 
LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; FS, fractional 
shortening; IVSd, diastolic interventricular septal thickness; LVMI, left ventricular mass index; LAVI, 
left atrial volume index; E,early diastolic mitral inflow velocity; A late diastolic mitral inflow velocity; E/A 
ratio of E to A; DT, deceleration time; IVRT, isovolumic relaxation time; e’ peak early diastolic 
myocardial mitral annular velocity; E/ e’; ratio of E to e’. 
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5.5.1 HAEMODYNAMIC CHANGES 
The resting and exercise heart rate and blood pressure were comparable between 
patients and controls (Table 5.3).  The increase in aortic outflow velocity time integral 
(VTI), peak left ventricular outflow track (LVOT) velocity, stroke volume and cardiac 
output on exercise were significantly higher in controls.  Even though controls had a 
slightly lower initial aortic outflow VTI, stroke volume and cardiac output, they were 
able to achieve a significant increase on exercise compared to patients (Table 5.3). 
 
 
108 
 
Table 5.3 Haemodynamic measurements at rest and on exercise – left 
ventricular function study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls 
p-value 
(unpaired 
t-test) 
BP systolic 
(mmHg) 
 
146±16 168±18 <0.001 140±15 163±15 <0.001  0.114 * 
 0.298 # 
BP diastolic 
(mmHg) 
 
75±10 86±13 <0.001 78±8 87±9 <0.001  0.166 * 
 0.687 # 
Heart rate 
(beats per 
minute) 
69±11 89±10 <0.001 67±9 92±5 <0.001  0.484 * 
 0.157 # 
VTI (cm) 
 
 
21.5±4.8 22.8±5.3 0.066 19.3±3.9 23.3±3.4 <0.001  0.045 * 
 0.743 # 
Δ VTI (cm) 
 
 
 1.3±4.2   4.3±1.9   0.003 # 
Stroke 
volume (ml) 
 
73±20 74±23 0.239 62±13 79±20 0.004  0.015 * 
 0.364 # 
Δ Stroke 
volume (ml) 
 
 4±24   18±24   0.039 #  
Cardiac 
output 
(l/min) 
4.8±1.5 6.4±2.0 <0.001 4.2±0.9 7.4±2.0 <0.001  0.059 * 
 0.097 # 
Δ Cardiac 
output 
(l/min) 
 1.6±2.2   3.1±2.4   0.027 # 
Peak LVOT 
velocity 
(m/s) 
1.1±0.2 1.2±0.3 0.004 1.0±0.2 1.2±0.1 <0.001  0.044 * 
 0.682 # 
Δ Peak 
LVOT 
velocity 
(m/s) 
 0.1±.2   0.2±0.1   0.007 # 
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
BP, blood pressure; VTI, velocity time integral; LVOT, left ventricular outflow tract. 
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5.5.2 LONGITUDINAL FUNCTION - TISSUE DOPPLER 
The mitral annular velocities in systole (S’), early diastole (e’) and late diastole (A’) at 
rest were significantly lower in patients compared to controls.  There was a significant 
increase in S’ and e’ in patients on exercise, but the differences in S’ and e’ between 
patients and controls became highly significant on exercise(Table 5.4).  This reflected 
a reduction in left ventricular reserve which was then calculated using the changes in  
S’ and e’ from rest to exercise to determine the systolic and diastolic longitudinal 
function reserve indexes respectively.  HFNEF patients had a significantly lower 
systolic (0.64 ± 0.51 versus 1.54 ± 0.51, p<0.001) and diastolic (1.49 ± 0.77 versus  
2.32 ± 1.24, p=0.011) longitudinal reserve compared to controls (Table 5.4) 
(Figure 5.1).  
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Table 5.4 Rest and exercise results of tissue Doppler imaging – left 
ventricular function study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls 
p-value 
(unpaired 
t-test) 
S’ (cm/s) 
 
 
5.1±1.0 6.0±1.0 <0.001 5.7±0.9 7.7±1.0 0.001  0.025 * 
 0.001 # 
e’(cm/s) 
 
 
4.4±1.2 6.4±1.5 <0.001 5.4±1.1 8.3±1.2 <0.001  0.004 * 
 0.001 # 
A’(cm/s) 
 
 
6.8±1.5 8.7±1.6 <0.001 7.8±1.4 9.7±1.7 <0.001  0.012 * 
 0.063 # 
E/e’ 
 
 
11.4±4.3 11.4±4.5 0.298 8.2±2.0 8.8±1.8 0.384  0.001 * 
 0.009 # 
Systolic 
reserve 
index 
 
 0.6±0.5   1.5±0.7   <0.001 # 
Diastolic 
reserve 
index 
 
 1.5±0.8   2.3±1.2   0.011 # 
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test):* t-test between patients and controls at rest and  
 # t-test between patients and controls on exercise. 
S’, peak systolic myocardial mitral annular velocity; e’, peak early diastolic myocardial mitral annular 
velocity; A’ peak late diastolic myocardial mitral annular velocity; E/e’ ratio of E to e’. 
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Figure 5.1 Illustration of systolic and diastolic longitudinal function reserve   
                  
 
a. TDI  of patient at rest; b. TDI of patient on exercise; c. TDI of control at rest; d. TDI 
of control on exercise.   
This example illustrates that both patient and control had appropriate increase in 
heart rate on exercise.  There was a significant increase in systolic and diastolic 
mitral annular velocity on exercise in the control subject which was not seen in the 
patient.  Hence, this patient showed a lack of systolic and diastolic longitudinal 
function reserve.   
Δ, change in (delta); S’, peak systolic myocardial mitral annular velocity; e’, peak early diastolic 
myocardial mitral annular velocity; SLFRI, systolic longitudinal function reserve index; DLFRI, diastolic 
longitudinal function reserve index. 
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5.5.3 LONGITUDINAL FUNCTION - SPECKLE TRACKING 
Using 2D speckle tracking technique, longitudinal strain at rest and on exercise was 
assessed using the apical four chamber and apical two chamber images.  
Longitudinal strain of 12 segments were studied (apical, mid and basal segments of 
the septal, lateral, inferior and anterior walls).  Patients had significantly lower 
longitudinal strain at rest regardless of the left ventricular wall used for assessment.  
Calculation of the average longitudinal strain using six segments of the septal and 
lateral walls (apical four chamber view), or the average from the six segments of the 
inferior and the anterior walls (apical two chamber view), or the average of all 12 
segments of all four walls (taken as global strain) yielded similar results.  This 
indicated a reduction in global longitudinal function in patients (Table 5.5).  Even 
though patients had a significant increase in longitudinal strain on exercise, the 
magnitude of longitudinal strain on exercise only approximated to the magnitude of 
longitudinal strain in controls at rest.  The longitudinal strain on exercise was 
significantly lower in patients compared to controls (Table 5.5). 
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Table 5.5 Longitudinal strain – left ventricular function study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls 
p-value 
(unpaired 
t-test) 
Long strain 
SepLat (%) 
 
-19.4±3.8 -20.4±4.2 0.082 -21.5±3.0 -24.4±2.6 <0.001  0.018 * 
 <0.001 # 
Δ Long 
strain 
SepLat (%) 
 
 -1.2±3.9   -3.1±2.8   0.051  
Long strain 
InfAnt (%) 
 
-18.4±3.8 -20.1±4.5 0.012 -20.4±3.7 -23.2±3.2 0.004  0.042 * 
 0.008 # 
Δ Long 
strain 
InfAnt (%)  
 
 -2.1±4.2   2.8±3.9   0.592  
Global long 
strain (%) 
 
-18.9±3.5 -20.1±4.1 0.005 -20.9±3.0 -23.8±2.5 <0.001  0.018 * 
 <0.001 # 
Δ Global 
long strain 
(%) 
 
 -1.9±3.3   -2.8±2.7   0.315  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
SepLat, septal and lateral walls; InfAnt, inferior and anterior walls; Δ, change in (delta). 
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5.5.4 RADIAL FUNCTION – SPECKLE TRACKING 
Radial strain was assessed by speckle tracking of the mid-ventricular short axis view.  
This was also significantly reduced in patients at rest, more so on exercise compared 
to healthy controls (Table 5.6).  Interestingly, similar to the findings in longitudinal 
strain, there was a significant increase in radial strain on exercise in patients but the 
mean radial strain on exercise in patients only equated to the resting radial strain in 
controls. 
 
Table 5.6 Radial strain – left ventricular function study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls 
p-value 
(unpaired 
t-test) 
Radial 
strain (%) 
 
41.8±13.5 49.1±15.4 0.020 49.2±12.9 61.9±12.8 0.001  0.030 * 
 0.002 # 
Δ Radial 
strain (%) 
 
 6.6±15.6   12.4±12.3   0.154  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
Δ, change in (delta). 
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5.5.5 LEFT VENTRICULAR ROTATION AND UNTWIST 
As discussed in Chapter 2, left ventricular torsion plays an important role in the 
overall left ventricular function.  In this study, rotation and untwisting of the left 
ventricle were studied by speckle tracking of the apical short axis images (full study 
of left ventricular torsion is discussed in the Chapter 7).  This study showed that the 
ability of the left ventricle to rotate in systole and untwist in diastole was significantly 
less in patients compared to controls both at rest and on exercise.  As described in 
Chapter 4, the left ventricular untwisting was taken as the magnitude of untwist at 
25%, 50% and 75% of the total untwisting duration to represent early, mid and late 
diastolic untwisting of the left ventricle (Figure 4.8).  The percentages of left 
ventricular untwist in early diastole (25% of untwist duration) and late diastole (75% 
of untwist duration) at rest were found to be significantly lower in patients compared 
to controls.  However, on exercise, the percentages of untwist in early and mid 
diastole (50% untwist duration) were significantly lower in patients, and the 
percentage of untwist in late diastole showed a trend to being significant.  The 
Echopac software generated speckle tracking result of left ventricular untwist rate 
was not significantly different at rest but became significantly different on exercise 
with controls having a significantly higher untwist rate compared to patients 
(Table 5.7) (Figure 5.2). 
 
Similar to the findings for longitudinal and radial strain, the magnitude of apical 
rotation, untwist rate and percentage of untwist in late diastole on exercise in patients 
increased only to a level comparable to controls at rest.  However, the percentage of 
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early untwist, which is the more crucial portion of the untwisting mechanics, is 
significantly lower in patients on exercise compared to the resting result of the 
controls.  Similar finding was seen for mid-diastolic untwisting (Table 5.7). 
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Table 5.7 Left ventricular rotation and untwist – left ventricular function 
study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls 
p-value 
(unpaired 
t-test) 
Apical 
Rotation 
( º ) 
10.4±4.0 13.5±4.7 0.008 13.0±2.8 17.7±3.6 0.003  0.015 * 
 0.005 # 
Δ Apical 
Rotation  
( º ) 
 3.0±4.9   4.9±4.1   0.216  
Untwist rate 
(º/s) 
 
-80±34 -105±32 <0.001 -96±30 -129±32 0.007  0.069 * 
 0.013 # 
Δ Untwist 
rate (º/s) 
 
 -33±35   -29±39   0.722  
25% 
Untwist 
 
23.7±9.3 21.2±8.5 0.465 30.9±9.7 29.2±7.7 0.477  0.006 * 
 0.002 # 
Δ 25% 
Untwist 
 
 -2.0±13.1   -2.4±14.1   0.922  
50% 
Untwist  
 
53.9±12.6 50.5±12.3 0.371 58.8±8.4 61.7±8.2 0.384  0.101 * 
 0.001 # 
Δ 50% 
Untwist  
 
 -3.3±17.7   3.0±14.2   0.223  
75% 
Untwist  
 
77.3±6.4 80.3±9.8 0.477 81.8±7.1 85.0±4.7 0.126  0.016 * 
 0.057 # 
Δ 75% 
Untwist  
 
 1.8±12.1   3.3±8.7   0.652  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
25% (50%, 75%) Untwist, percentage untwist at 25% (50%, 75%) of total untwist duration; Δ, change 
in (delta). 
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Figure 5.2 Illustration of left ventricular rotation and untwist in patient with 
HFNEF and control 
 
       
This example illustrates the significantly lower magnitude of systolic rotation and 
early diastolic untwist in patient compared to control.  The duration of untwist in 
patient with HFNEF is significantly longer despite a lower peak rotation.  
 
AVC, aortic valve closure; UT,untwist. 
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5.5.6 MITRAL FLOW PROPAGATION VELOCITY  
Mitral flow propagation velocity (Vp) was used as an approximation to the 
intraventricular pressure gradient, reflecting ventricular suction.  Vp was comparable 
between the two groups at rest but became significantly different on exercise with the 
controls having a higher increase in Vp on exercise compared to patients.  Patients 
had a significant increase in Vp on exercise, but the magnitude of the increase was 
significantly less than controls (Table 5.8) (Figures 5.3 and 5.4).  Vp on exercise 
correlated with S’ on exercise (r=0.47, p=0.005) suggesting a mechanistic link 
between systole and diastolic suction.  
 
Table 5.8 Mitral flow propagation velocity 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls 
p-value 
(unpaired 
t-test) 
Vp (m/s) 
 
 
40±10 49±11 <0.001 39±7 61±14 <0.001  0.516 * 
 <0.001 # 
ΔVp  (m/s) 
 
 
 11±13   22±14   0.001  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
Vp, mitral flow propagation velocity; Δ, change in (delta). 
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Figure 5.3 Illustration of mitral flow propagation velocity at rest and on 
exercise in patient with HFNEF and control 
 
 
 
This example illustrates that there was only a 17% increase in mitral flow propagation 
velocity in the patient with HFNEF despite a similar increase in heart rate on 
exercise, compared to the control who achieved a 74% increase in mitral flow 
propagation velocity on exercise.  
Av Vp, average mitral flow propagation velocity; HR, heart rate. 
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Figure 5.4 Boxplot of mitral flow propagation velocity at rest and on exercise 
 
Boxplot shows minimum, first quartile, median, third quartile and maximum. 
Vp, mitral flow propagation velocity; p, probability; n.s., not significant. 
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5.5.7 CORRELATIONS BETWEEN PEAK VO2 ON EXERCISE AND 
ECHOCARDIOGRAPHIC PARAMETERS 
The aim of this study was to relate the symptoms of patients to echocardiographic 
findings.  All patients were breathless at the time of image acquisition during exercise 
echocardiography on the ergometer.  This study found significant correlation of left 
ventricular systolic and diastolic parameters on exercise with peak VO2.  Peak VO2 
correlated with the following echocardiographic parameters on exercise: Sm (r=0.61, 
p=0.003), Em (r=0.417, p=0.038), apical rotation (r=0.44,p=0.026), E/e’ (r=-0.34, 
p=0.04), Vp (r=0.35, p=0.03) and early diastolic (25%) untwisting (r=0.53, p=0.007).  
There were no significant correlations of echocardiographical parameters at rest with 
peak VO2. 
 
5.5.8 DERIVED MEASUREMENTS 
There was no significant difference in arterial elastance or end-systolic elastance (a 
measure of systolic function and end-systolic stiffness) at rest.  However, there was 
an increase, although not statistically significant, in arterial elastance in patients on 
exercise while controls had a reduced arterial elastance on exercise, resulting in a 
significant difference in the change in arterial elastance on exercise (Table 5.9).  
Stroke work index was similar between patients and controls at rest and on exercise, 
rising in both groups to the same degree.  Estimated ‘chamber stiffness’ was also 
comparable in both groups.   
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Table 5.9 Derived measurements 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls 
p-value 
(unpaired 
t-test) 
Pressure / 
Volume 
(1/ml) 
0.17±0.80 0.17±0.70 0.135 0.13±0.50 0.14±0.44 0.543  0.035 * 
 0.039 # 
Δ P / V  
(1/ml) 
 
 0.01±0.05   0.01±0.06   0.744  
Arterial 
elastance 
(mmHg/ml)  
2.0±0.7 2.2±0.9 0.083 2.1±0.5 1.9±0.4 0.227  0.403 * 
 0.145 # 
Δ Ea 
(mmHg/ml) 
 
 0.2±0.7   -0.2±0.7   0.044  
Chamber 
stiffness (K) 
(mmHg/ml) 
1.6±0.7 3.4±1.6 <0.001 1.4±0.6 3.8±1.4 <0.001  0.200 * 
 0.380 # 
Δ Κ 
(mmHg/ml) 
 
 1.9±1.7   2.4±1.7   0.249  
Power peak 
index 
(mmHg/s)  
2.2±0.7 3.1±1.1 <0.001 2.2±0.7 3.1±0.8 <0.001  0.793 * 
 0.947 # 
Δ PPI 
(mmHg/s) 
 
 1.0±1.0   0.9±0.8   0.702  
End-
systolic 
elastance 
(mmHg/ml) 
4.9±1.9 7.4±2.7 <0.001 5.6±2.2 6.9±1.7 <0.001  0.206 * 
 0.461 # 
Δ Ees 
(mmHg/ml) 
 
 2.5±2.6   1.4±2.3   0.138  
Stroke work 
index 
(mmHg) 
94±26 132±49 0.001 101±36 140±46 0.02  0.405 * 
 0.579 # 
 Δ SWI 
(mmHg) 
 
 39.4±52.9   36.6±56.2   0.872  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
 
P / V, pressure volume ratio; Ea, arterial elastance; K, chamber stiffness; PPI, peak power index; Ees, 
end-systolic elastance; SWI, stroke work index; Δ, change in (delta). 
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5.5.9 INTER-OBSERVER AND INTRA-OBSERVER VARIABILITY 
Inter-observer and intra-observer agreements for parameters measured by different 
modalities, both at rest and on exercise, were performed using readings of 10 
randomly selected subjects and calculated using Alpha model reliability analysis and 
reported as interclass correlation coefficient (ICC) with 95% confidence interval (CI) 
as described in Chapter 4.  
 
In this study, three methods of echocardiography were used to generate the raw data 
(tissue Doppler, speckle tracking and colour M-mode Doppler) at rest and on 
exercise.  The variability of these methods is listed below.  
 
The inter-observer variability for parameters measured at rest were:  
 TDI measurement of Sm, ICC=0.88, 95% CI=0.52-0.97;  
 TDI measurement of Em, ICC=0.96, 95% CI=0.83-0.99;  
 Speckle tracking of long axis images, ICC=0.92, 95% CI=0.68-0.98;  
 Speckle tracking of short axis images, ICC=0.90, 95% CI=0.57-0.98; and  
 Colour M-mode Doppler measurement of Vp, ICC=0.82, 95% CI=0.43-0.94. 
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The inter-observer variability for parameters measured on exercise were:  
 TDI measurement of Sm, ICC=0.99, 95% CI=0.97-0.99;  
 TDI measurement of Em, ICC=0.99, 95% CI=0.78-0.99;  
 Speckle tracking of long axis images, ICC=0.75, 95% CI=0.01-0.94;  
 Speckle tracking of short axis images, ICC=0.80, 95% CI=0.13-0.96; and  
 Colour M-mode Doppler measurement of Vp, ICC=0.79, 95% CI=0.42-0.94. 
 
The intra-observer variability for parameters measured at rest were:  
 TDI measurement of Sm, ICC=0.91, 95% CI=0.65-0.98;  
 TDI measurement of Em, ICC=0.95, 95% CI=0.80-0.99;  
 Speckle tracking of long axis images, ICC=0.90, 95% CI=0.61-0.98;  
 Speckle tracking of short axis images, ICC=0.98, 95% CI=0.90-0.99; and  
 Colour M-mode Doppler measurement of Vp, ICC=0.88, 95% CI=0.70-0.95. 
 
The intra-observer variability for parameters measured on exercise were:  
 TDI measurement of Sm, ICC=0.91, 95% CI=0.62-0.98;  
 TDI measurement of Em, ICC=0.97, 95% CI=0.86-0.99;  
 Speckle tracking of long axis images, ICC=0.97, 95% CI=0.89-0.99;  
 Speckle tracking of short axis images, ICC=0.98, 95% CI=0.91-0.99; and  
 Colour M-mode Doppler measurement of Vp, ICC=0.66, 95% CI= 0.49-0.89. 
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5.6 DISCUSSION 
In this study a comprehensive assessment of systolic and diastolic ventricular 
function was performed using non-invasive techniques at rest and on exercise, and 
demonstrated that breathlessness on exercise in HFNEF patients is associated with 
a variety of abnormalities of both systolic and diastolic function.  These include 
reduced radial and longitudinal myocardial systolic strain both at rest and on 
exercise, reduced systolic and diastolic longitudinal functional reserve, reduced left 
ventricular rotation at rest which fails to increase normally on exercise, and delayed 
ventricular untwisting which became worse on exercise.  These abnormalities were 
associated with reduced left ventricular suction consequently leading to failure of 
stroke volume to rise on exercise.   
 
These results are consistent with previous studies (96;97) using similar 
echocardiographic techniques which have demonstrated the close temporal, 
functional and tightly coordinated relationships between left ventricular twist during 
systole, the mitral annular motion towards the apex during systole, and in early 
diastole, how the untwisting process and recoil generates the negative 
intraventricular pressure gradient or left ventricular suction coinciding with the rapid 
motion of the mitral annulus back towards the base of the heart which aids left 
ventricular filling by enveloping the incoming column of blood (44).  As discussed in 
Chapter 2, left ventricular torsion or twist is a mechanism for generating stored 
energy during systole which is released during early diastole to produce ventricular 
recoil, upward annular motion and generation of intraventricular pressure gradient to 
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facilitate left ventricular suction.  This mechanism occurs to complete a cardiac cycle 
and confirms the close relationship between systole and early diastole (57). 
   
All these aspects of left ventricular function increase on exercise in the normal heart 
to aid rapid ejection and more importantly, to enable efficient filling of the left ventricle 
during a shortened diastole period, associated with increased heart rate, while 
maintaining a normal filling pressure.  Notomi et al. showed that when this 
mechanism is disrupted, such as in hypertrophic cardiomyopathy, there is an 
associated rise in left ventricular end-diastolic and left atrial pressures (97).  Their 
findings confirmed early studies which also linked diastolic dysfunction with regional 
inhomogeniety of contraction and relaxation in similar condition (74). 
   
The findings in this chapter are similar to the results reported by Notomi et al. in 
hypertrophic cardiomyopathy (97).  It is likely that these fundamental abnormalities of 
both systolic and diastolic left ventricular function are more relevant to the genesis of 
the symptoms of breathlessness than the increased passive myocardial stiffness 
measured at end-diastole at rest, as previously suggested (4;5). 
 
This study only reported the left ventricular apical rotation because it has been shown 
that the apical rotation represents the dominant contribution to the overall left 
ventricular twist over a range of haemodynamic conditions (126;127).  As outlined in 
Chapter 2, the left ventricular twisting motion is a consequence of myocardial fibre 
orientation, which changes from an approximately longitudinal but slightly oblique 
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orientation in the subendocardium, to a circumferential orientation in the mid-wall and 
to an oblique orientation in the subepicardium (84;128).  Thus, the subendocardial 
and subepicardial fibres represent two oppositely directed spirals.  Due to their larger 
radii, the torque of the subepicardial fibres dominates and accounts for the 
counterclockwise rotation of the left ventricular apex.  
 
Previous studies have found that in left ventricular hypertrophy or those with diastolic 
dysfunction, apical twist and untwisting may be augmented or reduced (119;129).  
Similarly, torsion is increased in patients with mild diastolic dysfunction, but reduced 
in those with more severe degrees of diastolic dysfunction (130).  These variable 
findings could be a consequence of the anatomical arrangement of the myocardial 
fibres.  In the early stage of myocardial insult, such as ischaemia or fibrosis, the more 
vulnerable subendocardial longitudinal fibres are primarily affected early so that 
unopposed epicardial torque will increase the apical twist.  When the disease 
progresses, more widespread fibrosis or damage will affect global function and lead 
to the overall reduced left ventricular twist with delayed untwisting.  This also explains 
the findings of reduced myocardial annular velocities, which were seen in HFNEF 
patients particularly on exercise as shown in the results of this chapter, given that the 
left ventricular longitudinal dysfunction primarily reflects subendocardial fibres 
damage, hence making them sensitive measures of left ventricular function (131).  All 
previous studies of torsion and untwisting in HFNEF were done at rest and this is the 
first study which has assessed both longitudinal function and apical rotation on 
exercise.  Reduced and delayed untwisting on exercise will undoubtedly impede left 
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ventricular suction in early diastole and delay rapid filling, so that more filling will 
occur in late diastole during atrial systole.  This explains the common finding of the 
delayed relaxation pattern (reduced early but increased atrial velocity) of the mitral 
inflow velocities associated with ageing and left ventricular hypertrophy (119;132).  
Late diastolic compensation depends on left atrial function, which is assessed in the 
next study reported in Chapter 6. 
 
The derived measurements of stiffness, arterial stiffness and ventricular systolic 
compliance did not show any major differences between patients and controls, at rest 
or on exercise.  In part, this may be because these measurements are often derived 
from single beats and have many assumptions involved in their calculations.  Left 
ventricular chamber stiffness is derived from the E-wave deceleration time (DT) but is 
probably only accurate in those with a short DT, whereas some of the HFNEF 
patients had a delayed DT and there is no data on the effects of exercise.  
Furthermore, DT has been shown to be a function of both chamber stiffness and 
chamber relaxation viscoelasticity hence applying DT alone may not estimate 
chamber stiffness accurately(133).  Pressure-volume index was higher in patients as 
expected.  Although in the study by Westerman et al., stiffness was different between 
groups at baseline and did not change significantly in HFNEF patients during 
handgrip exercise (4), it is likely that there are other non-cardiac factors involved in 
the symptom generation.  Apart from ventricular-arterial interactions, some 
investigators have reported that a significant number of HFNEF patients have 
attenuated heart rate response to exercise, similar to patients with HFREF (24;134).  
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Furthermore, those with such chronotropic incompetence have even more severe 
exercise intolerance than those without it.   
 
Exercise echocardiographic studies were deliberately done during sub-maximal 
exercise to optimise image quality.  However, the end results of arterial compliance 
and ventricular interactions will be to impair ventricular function on exercise.  
Interestingly, the other derived measures of global systolic function (end-systolic 
elastance, stroke work index and peak power index) were not significantly different 
from the control group.  This may reflect the methodology or the fact that the 
abnormalities of systolic function are more subtle and are not affecting pump function 
to any great degree but have a profound influence on early diastolic filling. 
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5.7 LIMITATIONS 
This study has potential limitations.  Firstly, all patients were taking medications as it 
was considered unethical to stop treatment entirely and it was important that blood 
pressure did not rise excessively on exercise compared to controls as this would 
have made interpretation of the results difficult.  However, it is difficult to know exactly 
what effect the drug therapy has on twist and longitudinal function.  Diuretics reduce 
symptoms and there is a suggestion that angiotensin converting enzyme inhibitors or 
angiotensin-1 antagonists may improve longitudinal function (135).  Despite being on 
medications, all patients remained symptomatic on exercise.  Secondly, exercise was 
sub-maximal, but all the patients were breathless at this level, therefore allowing 
correlation between symptoms and echocardiographic findings.  Also, in a more 
elderly population, sub-maximal exercise is more relevant and comparable to daily 
activities than exercising to exhaustion which is probably done very rarely in life.  
Thirdly, the diagnostic criteria for HFNEF patients on treatment are not available and 
the NT pro-BNP results were very variable but these were taken on treatment.  
Nevertheless, cardiopulmonary exercise testing was used to confirm that the 
symptoms of breathlessness in all patients were cardiac in origin. 
132 
 
5.8 CONCLUSION 
This study demonstrated that HFNEF patients have a combination of systolic and 
diastolic abnormalities of the left ventricular function which are more obvious on 
exercise than at rest.  These include reduced myocardial systolic strain, rotation, left 
ventricular suction, longitudinal function and delayed untwisting (Figure 5.5).  This is 
not a condition of isolated diastolic dysfunction or a problem of ventricular stiffness 
alone.  A variety of aetiologies commonly seen in HFNEF including ageing, 
hypertension, left ventricular hypertrophy, fibrosis and diabetes could all induce 
changes in the myocardial tissue which affect the architecture of the heart and its 
global function.  Treatments which only reverse myocardial tissue changes without 
restoring the architectural function of the heart are unlikely to improve symptoms.   
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Figure 5.5 Schema illustrating the pathophysiology of HFNEF 
 
 
LVH, left ventricular hypertrophy; LV left ventricular. 
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LEFT ATRIAL DYSFUNCTION  
ON EXERCISE 
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6. LEFT ATRIAL DYSFUNCTION ON EXERCISE 
6.1 SUMMARY 
This study tested the hypothesis that failure of left atrial compensatory mechanism 
particularly on exercise, contributes to the genesis of symptoms in HFNEF patients. 
 
Fifty HFNEF patients, 15 asymptomatic hypertensive subjects and 30 healthy 
controls underwent rest and sub-maximal exercise echocardiography to assess 
systolic (Sm), early diastolic (Em) and late diastolic (Am) mitral annular velocities.  
Left atrial functional reserve index (LAFRI) was used as an index of left atrial 
function. 
 
Left atrial volume index was significantly higher in HFNEF patients.  Am at rest was 
comparable between all three groups but exercise Am was significantly lower in 
HFNEF patients compared to both hypertensive subjects and healthy controls 
resulting in a lower LAFRI.  There was a significant correlation between Am on 
exercise with peak VO2 and E/e’ on exercise.  The area under the receiver operator 
curve for Am on exercise to differentiate HFNEF patients from controls was 0.768 
(95% CI = 0.660-0.877). 
 
These results demonstrate that HFNEF patients have reduced left atrial function on 
exercise in addition to left ventricular systolic and diastolic dysfunction shown in 
136 
 
Chapter 5.  Reduced left atrial function probably contributes significantly to exercise 
intolerance and breathlessness in HFNEF patients.    
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6.2 INTRODUCTION 
There are a variety of abnormalities of systolic and diastolic function in patients with 
HFNEF, all of which failed to increase normally on exercise as shown in 
Chapter 5 (136).  These abnormalities of systolic function were associated with 
subsequent reduced early diastolic filling.  Given that the left atrium is in direct 
communication with the left ventricle when the mitral valve opens in early diastole, 
any increase in the left ventricular filing pressure would lead to raised left atrial 
pressure.  There is a greater dependence on late diastolic filling contributed by left 
atrial contraction to compensate for reduced early diastolic filling.  Also, the degree to 
which the left atrial pressure rises on exercise will depend critically on the left atrial 
function.  An enlarged left atrium is associated with adverse outcome (66;72) and 
with worse left ventricular diastolic dysfunction (67).  However, there is little 
information on left atrial function in HFNEF.  In other conditions such as HFREF, 
cardiomyopathy, coronary artery disease and normal ageing in which systolic 
function and early diastolic filling are impaired, left atrial function contributes 
significantly to stroke volume (137-139).  
       
Hypertension is one of the commonest aetiology of HFNEF and therefore 
asymptomatic, but treated, hypertensive subjects make an appropriate control 
population and provide a better understanding of the pathophysiology of symptoms in 
HFNEF patients compared to hypertension alone. 
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This study was to test the hypothesis that patients with HFNEF have reduced left 
atrial functional reserve on exercise, in addition to the combined systolic and diastolic 
impairments found in Chapter 5.  Left atrial function both at rest and on exercise was 
studied in a group of asymptomatic hypertensive subjects, in addition to patients with 
HFNEF and healthy controls. 
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6.3 METHODS 
Left ventricular and left atrial functions were assessed non-invasively at rest and on 
sub-maximal exercise in the three groups of subjects.  Patients with clinical diagnosis 
of HFNEF, asymptomatic hypertensive subjects and healthy controls were recruited 
as outlined in Chapter 4.  All subjects underwent pulmonary function test and 
cardiopulmonary exercise test to determine their peak oxygen consumption and to 
rule out pulmonary causes of their breathlessness prior to the rest and exercise 
echocardiography studies. 
 
 All study subjects underwent cardiopulmonary exercise testing achieving a RER >1, 
and full echocardiography at rest and on semi-recumbent exercise on a tilting bicycle 
ergometer as described in Chapter 4.  
  
Two-dimensional echocardiography, tissue Doppler and speckle tracking imaging 
and analyses were performed as described in Chapter 4. 
 
Left atrial function was assessed by using the left atrial functional reserve index, 
which was calculated as: ΔAm x [1-(1/Amrest)] equivalent to the method applied in the 
study by Ha et al. (125). 
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6.4 STATISTICS 
Statistical analyses were performed as described in Chapter 4. 
 
One way analysis of variance (ANOVA) was used for normally distributed data to 
compare all three groups of study subjects, followed by Tukey post hoc analysis to 
determine significant pairwise differences.  Interclass comparisons of the changes of 
parameters from rest to exercise were made using a general linear model for 
repeated measurements at two levels.  Non-normally distributed data was analysed 
using the Mann-Whitney U Test. 
 
Pearson’s correlation coefficient was used to examine associations between 
variables.  Linear regressions were performed using peak VO2 and E/e’ as 
dependent variables against Am on exercise. 
 
In addition, receiver operator curves were plotted to examine the ability of Am at rest 
and on exercise to differentiate HFNEF patients and healthy controls.   
 
Inter-observer and intra-observer agreements were performed as described in 
section 4.6, similar to those applied in Chapter 5. 
 
141 
 
6.5 RESULTS 
A total of 148 subjects were recruited in this study (90 symptomatic patients and 58 
asymptomatic subjects).  Forty patients were excluded (7 had evidence of respiratory 
restriction, 5 had atrial fibrillation, 1 had significant coronary artery disease, 1 had 
normal peak oxygen consumption on cardiopulmonary exercise testing, 2 failed to 
increase their heart rate on exercise, 24 did not have adequate exercise images for 
analysis either due to fusion of E and A or poorly defined Am on exercise).  Thirteen 
asymptomatic subjects were excluded (one was tachycardic at rest due to anxiety, 12 
did not have adequate exercise images for analysis).  The remaining 50 symptomatic 
patients fulfilled the recent American Society of Echocardiography recommendations 
for diastolic dysfunction (38 grade I diastolic dysfunction and 12 grade II diastolic 
dysfunction) (32) and were classified as HFNEF patients.  The remaining 45 
asymptomatic subjects were further divided into asymptomatic hypertensive subjects 
(n=15) and healthy controls (n=30).  The mean age of all study subjects was 
comparable between the three groups (Table 6.1).  HFNEF patients were all 
symptomatic and were classified according to New York Heart Association 
classification class II and III, and had a significantly higher BMI compared to 
hypertensive subjects and controls.  The peak VO2 and the achieved percentage of 
predicted oxygen consumption were significantly lower in HFNEF patients but were 
comparable between hypertensive patients and healthy controls.  The past medical 
history and drug history of all subjects are summarised in Table 6.1.  All HFNEF 
patients had a history of hypertension and the duration of diagnosis of hypertension 
is significantly longer than that of the hypertensive subjects. 
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Table 6.1 Clinical characteristics – left atrial study 
 HFNEF 
patients 
 
Hypertensive 
subjects 
Controls p-value 
Number of subjects 50 15 30  
Age (years) 72±8 70±7  71±6  0.541 * 
Gender 35♀ / 15♂ 9♀ / 6♂ 22♀ / 8♂  0.655 † 
BMI (kg/m2) 31±5 ¶ # 25±4 24±4  <0.001 * 
NYHA  class II =37 
class III=13 
n/a n/a  
Peak VO2 (ml/min/kg) 
(percent of predicted)  
18.2±4.4 ¶ # 
(83±17%) 
28.4±9.4 
(118±28%) 
29.6±.5.0 
(128±21
%) 
 <0.001 * 
 <0.001 * 
Submaximal work 
load (watts) 
27±8 32±12 31±10  0.197 * 
Years of hypertension  8.7±6.9 ¶ # 3.7±2.4  0  <0.001 ‡ 
Diabetes mellitus 15 (30%)  0 (0%) 0 (0%)  0.014 § 
Coronary artery 
disease 
9 (18%)  0 (0%) 0 (0%)  0.103 § 
ACE-Inhibitor 18 (36%)  4 (27%)  0 (0%)  0.757 § 
AR1-Blocker 14 (28%)  0 (0%) 0 (0%)  0.028 § 
β-Blocker 19 (38%)  4 (27%) 0 (0%)  0.544 § 
Ca-Channel-Blocker 17 (34%)  2 (13%) 0 (0%)  0.196 § 
Diuretic 26 (52%) 6 (40%)  0 (0%)  0.558 § 
α-Blocker 15 (30%)  0 (0%) 0 (0%)  0.014 § 
Statin 22 (44%)  5 (33%)  0 (0%)  0.558 § 
 
Data is presented as number (and %) or mean ± standard deviation. 
* One Way Anova for normally distributed data. 
  Tukey post hoc analysis:  # p < 0.05 compared to hypertensive group 
     ¶ p < 0.05 compared to healthy controls 
† Fisher’s exact test for nominal data comparing all three groups.  
§ Fisher’s exact test for nominal data comparing patients to hypertensive group 
‡ Mann-Whitney U Test comparing patients to hypertensive group.  
 
 
Annotations as per Table 5.1. 
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6.5.1 2D ECHOCARDIOGRAPHY 
The left ventricular ejection fraction, fractional shortening, end-systolic and end-
diastolic dimensions, and the left ventricular end-systolic and end-diastolic volume 
indexes were all comparable between the three groups (Table 6.2).  The left 
ventricular mass index (LVMI) was not significantly different between all three groups.  
The diastolic interventricular septum of HFNEF patients was significantly thicker than 
healthy controls whereas the posterior wall was significantly thicker than both 
hypertensive subjects and healthy controls (Table 6.2).  These findings are 
consistent with the longer duration of hypertension in HFNEF patients.  The heart 
rate and blood pressure at rest and on exercise were comparable between all three 
groups (Table 6.3). 
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Table 6.2 Standard echocardiographic parameters – left atrial study 
 
 
HFNEF 
patients 
Hypertensive 
subjects 
Controls p-value 
IVSd (mm) 10.9±3.1 ¶ 9.7±2.3 9.3±1.7  0.040 * 
PWd (mm) 10.9±2.4 ¶ # 8.6±1.2 9.2±1.4  <0.001 * 
LVEDD (mm) 46.1±5.6 47.7±3.9 45.3±5.1  0.392 * 
LVESD (mm) 28.3±5.2 30.0±4.0 28.7±4.5  0.463 * 
FS (%) 39±7 38±6 37±7  0.505 * 
LVMI (g/m2) 93.1±36.3  82.9±22.1 76.0±18.3  0.100 * 
LVEDVI (ml/m2) 40.4±9.4 41.4±9.4 39.1±9.2  0.108 * 
LVESVI (ml/m2) 15.5±4.8 15.7±5.2 15.3±5.4  0.784 * 
LVEF (Simpson) (%) 62±6 62±9 62±7  0.989 * 
LA (cm) 3.8±0.6 ¶ 3.5±0.5 3.2±0.5  <0.001 * 
LAVI (ml/m2) 30.4±9.2 ¶ 27.9±6.3  23.2±7.1  0.002 * 
  
Data is presented as mean ± standard deviation. 
* One Way Anova for normally distributed data. 
 
  Tukey post hoc analysis: # p < 0.05 compared to hypertensive group 
      ¶ p < 0.05 compared to healthy controls  
IVSd, diastolic interventricular septal thickness; PWd, diastolic posterior wall thickness; LVEDD, left 
ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; FS, fractional 
shortening; LVMI, left ventricular mass index; LVEDVI, left ventricular end-diastolic volume index; 
LVESVI, left ventricular end-systolic volume index, LVEF, left ventricular ejection fraction; LA, left 
atrial; LAVI, left atrial volume index. 
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Table 6.3 Haemodynamic and Doppler parameters – left atrial study 
 HFNEF 
patients 
Hypertensive  
subjects 
Controls p-value 
one-way 
Anova 
HR rest (bpm) 72±13 65±8 70±9 0.384 
HR ex (bpm) 91±11 90±11 93±5 0.117 
Δ HR (bpm) 21±7 24±7 23±8 0.138 
BP Rest (mmHg)  142±16/ 
 77±11 
141±20 / 
77±7 
137±15 / 
79±8 
0.466 
0.526 
BP Ex (mmHg)  167±19 / 
 87±12 
165±20 / 
89±8 
160±12 / 
85±8 
0.181 
0.556 
E Rest (m/s) 0.69±0.17  * 0.64±0.13 0.58±0.11 0.006 
E ex (m/s) 0.95±0.17 1.05±0.16  0.94±0.12 0.101 
E/A rest 0.83±0.21 0.94±0.33 0.85±0.18 0.286 
E/A ex 0.96±0.21 # 1.15±0.29 1.08±0.26 0.020 
DT (ms) 241±53     # 268±56 * 252±45 0.184 
IVRT (ms) 97±23 97±24 103±19 0.449 
Sm rest (cm/s) 5.3±1.2 5.8±1.8 5.8±1.2 0.244 
Sm ex (cm/s) 6.3±1.6  * 7.4±1.8 7.7±1.5 <0.001 
Δ Sm (cm/s) 1.0±1.2   * 1.8±1.4 2.0±1.3 0.003 
Em rest (cm/s) 4.3±1.3 # * 6.0±1.9 5.4±1.1 <0.001 
Em ex(cm/s) 6.6±1.5 # * 7.9±1.4 * 8.6±1.5 <0.001 
Δ Em (cm/s) 2.2±1.3  * 1.5±2.3 * 3.3±1.6 0.003 
 
Data is presented as mean ± standard deviation. 
Tukey post hoc analysis:  * p<0.05 compared to healthy controls 
      # p<0.05 compared to hypertensive group 
 
ex, exercise; HR, heart rate; BP, blood pressure; E, early diastolic mitral inflow velocity; A, late 
diastolic mitral inflow velocity; E/A, ratio of E to A; DT, deceleration time; IVRT, isovolumic relaxation 
time; Sm, peak systolic myocardial mitral annular velocity; Em, peak early diastolic myocardial mitral 
annular velocity; Δ, (delta) change in. 
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6.5.2 LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTIONS 
Peak E at rest was significantly higher in HFNEF patients but became comparable 
between all three groups on exercise.  There was no significant difference in the 
isovolumic relaxation time (IVRT) between the three groups.  The deceleration time 
(DT) was significantly longer in the hypertensive group compared to healthy controls 
(Table 6.3).  Sm at rest was comparable between all subjects but was significantly 
lower in HFNEF patients compared to healthy controls on exercise similar to the 
finding in Chapter 5, but not significantly lower compared to the hypertensive group.  
However, Em at rest and on exercise was significantly lower in HFNEF patients 
compared to both hypertensive subjects and healthy controls.  While there was no 
significant difference in Sm on exercise between hypertensive subjects and healthy 
controls, Em on exercise was significantly lower in hypertensive subjects compared 
to healthy controls (Table 6.3). 
 
E/e’ of HFNEF patients at rest was significantly higher than that of hypertensive 
subjects and healthy controls.  Despite an increase in E/e’ on exercise in 
hypertensive subjects approximating the same level of increase in E/e’ in HFNEF 
patients on exercise, they remained asymptomatic at the time of exercise, indicating 
that hypertensive subjects had an increase in left atrial pressure on exercise to a 
similar level of HFNEF patients but remained asymptomatic (Table 6.4).   
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Table 6.4 Results of left atrial function and pressure 
 HFNEF 
patients 
Hypertensive 
subjects 
Controls 
 
p-value  
one-way 
Anova 
A rest (m/s) 0.86±0.18 # * 0.73±0.17 0.69±0.12 <0.001 
A ex (m/s) 1.01±0.18  * 0.95±0.22 0.91±0.17 0.049 
Δ A (m/s) 0.16±0.13   0.22±0.16 0.22±0.13 0.132 
E/e’ rest 11.9±4.5 # * 8.1±1.5 8.4±1.8 <0.001 
E/e’ ex 10.9±3.3  * 10.1±2.6 8.3±1.6 0.035 
Am rest (cm/s) 7.2±1.5 6.7±2.3 7.9±1.6 0.057 
Am ex (cm/s) 8.2±1.7 # * 9.6±2.6 10.0±2.2 0.001 
Δ Am (cm/s) 1.0±1.6 # * 2.9±1.5 2.1±1.6 <0.001 
LAFRI 0.84±1.34 # * 2.39±1.27 1.81±1.39 <0.001 
 
Data is presented as mean ± standard deviation. 
Tukey post hoc analysis:  * p<0.05 compared to healthy controls;  
    # p<0.05 compared to hypertensive group 
ex, exercise; A, late diastolic mitral inflow velocity; E, early diastolic mitral inflow velocity; e’, peak early 
diastolic myocardial mitral annular velocity; E/e’, ratio of E to e’; Am, atrial systolic myocardial velocity; 
LAFRI, left atrial functional reserve index; Δ, (delta) change in. 
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6.5.3 LEFT ATRIAL FUNCTION 
HFNEF patients had significantly larger left atrial dimensions than healthy controls 
but not significantly different compared to hypertensive subjects (Table 6.2).  Left 
atrial volume index was also comparable between HFNEF patients and hypertensive 
subjects, but was significantly higher than healthy controls.  Peak A at rest was 
significantly higher in HFNEF patients compared to both hypertensive subjects and 
healthy controls, but was only significantly higher compared to healthy controls on 
exercise as the peak A of hypertensive subjects approximated to that of HFNEF 
patients on exercise (Table 6.4).  Colour tissue Doppler imaging was used to 
measure the late diastolic mitral annular velocity, Am, which is also equivalent to the 
atrial systolic myocardial velocity.  There was no significant difference in Am at rest 
between the three groups.  However, Am on exercise was lowest in HFNEF patients 
and was significantly lower compared to the other two groups.  HFNEF patients failed 
to increase Am on exercise and as a result they had the lowest left atrial functional 
reserve index compared to all other subjects.  Am at rest was lowest in hypertensive 
subjects, although not statistically significant, but the increase in Am on exercise was 
greatest in this group of subjects resulting in a similar magnitude of increase seen in 
the healthy controls.  Hence, the hypertensive subjects had the highest left atrial 
functional reserve index indicating a more efficient atrial compensatory mechanism 
on exercise in this group of subjects (Table 6.4, Figures 6.1 and 6.2). Overall, this 
result suggests that the hypertensive subjects were able to compensate for their 
reduced Em (early diastolic function) and an increased in E/e’ on exercise by 
increasing their Am which was not achieved by HFNEF patients. 
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Figure 6.1 Left atrial function by colour tissue Doppler imaging at rest and on 
exercise 
 
Am, atrial systolic myocardial  velocity ; LAFRI, left atrial functional reserve index; HR, heart rate; Δ, 
(delta) change in. 
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Figure 6.2 Boxplot illustrating atrial systolic myocardial  velocity at rest and 
on exercise 
 
Boxplot shows minimum, first quartile, median, third quartile and maximum. 
Am, atrial systolic myocardial velocity; p, probability. 
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The receiver operator curve (ROC) showed that Am on exercise was better at 
differentiating patients from controls (area under ROC 0.77, 95% CI = 0.66-0.88).  
The area under the ROC for Am at rest was 0.64 (95% CI = 0.51-0.76) (Figure 6.3).   
 
Figure 6.3   Receiver operator curve of atrial systolic myocardial velocity at rest 
and on exercise 
 
Am, atrial systolic myocardial velocity. 
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6.5.4 CORRELATIONS 
Although Am at rest has a significant correlation with peak VO2, (r=0.425, p<0.01) 
and E/e’ (r= -0.315, p<0.01), Am on exercise had a stronger correlation with both 
peak VO2 (r=0.514, p<0.001) and E/e’ (r= -0.547, p<0.001) (Figure 6.4).  There was 
only a weak correlation between left atrial functional reserve index and peak VO2 
(r=0.257, p=0.039).  This indicates that a significantly reduced left atrial functional 
reserve is not the predominant cause of patients’ limited exercise capacity, but it is 
the ultimate magnitude of Am achieved on exercise which is more important. 
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Figure 6.4    Correlations of peak oxygen consumption and E/e’ with atrial 
systolic myocardial  velocity on exercise 
E/e’ on
exercise r=-0.547
p<0.001
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Am, atrial systolic myocardial velocity; E, early diastolic mitral inflow velocity; e’,  early diastolic 
myocardial mitral annular velocity; E/e’, ratio of E to e’; VO2, oxygen consumption; r, correlation; p, 
probability. 
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6.5.5 INTER-OBSERVER AND INTRA-OBSERVER VARIABILITY 
The inter-observer variability of tissue Doppler imaging parameters used for the 
assessment of systolic, early and late diastolic myocardial velocities at rest by 
interclass correlation coefficient (ICC) was between 0.91 and 0.96.  On exercise the 
ICC was between 0.85 and 0.94.  The intra-observer variability  at rest varied from 
0.91 and 0.98 and on exercise between 0.87 and 0.98.  The breakdown of variability 
of individual parameters was reported in section 5.5.9.  
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6.6 DISCUSSION 
This study demonstrated that left atrial function is impaired on exercise in patients 
with HFNEF and may therefore contribute to the genesis of the symptom of 
dyspnoea in this condition.  In addition, the major difference between HFNEF 
patients and asymptomatic hypertensive patients was left atrial functional reserve on 
exercise.  Since hypertension is a common precursor of HFNEF, one of the factors 
that may account for the development of symptoms is progressive left atrial failure.  
This study, therefore, suggests that impaired left atrial function may be another factor 
that leads to shortness of breath in addition to the abnormalities of left ventricular 
function demonstrated in Chapter 5 (136).  These results support the findings of 
Melenovsky et al. who found evidence of reduced left atrial functional reserve on 
handgrip exercise in HFNEF patients in comparison to both hypertensive controls 
and normal subjects of a comparable age (71).  An inability to increase atrial systolic 
function on exercise may have a significant negative impact on effective and rapid 
diastolic filling especially during the very short time available in diastole with higher 
heart rates on exercise. 
 
The atrial systolic myocardial velocity at rest is also a significant predictor of 
cardiovascular risk.  Wang et al. demonstrated that when the Am was >4 but 
<7 cm/s, the hazard ratio of cardiac death was increased compared with an Am >7 
cm/s, and when the Am was <4 cm/s the hazard ratio was significantly increased 
compared with an Am >7 cm/s (47).  The predictive power of Am alone was greater 
than the ratio of E/e’ which has been claimed to be an index of left ventricular end-
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diastolic pressure (47;50).  Am has also been found to be predictive of exercise 
capacity in chronic heart failure in several previous studies (47;69;70). 
   
In this study, the magnitude of Am achieved on exercise correlated better with 
exercise capacity as measured by peak VO2, suggesting again that peak atrial 
performance on exercise is the more critical and relevant measurement.  The initial 
rise in left atrial contribution to left ventricular filling in mild left ventricular dysfunction 
probably represents a compensatory response to the reduction of early left 
ventricular filling.  As the left ventricular function worsens, the work load of the left 
atrium increases further , consequently causing left atrial morphological changes and 
remodelling, which leads to a subsequent impairment of left atrial function.  This has 
been shown in an early study in dogs (140). 
 
Left atrial volume index (LAVI) is used as one of the diagnostic parameters for 
diagnosing HFNEF.  It is not surprising that LAVI was increased in the HFNEF 
patients.  The hypertensive subjects in this study had a LAVI in between HFNEF 
patients and controls, similar to the results reported by Wakatsuki et al. (141).  Left 
atrial volumes are viewed increasingly as a marker of chronic elevation of left atrial 
pressure and hence indirectly used as a marker of diastolic dysfunction.  The fact 
that LAVI was higher in the HFNEF patients suggests that over time, left atrial 
pressure was higher than in the hypertensive subjects leading to more atrial 
remodelling as discussed in section 1.4.3.  This would lead to reduced contractile 
function which would also be affected directly by the high incidence of co-morbidities 
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in HFNEF, such as diabetes (present in about 30%), sub-clinical coronary artery 
disease (approximately 40-50%), obesity (prevalence of body mass index >30 kg/m2 
approximately 40%) and renal failure (23).   
 
Atrial fibrillation (AF) is common in HFNEF and the prevalence ranges from 20 to 
40% in both epidemiological studies and randomised controlled clinical trials (23).  
Fung et al. reported that HFNEF patients with AF had a poorer quality of life, lower 
exercise capacity and, as expected, larger left atrial dimensions (65).  In addition, 
patients with HFNEF and AF had more severe diastolic dysfunction when compared 
to those in sinus rhythm.  It is likely that left atrial remodelling combined with 
progressive left atrial failure will lead to the onset of AF.  Hypertension itself is also 
associated with a higher prevalence of AF and structural changes of the extracellular 
matrix, perhaps related to activation of the renal-angiotensin-aldosterone 
system (142). 
158 
 
6.7 LIMITATIONS 
The number of asymptomatic hypertensive subjects was smaller than the other two 
groups but the exercise data illustrated a significant difference despite the similarity 
of the echocardiographic findings at rest.   
 
The late diastolic myocardial velocity was used as an index of left atrial systolic 
function.  The limitation of this measurement is that it only reflects left atrial 
mechanical function in the long axis.  Newer techniques measuring strain by tissue 
Doppler imaging or speckle tracking may provide a better measurement of global left 
atrial function (143;144).  However, it is technically challenging to obtain sufficiently 
good images of the left atrium, particularly on exercise for meaningful speckle 
tracking analysis.  As mentioned in section 5.7, exercise was submaximal to maintain 
a maximum heart rate of 100 beats per minute to avoid fusion of E and A waves and 
to allow image acquisition while patients are breathless.   
 
As similarly mentioned in section 5.7, all HFNEF patients and hypertensive subjects 
with regular prescriptions were studied on medications.  The proportion of HFNEF 
patients and hypertensive subjects who were on angiotensin converting enzyme 
inhibitors, beta-blockers, calcium channel blockers and diuretics were comparable, 
although 28% of HFNEF patients were on angiotensin-1 receptor blocker compared 
to none of the hypertensive subjects, but this is unlikely to have affected the results 
as there is no evidence that angiotensin-1 receptor blocker therapy impairs left atrial 
function, in fact the contrary (135). 
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6.8 CONCLUSION 
In summary, this study demonstrated that left atrial function is impaired on exercise 
with an impaired left atrial reserve in patients with HFNEF.  Combined with the 
findings in Chapter 5 demonstrating reduced early diastolic filling, suction and 
delayed untwisting (136), these observations add further to the understanding of left 
ventricular and left atrial function at rest and on exercise in a typical cohort of HFNEF 
patients, illustrating the wider spectrum of abnormalities in this condition. 
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7. TORSIONAL DYSSYNCHRONY ON EXERCISE  
7.1 SUMMARY  
Left ventricular systole and diastole are intimately dependent on myocardial torsion, 
which involves coupling between myocardial rotation (twisting in systole and 
untwisting in diastole) and longitudinal motion.  This study tested the hypothesis that 
HFNEF involves torsional dyssynchrony and that these disturbances are 
exaggerated by exercise.  
 
Seventy two patients with HFNEF and 38 healthy controls underwent 
echocardiography study at rest and on supine exercise.  Analysis of three plane 
motion was performed using a combination of speckle tracking and tissue Doppler 
imaging.  Torsional dyssynchrony was quantified as the standard deviation of the 
time to peak systolic motions (SDSM) (basal and apical rotation, longitudinal and 
radial displacement); the time difference between peak twist and peak longitudinal 
displacement (twist-longitudinal motion delay, TLMD) and the ratio of untwist to 
longitudinal extension (UT:LE). 
 
At rest, SDSM, TLMD and UT:LE were not significantly different between patients 
with HFNEF and controls.  However, exercise was associated with significant systolic 
and diastolic dyssynchrony in the HFNEF patients.  The SDSM correlated with left 
ventricular wall thickness (r= 0.45, p<0.001), peak VO2 (r=-0.27, p=0.030) and 
changes in stroke volume on exercise (r=-0.38, p=0.003). 
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This study concluded that HFNEF involves exercise induced torsional dyssynchrony 
in systole and diastole, which relates to left ventricular hypertrophy as well as 
exercise capacity.  
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7.2 INTRODUCTION 
In this chapter, the role of left ventricular dyssynchrony in HFNEF was studied at rest 
and on exercise.  Left ventricular dyssynchrony is another factor that could impact 
upon left ventricular function and could contribute to the haemodynamic disturbances 
observed in HFNEF.  Previously, studies have shown a high prevalence of 
dyssynchrony in HFNEF (78;79).  As discussed in section 1.4.4, these studies 
assessed dyssynchrony in single myocardial planes, assessing time delays between 
different left ventricular segments using tissue Doppler imaging.  Importantly 
however, myocardial motion occurs in various directions, namely longitudinal, radial, 
circumferential and oblique directions, reflecting the orientations of myocardial fibres 
throughout the left ventricular wall (80).  The combined effect of such motion is 
torsion, or wringing and unwringing of the left ventricle in systole and diastole 
respectively.   
 
The notion of torsional synchrony arises from the recognition that cardiac motion 
occurs in three dimensions involving the cohesive movement of all the myocardial 
fibres, particularly the longitudinal and the oblique fibers, to enable synchronous and 
energy-efficient left ventricular mechanics throughout the cardiac cycle especially 
during exercise when the duration of diastole shortens significantly with increase in 
heart rate.  In addition, changes in left ventricular wall properties such as left 
ventricular hypertrophy and fibrosis may lead to temporal dispersion of wall motion 
contributing to torsional dyssynchrony which could affect both systole (left ventricular 
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ejection) and diastole (relaxation and suction).  Thus, torsional dyssynchrony could 
account for the impairment of functional capacity observed in patients with HFNEF.   
 
As an extension to the findings of exercise induced left ventricular and left atrial 
dysfunction in patients with HFNEF reported in Chapters 5 and 6 (136;145), this 
study explores whether torsional dyssynchrony in systole and / or diastole, at rest or 
during exercise, relates to cardiac output and functional capacity in patients with 
HFNEF.  In addition, the effects of exercise on torsional dyssynchrony and relevant 
aetiological factors were also explored.    
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7.3 METHODS 
The left ventricular systolic and diastolic function was assessed non-invasively at rest 
and on exercise in patients with the clinical diagnosis of HFNEF and in healthy 
controls.  Patients and age-matched healthy controls were recruited as described in 
Chapter 4.  
  
All study subjects underwent cardiopulmonary exercise testing and full 
echocardiography at rest and on semi-recumbent exercise on a tilting bicycle 
ergometer as described in Chapter 4.   
 
Two-dimensional echocardiography, tissue Doppler and speckle tracking imaging 
and analyses were undertaken as described in Chapter 4. 
 
In addition, the raw data from speckle tracking of apical and basal rotation and 
rotation rate, radial displacement and displacement velocity from the short axis mid 
ventricular level, and the longitudinal displacement and displacement rate derived 
from colour tissue Doppler of the septal and lateral mitral annulus, was transferred to 
a custom written Microsoft Excel algorithm for further analysis.  All co-ordinates were 
interpolated and all time intervals were normalised to enable comparison of events of 
different durations within the cardiac cycle.  The raw data was used to plot and 
construct the twist-displacement loops to illustrate the coordination of these two 
motions at rest and on exercise.  This  algorithm was applied from methods used by 
Borg et al. (146), and they provided the algorithm software. 
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7.3.1   TORSIONAL DYSSYNCHRONY IN SYSTOLE 
Dyssynchrony in three planes namely longitudinal, radial and rotation, was calculated 
using the interpolated timing information.  The standard deviation of the time to peak 
systolic motions (SDSM), timed from R-wave to the peak of the individual motions 
(basal rotation, apical rotation, longitudinal displacement and radial displacement), 
was taken as a measure of systolic torsional dyssynchrony.  The maximum time 
difference between the duration to reach peak twist and peak longitudinal 
displacement was calculated and expressed as twist-longitudinal motion delay 
(TLMD).  All measurements were undertaken at rest and on exercise. 
 
7.3.2 TORSIONAL DYSSYNCHRONY IN DIASTOLE 
In diastole, there is no obvious peak motion due to the split in an early (E) and a late 
(A) component of the motion.  Therefore, the ratio of the percentage change in 
untwist to longitudinal extension (UT:LE) over a set time duration (isovolumic 
relaxation time, IVRT) was taken as a measure of torsional dyssynchrony in diastole.  
Accordingly, UT:LE was calculated as follows: 
    
This ratio is consistent with the early slope of the diastolic limb (red arrow) of the 
twist-displacement loops in Figures 7.4 and 7.5 illustrated in the results section later 
in this chapter. 
Δ Untwist % 
Δ Longitudinal extension % 
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7.4 STATISTICS 
Statistical analyses were performed as described in Chapter 4. 
 
Comparisons between HFNEF patients and controls were performed using unpaired 
t-test for normally distributed data and the Mann-Whitney U-test for non-normally 
distributed data.  Comparisons within HFNEF patients and controls were performed 
using paired t-test for normally distributed data and the Wilcoxon test was used for 
non-normally distributed data.  Logarithmic transformation was used when variables 
were not normally distributed.  Linear regression was performed to test correlations. 
 
Inter-observer and intra-observer agreements for measurements that were applied 
for torsional dyssynchrony (rotational by speckle tracking, radial strain by speckle 
tracking, longitudinal displacement by colour TDI) were performed as described in 
section 4.5. 
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7.5 RESULTS  
A total of 148 subjects were recruited in this study (90 patients and 58 asymptomatic 
healthy subjects).  Eighteen patients were excluded (seven had evidence of 
respiratory restriction, one had significant coronary artery disease, two were unable 
to exercise, one had normal peak VO2, two failed to increase their heart rate on 
exercise and five did not have adequate images for analysis).  Twenty asymptomatic 
subjects were excluded (16 had elevated blood pressure not previously diagnosed), 
one was tachycardic at rest due to anxiety, three did not have adequate images for 
analysis).  The remaining 72 symptomatic patients fulfilled the criteria of Vasan and 
Levy for probable diastolic heart failure (33).  Thirty eight remaining asymptomatic 
subjects had no past medical history and were not on any medications.  
  
The mean age of the patients was 73 ± 7 years and 67% were female.  Control 
subjects were of comparable age (71 ± 7 years) and 76% were female.  The past 
medical history and drug history of patients are summarised in Table 7.1.  All patients 
had symptoms of heart failure with New York Heart Association (NYHA) class II or III 
despite being on medications.  Patients had a significantly higher BMI compared to 
controls but the peak VO2 which was indexed to BMI was significantly lower in 
patients compared to controls (Table 7.1). 
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Table 7.1 Clinical characteristics – dyssynchrony study 
 HFNEF  
patients 
Controls p-value 
Number of subjects 72 38  
Age (years) 73±7 71±7  0.219  
Gender 48♀ / 24♂ 29♀ / 9♂  0.383 * 
BMI (kg/m2) 30±5 24±4  <0.001  
NYHA  class II =51 
class III=21 
n/a  
Peak VO2 (ml/min/kg) 
(percent of predicted)  
18.4±4.9 
(80±17%) 
28.6±5.1 
(123±21%) 
 <0.001  
Years of hypertension  8.2±9.9 0  <0.001 ‡ 
Atrial fibrillation 5 (7%) 0  
Diabetes mellitus 17 (24%) 0  
ACE-Inhibitor 25 (35%) 0  
AR1-Blocker 21 (29%) 0  
β-Blocker 11 (15%) 0  
Calcium Channel-Blocker 19 (26%) 0  
Diuretic 36 (50%) 0  
α-Blocker 15 (21%) 0  
Statin 33 (46%) 0  
 
Data is presented as number (and %) or mean ± standard deviation. 
p-value: unpaired t-test between patients and controls except * Fisher exact test between patients and 
controls and ‡ Mann-Whitney U test between patients and controls. 
 
Annotations as per Table 5.1.  
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7.5.1 2D ECHOCARDIOGRAPHY 
The left ventricular ejection fraction, fractional shortening, end-systolic and end-
diastolic dimensions, E/A ratio, deceleration time (DT) and isovolumic relaxation time 
(IVRT) were all comparable between the two groups (Table 7.2).  Patients had a 
significantly increased left ventricular wall thickness (posterior and interventricular 
septal walls), left ventricular mass index, left atrial volume index, mitral inflow E and A 
waves and E/e’. 
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Table 7.2 Standard echocardiographic parameters – dyssynchrony study 
 Patients Controls  p-value  
IVSd(mm) 11.1±3.0 9.4±1.9 0.004 
PWd (mm) 11.0±2.4 9.1±1.4 <0.001 
LVEDD(mm) 46.7±6.9 45.7±4.9 0.459 
LVEDDI (mm/m2) 25.2±3.8 27.4±2.7 0.007 
LVESD(mm) 33.1±3.7 28.7±4.2 0.497 
FS (%) 39.7±9.2 36.8±7.4 0.118 
LVMI (g/m2) 94.2±32.4 78.9±21.4 0.022 
LVEF (%) 60.4±6.6 62.6±6.9 0.132 
LAVI (ml/m2) 32.6±10.9 23.9±8.6 <0.001 
E (m/s) 0.70±0.17 0.59±0.10 0.001 
A (m/s) 0.84±0.19 0.71±0.14 <0.001 
E/A 0.83±0.22 0.88±0.22 0.374 
DT (ms) 239.1±55.4 242.3±43.4 0.758 
IVRT (ms) 99.5±24.4 96.9±18.3 0.568 
E/e’ 11.5±4.4 8.1±1.2 <0.001 
 
Data is presented as mean ± standard deviation. 
p-value: unpaired t-test between patients and controls. 
 
IVSd, diastolic interventricular septal thickness;  PWd, posterior wall thickness; LVEDD, left ventricular 
end-diastolic diameter; LVEDDI, left ventricular end-diastolic diameter index; LVESD, left ventricular 
end-systolic diameter; FS, fractional shortening; LVMI, left ventricular mass index;  LVEF, left 
ventricular ejection fraction; LAVI, left atrial volume index; E, early mitral diastolic inflow velocity; A, 
late mitral diastolic inflow velocity; E/A, ratio of early to late mitral inflow velocities; DT, deceleration 
time of peak early Doppler mitral filling velocity; IVRT, isovolumic relaxation time; E/e’, ratio of early 
mitral diastolic inflow velocity to early diastolic mitral annular velocity. 
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7.5.2 HAEMODYNAMIC CHANGES  
Heart rate and blood pressure were comparable between the two groups at rest and 
were maintained at comparable levels on exercise (Table 7.3).  Cardiac output was 
not significantly different at rest.  Despite a significant increase in cardiac output on 
exercise in both groups, the cardiac output of patients was lower than controls on 
exercise.  While there was increase in stroke volume index in the control group, there 
was no significant increase in HFNEF patients on exercise.  There were no significant 
changes in left ventricular volumes in both groups.   
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Table 7.3 Haemodynamic measurements at rest and on exercise – 
dyssynchrony study 
 
 
 
Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
HR (bpm) 
 
69±11 91±10 <0.001 69±10 93±8 <0.001  0.842 * 
 0.138 # 
BP 
(mmHg) 
145±16 / 
 
77±11 
167±17 / 
 
87±12 
<0.001 
 
<0.001 
136±15 / 
 
78±7 
162±15 / 
 
86±8 
<0.001 
 
<0.001 
 0.008 * 
 0.139 # 
 0.362 * 
 0.717 # 
LVEDVI 
(ml/m
2
) 
40.3±10.5 38.7±8.1 0.192 38.1±8.4 40.1±7.1 0.475  0.414 * 
 0.190 # 
LVESVI 
(ml/m
2
) 
15.6±5.0 14.7±3.5 0.368 14.4±5.0 13.7±2.8 0.491  0.289 * 
 0.040 # 
SV (ml) 
 
72.9±23.0 76.7±24.2 0.216 63.5±14.6 82.5±23.9 0.001  0.033 * 
 0.314 # 
ΔSV (ml) 
 
 4.4±24.0   18.8±25.7   0.019 
SVI 
(ml/m
2
) 
39.1±9.9 43.8±13.8 0.101 37.2±8.4 48.8±13.0 0.001  0.361 * 
 0.045 # 
ΔSVI 
(ml/m
2
) 
 3.9±12.8   11.2±14.8   0.038 
CO (l/min) 
 
5.1±2.0 6.6±2.3 <0.001 4.4±1.2 7.8±2.5 <0.001  0.079 * 
 0.034 # 
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest   
 # unpaired t-test between patients and controls on exercise. 
HR, heart rate; BP, blood pressure; LVEDVI, left ventricular end-diastolic volume index; LVESVI, left 
ventricular end-systolic volume index; SV, stroke volume; SVI, stroke volume index; CO, cardiac 
output; Δ, (delta) change. 
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7.5.3 TISSUE DOPPLER IMAGING AND SPECKLE TRACKING 
In HFNEF patients, left ventricular twist and torsion were significantly lower at rest 
compared to the controls, but this difference became even more significant on 
exercise.  In fact, the magnitude of these measurements on exercise in patients 
remained lower than the resting results of control subjects (Table 7.4).  These results 
are consistent with the findings of the stand alone apical rotation in Chapter 5.  
Longitudinal and radial displacement were comparable at rest, but became 
significantly different on exercise (Table 7.4).     
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Table 7.4 Tissue Doppler and speckle tracking results – dyssynchrony study 
 
 
 
Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
Twist (°) 
 
18.0±5.7 19.5±5.9 0.066 21.0±4.9 25.9±6.0 <0.001  0.010 * 
 <0.001 # 
LV length 
(mm) 
70.8±6.9 69.3±7.9 0.184 70.4±6.0 69.9±6.1 0.653  0.750 * 
 0.728 # 
Torsion 
(º/cm) 
2.6±0.8 2.9±0.9 0.035 3.0±0.7 3.7±1.0 <0.001  0.009 * 
 <0.001 # 
Long. 
disp. 
(mm) 
-9.5±2.6 -11.0±2.7 0.001 -10.4±2.4 -12.7±3.1 0.001  0.073 * 
 0.011 # 
Radial 
disp. 
(mm) 
-6.9±1.5 -6.9±1.6 0.524 -6.7±0.8 -7.7±1.4 0.001  0.427 * 
 0.039 # 
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test of patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest   
    # unpaired t-test between patients and controls on exercise. 
 
LV, left ventricular; Long., longitudinal; disp., displacement. 
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There was a good correlation between the magnitude of left ventricular twist and 
longitudinal displacement on exercise (r=-0.583, p<0.001) (Figure 7.1), confirming 
the important mechanical link between these two motions which contribute to the 
overall mitral annular motion.  Any time delay between these two motions would 
contribute to the uncoupling of left ventricular mechanics.  The overall mitral annular 
motion is dependent on the coherent motion of the longitudinal fibres and the oblique 
fibres, resulting in the coordinated longitudinal displacement and twist in systole, both 
reaching peak at about the same time.  Due to their strong mechanical association, 
any disco-ordination between these two motions is expected to affect left ventricular 
systolic function particularly on exercise (Figure 7.2).  
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Figure 7.1 Correlation between longitudinal displacement and twist on 
exercise 
 
r, correlation; p, probability. 
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Figure 7.2 Twist-longitudinal motion delay in HFNEF 
 
AVC, aortic valve closure. 
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7.5.4 SYSTOLIC TORSIONAL DYSSYNCHRONY  
At rest, the time to reach peak systolic motion (peak longitudinal displacement, radial 
displacement, basal and apical rotation), expressed as the standard deviation of 
systolic motion (SDSM), was comparable between HFNEF patients and controls 
(48.6 ± 32.9 ms versus 43.1 ± 25.3 ms, p=0.63).  On exercise, controls were able to 
reduce SDSM significantly (p=0.002) whereas patients failed to show a significant 
decrease (p=0.505) (Table 7.5).  The SDSM correlated inversely with peak oxygen 
consumption (r= -0.27, p=0.03) as well as with the increase in stroke volume on 
exercise (r=-0.38, p=0.003) (Figure 7.3).  Importantly, the lower SDSM in control 
subjects on exercise was mainly due to a reduction in the time delay between twist 
and longitudinal contraction (twist-longitudinal motion delay, TLMD) (25.5 ± 54.3 ms 
at rest and 2.9 ± 31.2 ms on exercise in controls, p=0.025) as illustrated in 
Figure 7.2.  However, this did not occur to the same extent in HFNEF patients (51.4 ±  
68.0 ms at rest and 26.1±48.6 ms on exercise, p=0.229) (Table 7.5) (Figure 7.2).  In 
addition, SDSM on exercise correlated strongly with interventricular septal wall 
thickness (IVSd) (r=0.36, p=0.005) and left ventricular posterior wall (PW) thickness 
(r=0.45, p<0.001). 
   
In view of the inclusion of patients with atrial fibrillation as part of the ESC 
recommendation for diagnosing HFNEF (31), this study included five HFNEF patients 
with atrial fibrillation.  Some might argue that the electrical and mechanical 
activations in patients with atrial fibrillation are different from those in sinus rhythm, 
despite comparable cycle length and heart rate.  It is possible that these differences 
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could amplify dyssynchrony when the heart rate is increased on exercise.  Sub-
analysis performed excluding patients with atrial fibrillation did not change the 
outcome of the study but strengthened the statistical data (Table 7.5). 
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Table 7.5 Torsional dyssynchrony measurements at rest and on exercise 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value † 
 
Controls 
rest 
Controls 
exercise 
Controls  
p-value† 
Patients / 
controls  
p-value 
 
SDSM 
(ms) 
48.6±32.9 40.1±27.2 0.505 43.1±25.3 25.9±15.5 0.002  0.630 ‡ 
 0.025 § 
TLMD 
(ms) 
51.4±68.0 26.1±48.6 0.229 25.5±54.3 2.9±31.2 0.025  0.127 ‡ 
 0.016 § 
UT:LE 25.3±51.4 9.6±14.7 0.135 7.1±10.7 3.3±3.8 0.095  0.279 ‡ 
 0.011 § 
UT:LE 
(log) 
1.77±1.63 1.54±1.13  0.506 ** 1.29±1.18 0.67±1.3  0.042 **  0.152 * 
 0.006 # 
SDSM 
nonAF 
(ms) 
47.7±32.5 38.8±27.6 0.655 43.1±25.3 25.9±15.5 0.002  0.469 ‡ 
 
 0.022 § 
TLMD 
nonAF 
(ms) 
56.1±67.0 28.4±46.2 0.205 25.5±54.3 2.9±31.2 0.025  0.033 ‡ 
 
 0.005 § 
UT:LE 
nonAF 
23.1±54.9 10.4±15.3 0.055 7.1±10.7 3.3±3.8 0.095  0.064 ‡ 
 0.022 § 
 
Data is mean ± standard deviation. 
† Wilcoxon test of patients (or controls) at rest and on exercise. 
‡ Mann-Whitney U test between patients and controls at rest. 
§ Mann-Whitney U test between patients and controls on exercise.  
* unpaired t-test between patients and controls at rest.   
# unpaired t-test between patients and controls on exercise. 
** paired t-test of patients (or controls) at rest and on exercise. 
 
SDSM, standard deviation systolic motion; TLMD, twist-longitudinal motion delay; UT:LE, ratio of 
untwist to longitudinal extension; log; logarithm; nonAF, data excluding patients with atrial fibrillation. 
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Figure 7.3 Correlations between systolic torsional dyssynchrony and peak 
oxygen consumption and change in stroke volume 
 
 
 
 
VO2, oxygen consumption; SDSM, standard deviation systolic motion; r, correlation; p, probability; Δ, 
(delta) change in. 
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7.5.5 DIASTOLIC TORSIONAL DYSSYNCHRONY   
The ratio of untwist to longitudinal extension (UT:LE) which was not significantly 
different between HFNEF patients and control subjects at rest, became significantly 
different on exercise (Table 7.5).   The logarithmic transformation of UT:LE 
(UT:LE(log)) was calculated in view of non-normally distributed UT:LE data.  This did 
not change the finding that diastolic dyssynchrony was present on exercise but not at 
rest (Table 7.5).  Excluding the patients with atrial fibrillation did not change the 
message of this study (Table 7.5). 
 
As shown in Figures 7.4 and 7.5, the relationship between twist and longitudinal 
displacement was very different in HFNEF patients, with a steeper slope in HFNEF 
patients during diastole, indicating that more untwist occurring before a given 
longitudinal displacement is achieved.  
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Figure 7.4 Twist-longitudinal displacement loops at rest 
 
This figure illustrates the twist and longitudinal displacement (LD) relationship during 
systole and diastole in a healthy control and a HFNEF patient at rest. Green curve, 
systolic motion; red curve, diastolic motion; orange arrow, untwist without longitudinal 
extension in diastole; blue arrow, untwist and longitudinal extension in diastole; 
purple arrow, longitudinal extension without untwist in diastole.  
AVO, aortic valve opening; AVC, aortic valve closure; MVO, mitral valve opening; MVC, mitral valve 
closure; Peak-E, peak mitral inflow E wave; End-E, end of mitral inflow E wave; Peak EJ, peak 
ejection; Peak T, peak twist; Peak TR, peak twist rate; Peak UTR, peak untwist rate. 
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Figure 7.5 Twist-longitudinal displacement loops on exercise 
 
Descriptions are as per Figure 7.4.  In addition to the synchronous untwist and 
longitudinal motion in diastole (blue arrow) seen in control subject, there are two 
distinct separation of motions (orange and purple arrows) in patient.  
Annotations as per Figure 7.4.  
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In addition, HFNEF involved a delay in both untwisting and longitudinal displacement, 
particularly on exercise.  In contrast, diastolic untwisting and longitudinal extension 
appeared to occur simultaneously in healthy controls.  This uncoupling of diastolic left 
ventricular motion correlated with interventricular septal wall thickness, IVSd 
(r=0.364, p=0.004) and posterior wall thickness (r=0.340, p=0.007).  There is a 
significant correlation between TLMD and UT:LE(log) at rest (r=0.265, p=0.014) which 
became stronger on exercise (r=0.702, p<0.001), indicating the close relationship 
between systole and diastole particularly during exercise (Figure 7.6). 
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Figure 7.6 Correlation between systolic and diastolic dyssynchrony 
 
TLMD, twist-longitudinal motion delay; UT:LE(log), log of ratio of untwist to longitudinal extension; r, 
correlation; p, probability.  
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7.5.6 INTER-OBSERVER AND INTRA-OBSERVER VARIABILITY 
The inter-observer variability at rest assessed by interclass correlation coefficient 
(ICC) was between 0.90 and 0.95.  On exercise, the ICC varied from 0.70 to 0.98.  
The intra-observer variability ICC at rest varied from 0.86 to 0.98 and on exercise 
from 0.88 to 0.98.  These were similar to the results reported in Chapter 5.  
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7.6 DISCUSSION 
In addition to the widespread left ventricular and left atrial dysfunction shown in 
Chapters 5 and 6, this chapter demonstrated that left ventricular dyssynchrony is 
present in patients with HFNEF especially on exercise, by employing novel measures 
of torsional dyssynchrony, which were derived from left ventricular myocardial 
rotation, radial and longitudinal displacement as well as the coupling between twist 
and longitudinal displacement.  The temporal dispersion of these parameters, 
quantified in terms of standard deviation, was used as a measure of torsional 
dyssynchrony.  This study showed that in healthy controls, exercise leads to marked 
reductions in the SDSM and the TLMD, reflecting a reduction in the temporal 
dispersion of motion in the three planes as well as the coupling of left ventricular twist 
with longitudinal motion.  In contrast, HFNEF was associated with lesser reductions 
in the SDSM and the TLMD, reflecting a proportionally greater temporal dispersion 
and uncoupling of left ventricular twist and longitudinal motion on exercise, when 
patients became breathless.  In addition, HFNEF was also associated with 
uncoupling of untwist and longitudinal motion (extension) in diastole, measured using 
the ratio UT:LE.  These observations indicate that HFNEF involves exercise induced 
torsional dyssynchrony, in both systole and diastole.  
 
The coupling between rotational and longitudinal wall motion is crucial for left 
ventricular ejection and suction.  As discussed in Chapters 2 and 5, during systole, 
contraction of the longitudinal fibres pulls the mitral annulus towards the apex at the 
same time as the oblique fibres contract resulting in the wringing motion to further 
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bring the mitral annulus towards the apex to maximise left ventricular ejection. During 
diastole, the release of potential energy enables the oblique fibres to spring back and 
hence untwisting the left ventricle, creating an apex-base pressure gradient to 
enhance diastolic filling while the simultaneous longitudinal fibres relax to facilitate 
mitral annulus movement towards the base .  The efficiency and coupling of these 
motions are crucial to maintain left ventricular systolic and diastolic function, and 
particularly on exercise as illustrated in the strong correlation between TLMD and 
UT:LE.  
 
This study showed no significant difference in torsional dyssynchrony between 
HFNEF patients and age-matched controls at rest.  On exercise however, 
dyssynchrony was observed in patients with HFNEF, evidenced by a relatively higher 
SDSM compared with control subjects.  Importantly, this measure of systolic torsional 
dyssynchrony correlated negatively with changes in stroke volume and with peak 
oxygen consumption on cardiopulmonary exercise testing.  This suggests that in 
HFNEF, torsional dyssynchrony contributes to the inability to increase stroke volume 
and that this is related to dyspnoea and reduced exercise tolerance.  Accordingly, a 
mechanical effect may ensue even in the absence of changes in traditional 
echocardiographic parameters, such as left ventricular volumes. 
 
This study also showed that in HFNEF, untwisting occurs before longitudinal 
extension, unlike the coupled and nearly simultaneous longitudinal and untwisting 
motion observed in control subjects.  This temporal dispersion, or uncoupling, of 
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diastolic motions amounts to diastolic torsional dyssynchrony.  Speculatively, early 
diastolic torsional dyssynchrony could lead to reduced suction and therefore, an 
increase in the left ventricular end-diastolic and left atrial pressure, hence the 
symptom of breathlessness, the hallmark of HFNEF.  Correction of systolic torsional 
dyssynchrony could, in theory,  lead to correction of early diastolic torsional 
dyssynchrony simply by correcting dyssynchrony before it continues into the diastolic 
phase, therefore, it is possible that cardiac resynchronisation therapy (CRT) might 
correct exercise induced torsional dyssynchrony by the same mechanism that it 
corrects dyssynchrony in HFREF.  
 
The primary abnormality most probably resides in the extracellular matrix and the 
nature of the collagen related to left ventricular hypertrophy, and this may be a 
promising therapeutic target (147).  It is well established that most of the known 
conditions associated with HFNEF such as diabetes, hypertension, ischaemia and 
ageing all affect the extracellular matrix (148).  In addition, the subendocardially 
situated fibres that sustain the long axis movement by the nature of their position are 
more prone to injury (22;149).  Left ventricular hypertrophy itself is known to be 
associated with abnormal coronary flow reserve that may result in subendocardial 
ischaemia particularly on exercise (150).  But it is unlikely there is one 
pathophysiology mechanism common to all HFNEF subjects and a variety of 
abnormalities of the left ventricular mechanics will be present depending on the exact 
underlying pathology. 
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In contrast to previous studies of dyssynchrony in HFNEF (78;79), this study found a 
close relationship between the degree of systolic and diastolic dyssynchrony.  This 
makes more sense as physiologically, systole and diastole are closely intertwined. 
For example, there is a close relationship between the mitral annular systolic and 
diastolic velocities across a wide range of left ventricular ejection fractions (57).  In 
addition, left ventricular wall thickness was found to correlate with the degree of 
dyssynchrony suggesting that there is a conduction delay particularly between the 
longitudinal fibres found mainly in the subendocardium and the oblique fibres located 
mainly in the subepicardium. 
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7.7 LIMITATIONS 
As discussed in previous chapters, one limitation of speckle tracking is a lower frame 
rate so possibly peak velocities could be missed.  However, the exercise during 
echocardiography was deliberately sub-maximal, enough to induce symptoms of 
breathlessness in patients while keeping the heart rate less than 100bpm.  This may 
reflect the limitation of speckle tracking itself.  Plane motion measurements and 
timings were not taken from the same frame but these were all corrected to cycle 
length and interpolated.  Given that this is the first study to demonstrate 
dyssynchrony in different planes, there was no standard value of plane motion 
dyssynchrony to compare. 
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7.8 CONCLUSION 
Using novel measures of left ventricular dyssynchrony, this study demonstrated that 
in HFNEF, exercise leads to systolic and diastolic torsional dyssynchrony.  This 
amounts to an increase in the temporal dispersion of motion in three planes as well 
as an uncoupling of the left ventricular twist and longitudinal motions.  
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8. LEFT VENTRICULAR DYSFUNCTION IN CONTROLLED 
HYPERTENSIVE SUBJECTS  
8.1 SUMMARY 
This study tested the hypothesis that hypertensive patients with exertional dyspnoea 
despite well-controlled blood pressure, normal resting echocardiographic findings 
and absence of left ventricular hypertrophy, may have abnormalities of left ventricular 
function which only occur on exercise and contribute to their symptoms.  
  
Symptomatic hypertensive patients with well-controlled blood pressure on 
medications and normal baseline echocardiography underwent cardiopulmonary 
exercise testing to determine their peak oxygen consumption, followed by rest and 
submaximal supine exercise echocardiography.  
 
Thirty treated hypertensive patients with exertional dyspnoea and 22 age-matched 
healthy controls had rest and exercise images of sufficient quality for analysis.  Both 
groups had comparable standard echocardiographic findings at rest.  On exercise, 
patients had reduced overall left ventricular long axis function and ventricular rotation 
in systole, delayed untwist and reduced suction in diastole in addition to significantly 
lower overall left ventricular longitudinal functional reserve which correlated with 
significantly reduced peak VO2. 
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This study concluded that treated hypertensive patients with exercise limitation can 
have widespread systolic and diastolic left ventricular dysfunction on exercise despite 
normal resting echocardiography.  Normal resting echocardiography does not 
preclude the presence of significant functional abnormalities on exercise that can 
contribute to symptoms.  This group of patients might progress to develop HFNEF 
with time. 
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8.2 INTRODUCTION 
There is a high prevalence of hypertension amongst patients diagnosed with 
HFNEF (3).  Melenovsky et al. found many shared clinical features between patients 
with HFNEF and asymptomatic hypertensive patients with left ventricular hypertrophy 
which are significantly different from healthy subjects (71).  This is one of the very 
few exercise studies which compared these two groups of subjects.  They found 
many left ventricular systolic, diastolic and arterial abnormalities which were thought 
to contribute to the pathophysiology of HFNEF in patients with hypertension and left 
ventricular hypertrophy without symptoms of heart failure.  However, many patients 
with treated hypertension have exercise-induced dyspnoea despite normal standard 
echocardiography (no evidence of left ventricular hypertrophy) and frequently it is 
concluded that the breathlessness is therefore not cardiac.   
 
In view of the previous findings in HFNEF patients shown in Chapters 5 to 7, this 
study aimed to establish if patients with hypertension alone and without left 
ventricular hypertrophy who complained of breathlessness, would have similar 
abnormalities of the left ventricular and left atrial function on exercise, particularly 
those involving longitudinal ventricular function and twist mechanics.  This study 
involved a group of treated hypertensive subjects without left ventricular hypertrophy 
or chamber dilatation and apparently normal systolic function on resting 
echocardiography.   
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8.3 METHODS 
Left ventricular systolic and diastolic functions were assessed non-invasively at rest 
and on sub-maximal exercise in patients with an established diagnosis of 
hypertension and healthy controls.  All subjects underwent pulmonary function test 
and cardiopulmonary exercise test, rest and exercise echocardiography studies as 
described in Chapter 4. 
 
8.3.1 STUDY SUBJECTS 
Patients with well controlled blood pressure on medication and complaining of 
exertional dyspnoea without an alternative explanation for their symptoms and with 
normal echocardiographic findings during their initial assessment were studied.  Data 
of the same cohort of healthy controls recruited for studies in Chapters 5 to 7 was 
used as comparison.   
 
Well controlled blood pressure was defined as systolic blood pressure of ≤ 140 
mmHg and / or diastolic blood pressure of ≤ 90 mmHg while on medication.  
Exclusion criteria applied in this study included uncontrolled blood pressure on 
medications and the presence of left ventricular hypertrophy on echocardiography, in 
addition to the exclusion criteria outlined in section 4.1.   
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8.3.2 CARDIOPULMONARY EXERCISE TESTING 
All subjects underwent full pulmonary function assessment with standard spirometry 
(forced expiratory volume in one second and forced vital capacity) followed by 
cardiopulmonary exercise testing as described in Chapter 4.   
 
8.3.3 TWO-DIMENSIONAL AND TISSUE DOPPLER 
ECHOCARDIOGRAPHY 
All subjects underwent full echocardiography examination at rest and on exercise 
using a semi-recumbent and tilting bicycle ergometer as described in Chapter 4.   
 
Two-dimensional (2D) images and colour-coded tissue Doppler images (TDI) from 
the parasternal (long axis and short axis at basal, mid ventricular and apical levels) 
and apex (two, three and four chamber views) were obtained and stored digitally and 
analysed as described in Chapter 4. 
   
Left ventricular dimensions, wall thickness, volume and ejection fraction were 
measured as previously described in Chapter 4.  Left ventricular mass was 
calculated according to Devereux formula (110).  Left ventricular mass index (LVMI) 
of > 115 g/m2 (male) and > 95 g/m2 (female) were defined as left ventricular 
hypertrophy.  Left atrial volume and left atrial volume index were measured and 
calculated as described in Chapter 4.  Systolic and diastolic longitudinal function 
reserve indexes were calculated by:  ΔSm (or Em) x [1-(1/Sm (or Em)rest)] (125).
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8.3.4 SPECKLE TRACKING ECHOCARDIOGRAPHY 
Left ventricular longitudinal strain, radial strain and rotation were assessed using the 
speckle tracking method and offline analysis was performed as described in 
Chapter 4.  The average longitudinal strain of all four walls (12 segments) was taken 
as the global longitudinal strain as reported in Chapter 5.  Radial strain was taken as 
the average of six segments of the mid ventricular short axis plane.  The percentage 
untwist was assessed by marking the averaged rotation curve at 25% time increment 
points from peak rotation (0%) to peak untwist (100%) as illustrated in Chapter 4 
(Figure 4.8).   
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8.4 STATISTICS   
Statistical analyses were performed as described in Chapter 4. 
 
Comparisons between patients and controls were performed using an unpaired t-test 
for normally distributed data and the Mann-Whitney U-test for non-normally 
distributed data.  Comparisons within patients and controls were performed using a 
paired t-test only as all data was normally distributed.  Linear regression was 
performed to test correlations. 
 
Inter-observer and intra-observer agreements were performed to test the variability of 
tissue Doppler analysis, speckle tracking analysis and mitral flow propagation 
velocity.   
 
 
203 
 
8.5 RESULTS 
A total 70 subjects were recruited in this study (48 patients and 22 controls).  
Eighteen patients were excluded: three had evidence of left ventricular hypertrophy 
on repeat echocardiography, one had evidence of ischaemia on exercise, six had 
poor picture quality not suitable for analysis, two were unable to exercise and six had 
left atrial enlargement on subsequent analysis of left atrial volume.  The remaining 30 
symptomatic hypertensive patients and 22 healthy controls had adequate images at 
rest and on exercise for analysis.   
 
The mean age of patients was 71 ± 8 years and 60% were female.  Control subjects 
were of comparable age (70 ± 6 years) and 72% were female.  The past medical 
history and drug history of patients are summarised in Table 8.1.  Patients had a 
significantly higher BMI compared to controls.  The peak VO2 and the achieved 
percentage of predicted oxygen consumption were significantly lower in patients than 
controls.   
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Table 8.1 Clinical characteristics – hypertension study 
 
 
 
Hypertensive 
patients 
Controls p-value 
Number of subjects 30 22  
Age 71±8 70±6  0.524  
Gender 18♀/ 12♂ 16♀/6♂  0.390 * 
BMI (kg/m2) 30±5 25±4  <0.001  
NYHA  class II =19 
class III =11 
n/a  
Peak VO2 (ml/min/kg) 
(percent of predicted)  
18.0±4.0 
(77±18%) 
29.0±.5.6 
(133±22%) 
 <0.001  
Years of hypertension 6.6±5.2 0  <0.001 ‡ 
Diabetes mellitus 6 (20%) 0 (0%)  
Coronary artery disease 6 (20%) 0 (0%)  
ACE-Inhibitor 10 (33%) 0 (0%)  
AR1-Blocker 7 (23%) 0 (0%)  
β-Blocker 11(37%) 0 (0%)  
Calcium channel blocker 9 (30%) 0 (0%)  
Diuretic 15 (50%) 0 (0%)  
α-Blocker 4 (13%) 0 (0%)  
Statin 11 (37%) 0 (0%)  
 
Data is presented as number (and %) or mean ± standard deviation. 
p-value: unpaired t-test between patients and controls except * Fisher exact test between patients and 
controls and ‡ Mann-Whitney U test between patients and controls. 
 
Annotations as per Table 5.1..  
 
205 
 
8.5.1 2D ECHOCARDIOGRAPHY 
The left ventricular ejection fraction, dimensions, wall thickness, left ventricular mass 
index (LVMI) and left atrial volume index (LAVI) were all comparable between 
patients and controls, and all parameters were within normal limits (Table 8.2).  
Diastolic parameters were also comparable between the two groups except the early 
(E) and the late (A) mitral inflow velocity, which were statistically significantly higher 
in patients but still within normal limits (Table 8.3).  Heart rate and blood pressure 
were comparable between the two groups both at rest and on exercise (Table 8.3).   
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Table 8.2 Standard echocardiographic parameters – hypertension study 
 Hypertensive 
patients 
Controls p-value 
IVSd (mm) 9.7±2.4 9.8±2.0 0.841 
PW thickness (mm) 9.6±1.7 9.0±1.1 0.158 
LVEDD (mm) 46.7±5.7 46.1±5.8 0.682 
LVESD (mm) 29.0±4.6 28.7±4.6 0.793 
FS (%) 38±7 38±7 0.859 
LVMI (g/m2) 78.6±22.4 81.0±18.8 0.693 
LVEDVI (ml) 42.7±12.2 40.9±9.6 0.614 
LVESVI (ml) 16.4±6.5 15.8±5.8 0.775 
LVEF (%) 62±6 62±8 0.944 
LAVI (ml/m2) 26.9±6.0 25.4±8.4 0.457 
 
Data is presented as mean ± standard deviation. 
p-value: unpaired t-test between patients and controls. 
 
IVSd, interventricular septal wall thickness; PW, posterior wall; LVEDD, left ventricular end-diastolic 
diameter ; LVESD, left ventricular end-systolic diameter; FS, fractional shortening; LVMI, left 
ventricular mass index; LVEDVI, left ventricular end-diastolic volume index; LVESVI, left ventricular 
end-systolic volume index; LVEF, left ventricular ejection fraction; LAVI, left atrial volume index. 
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Table 8.3 Haemodynamic and Doppler data – hypertension study  
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
HR (bpm) 69±12 89±9 <0.001 70±10 91±5 <0.001  0.877 * 
 0.271 # 
BP 
(mmHg) 
141±18 /  
 
74±11 
163±19 /  
 
85±14 
<0.001 
 
<0.001 
 
139±14 / 
 
79±9 
163±12 / 
 
87±9 
<0.001 
 
<0.001 
 
 0.617 * 
 0.934 # 
 0.081 * 
 0.564 # 
E (m/s) 0.68±0.16 0.93±0.15 <0.001 0.56±0.12 0.96±0.11 <0.001  0.006 * 
 0.420 # 
Δ E (m/s) 
 
 0.26±0.15   0.40±0.12   0.001  
A (m/s) 
 
0.84±0.20 1.00±0.19 <0.001 0.68±0.15 0.90±0.18 <0.001  0.003 * 
 0.070 # 
E/A 0.83±0.20 0.96±0.23 <0.001 0.86±0.27 1.10±0.24 <0.001  0.569 * 
 0.039 # 
DT (ms) 250±48 180±39 <0.001 257±47 166±45 <0.001  0.599 * 
 0.234 # 
IVRT (ms) 93±19 61±13 <0.001 100±24 67±11 <0.001  0.293 * 
 0.155 # 
E/e’ 9.4±2.6 10.1±2.1 0.178 8.4±2.1 9.3±2.2 0.367  0.141 * 
 0.171 # 
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test for patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
HR, heart rate; BP, blood pressure; E, early diastolic mitral inflow velocity; A, late diastolic mitral inflow 
velocity; E/A, ratio of E to A; DT, deceleration time; IVRT, isovolumic relaxation time; e’, peak early 
diastolic myocardial mitral annular velocity; E/e’ ratio of E to e’; Δ, (delta) change in. 
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8.5.2 LONGITUDINAL FUNCTION 
 
Sm and Em at rest were comparable between patients and controls but became 
significantly different on exercise (Table 8.4).  Exercise tissue Doppler imaging data 
of 83% of patients and 91% of controls were acceptable for analysis.  An example of 
a recording is given in Figure 8.1.  Patients failed to increase Sm and Em to the 
same extent as controls on exercise (Figure 8.2a).  As a result, the systolic and 
diastolic longitudinal function reserve indexes were significantly lower in patients 
(Table 8.4). These results were very similar to those reported in Chapter 5 comparing 
HFNEF patients and healthy controls.  In addition, Am was significantly higher in 
controls at rest and on exercise, similar to the results in Chapter 6 comparing Am 
between HFNEF patients and healthy controls. 
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Table 8.4 Tissue Doppler data – hypertension study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
Sm 
(cm/s) 
5.41±1.23 6.12±1.07 <0.001 5.75±0.91 7.77±0.95 <0.001  0.336 * 
 <0.001 # 
Δ Sm 
(cm/s) 
 0.82±0.59   1.85±0.95   0.003 
SLFRI 
 
 0.97±1.34   2.32±1.24   0.001  
Em 
(cm/s) 
4.82±1.02 6.74±1.34 <0.001 5.39±1.14 8.48±1.19 <0.001  0.103 * 
 0.001 # 
Δ Em 
(cm/s) 
 1.92±1.19   3.05±1.63   0.042  
DLFRI 
 
 1.83±1.65   3.40±3.02   0.020  
Am  
(cm/s) 
7.12±1.23 8.37±1.20 0.008 8.12±1.24 9.79±1.79 0.002  0.016 * 
 0.022 # 
ΔAm 
(cm/s) 
 1.33±1.50   1.54±1.45   0.721  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test for patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
Sm, peak systolic myocardial mitral annular velocity; SLFRI, systolic longitudinal function reserve 
index; Em, peak early diastolic myocardial mitral annular velocity; DLFRI, diastolic longitudinal function 
reserve index; Am, peak late diastolic myocardial mitral annular velocity; Δ, (delta) change in. 
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When longitudinal function was assessed using speckle tracking, the global 
longitudinal strain was found to be significantly lower in patients not only on exercise 
but also at rest (Table 8.5).  The global longitudinal strain result was based on the 
63% of patients and 82% of controls who had exercise images of sufficient quality for 
speckle tracking.  Even though patients had a significant increase in longitudinal 
strain on exercise, the magnitude of longitudinal strain on exercise was only 
comparable to the magnitude of longitudinal strain in controls at rest.  An example of 
longitudinal strain recording is given in Figure 8.1.  Only Am and global longitudinal 
strain were found to be significantly lower in patients compared to controls at rest, 
while other parameters were comparable at rest and only became abnormal on 
exercise.  These results are in contrast with the results of patients with HFNEF 
reported in Chapter 5 which showed that measures of longitudinal function, radial 
function, apical rotation and untwist were all significantly lower than controls at rest.   
211 
 
Figure 8.1 Example of exercise parameters of hypertensive patient and 
control 
Healthy control Patient
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TDI, tissue Doppler imaging; Sm, peak systolic myocardial mitral annular velocity; Em, peak early 
diastolic myocardial mitral annular velocity; MVC, mitral valve closure; AVO, aortic valve opening; 
AVC, aortic valve closure; MVO, mitral valve opening; Vp, mitral flow propagation velocity. 
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Table 8.5 Speckle tracking and mitral flow propagation velocity data – 
hypertension study  
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
GlobLong 
Strain (%) 
-19.0±2.4 -21.2±3.8 0.007 -20.9±3.1 -23.8±2.6 0.001  0.031 * 
 0.020 # 
Rad 
Strain (%) 
41.6±9.9 53.3±14.4 0.014 45.3±8.5 59.6±14.5 <0.001  0.204 * 
 0.185 # 
Apical Rot 
(º) 
10.9±4.3 13.1±4.6 0.056 12.8±2.7 17.0±3.4 <0.001  0.106 * 
 0.013 # 
Early UT 
(%) 
27.6±10.5 20.4±7.6 0.056 29.9±9.5 30.6±7.8 0.907  0.518 * 
 0.001 # 
Mid UT 
(%) 
55.0±13.3 51.9±14.1 0.829 57.4±8.3 63.3±7.5 0.040  0.533 * 
 0.012 # 
Late UT 
(%) 
77.2±4.5 78.7±12.4 0.986 81.3±7.9 84.7±5.0 0.111  0.090 * 
 0.105 # 
Vp (m/s) 37.3±7.6 47.2±9.7 0.001 38.4±7.3 63.3±12.3 <0.001  0.615 * 
 <0.001 # 
Δ Vp 
(m/s) 
 10.6±10.9   24.5±12.2   <0.001  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test for patients (or control)  at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
 
GlobLong, global longitudinal; Rad, radial; Rot, rotation; UT, untwist; Vp, mitral flow propagation 
velocity; Δ, (delta) change in. 
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Figure 8.2 Boxplots of long axis function, radial function, apical rotation and 
mitral flow propagation velocity at rest and on exercise 
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Boxplot shows minimum, first quartile, median, third quartile and maximum. 
 
Sm, peak systolic myocardial mitral annular velocity; Em, peak early diastolic myocardial mitral 
annular velocity; p, probability. 
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8.5.3 RADIAL FUNCTION, ROTATION AND UNTWIST 
Only 63% of patients and 82% of controls had mid left ventricular short axis images 
of adequate quality on exercise for analysis.  There were no significant differences in 
radial strain at rest and on exercise between patients and controls (Table 8.5, 
Figure 8.2b).  This was reflected in the comparable ejection fraction and fractional 
shortening between the two groups of subjects at rest indicating that radial function is 
largely preserved.  However, ventricular rotation in systole which was comparable at 
rest in both groups, was found to be significantly reduced in patients on exercise 
(Table 8.5, Figure 8.2c).  An example of left ventricular rotation analysis is given in 
Figure 8.1. 
 
Five patients were found to have increased peak apical rotation at rest (> 15˚).  
Patients who had higher peak rotation at rest failed to increase left ventricular 
rotation on exercise.  Similar to the findings for longitudinal strain, the magnitude of 
apical rotation on exercise in patients increased only to a level comparable to 
controls at rest, which is very similar to the findings in HFNEF patients as reported in 
previous chapters.  In diastole, the percentage left ventricular untwist in early diastole 
and mid-diastole were comparable at rest but became significantly different on 
exercise, indicating delayed untwisting in early diastole on exercise (Table 8.5, 
Figure 8.3).  
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Figure 8.3 Percentage untwist at rest and on exercise between hypertensive 
patients and controls 
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Boxplot shows minimum, first quartile, median, third quartile and maximum. 
p, probability. 
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8.5.4 LEFT VENTRICULAR SUCTION  
Ninety seven percent of patients and 100% of controls had good quality colour M-
mode profile on exercise for analysis.  Mitral flow propagation velocity (Vp) was found 
to be comparable between patients and controls at rest but became significantly 
different only on exercise due to a significant increase in Vp on exercise in control 
subjects (Table 8.5, Figure 8.2d).  
 
Peak VO2 correlated with the following echocardiographic parameters on exercise 
(Figure 8.4): Sm (r=0.66, p<0.001), Em (r=0.645, p<0.001), apical rotation (r=0.611, 
p<0.001), Vp (r=0.594, p<0.001) and early untwist (r=0.523, p=0.007).   
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Figure 8.4 Correlation between parameters on exercise and peak VO2 
 
 
 
VO2, oxygen consumption; Sm, peak systolic myocardial mitral annular velocity; Em, peak early 
diastolic myocardial mitral annular velocity; Vp, mitral flow propagation velocity; r, correlation; p, 
probability. 
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8.5.5 INTER-OBSERVER AND INTRA-OBSERVER VARIABILITY 
Similar to Chapter 5, the interclass correlation coefficient (ICC) for inter-observer 
variability at rest was between 0.88 and 0.95.  On exercise the ICC varied from 0.70 
to 0.98 and Vp had the highest inter-observer variability.  The intra-observer 
variability ICC at rest varied from 0.88 to 0.98 and on exercise from 0.69 to 0.98 and 
Vp had the highest variability. 
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8.6 DISCUSSION 
This study showed that in patients with well-treated hypertension, there were 
surprisingly significant abnormalities of ventricular function affecting longitudinal 
function, rotation, untwisting rates and left ventricular suction on exercise despite a 
normal standard echocardiography examination at rest and in the absence of left 
ventricular hypertrophy.  These abnormalities, which are only apparent on exercise, 
correlate significantly with peak oxygen consumption and probably account for the 
symptom of breathlessness on exertion.   
 
The results of this study have significant implication for the treatment of hypertension 
and emphasise the importance of using agents that may prevent or reverse these 
early significant abnormalities of ventricular architecture and function.   
  
These results are especially relevant to the clinical problem of deciding whether the 
symptom of breathlessness is cardiac in origin or not.  Often in practice a normal 
echocardiogram is used to exclude a cardiac cause and the breathlessness is then 
considered to be respiratory or due to obesity.  Previous studies have questioned the 
true incidence of HFNEF because of normal echocardiography and other presumed 
aetiologies such as obesity or lung disease (151).  Patients in this study had higher 
BMIs but this study confirmed that despite normal standard echocardiography these 
patients have major abnormalities of the left ventricular function which become 
apparent only on exercise and are only detected with more sophisticated 
measurements and analysis.  Left ventricular function is clearly not normal despite a 
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normal left ventricular ejection fraction at rest.  More importantly, the trend of the 
abnormalities found in this group of patients was very similar to those found in 
patients with HFNEF. 
 
Previous studies have shown reduced long axis function or mitral annular motion 
associated with left ventricular hypertrophy and hypertrophic cardiomyopathy 
(152;153).  However, this study demonstrated the presence of a reduced long axis 
function at rest in hypertensive patients without left ventricular hypertrophy.  There 
was also markedly reduced longitudinal functional reserve on exercise in this group 
of patients.  Borges et al. also found reduced mitral annular systolic and diastolic 
velocities in hypertensive subjects with or without left ventricular hypertrophy 
compared to normotensive controls (154).  In their study mitral annular velocities 
correlated with left ventricular mass index (LVMI) and hypertensive subjects with 
clinically defined ‘normal’ LVMI had higher LVMI than normotensive subjects, 
implying that even sub-clinical levels of left ventricular mass increase are associated 
with impaired long axis function.  They also found a significant correlation between 
the systolic and diastolic velocities similar to another study (57), illustrating the 
important link between systolic and early diastolic filling.  As discussed in previous 
chapters, longitudinal shortening is mainly dependent on the subendocardial fibres 
(155) and these may be affected first by the effects of fibrosis and reduced 
subendocardial flow reserve (156). 
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There have been a few studies on the effects on anti-hypertensive therapies on 
longitudinal ventricular function.  Borges et al. found that acute treatment with 
Captopril had no significant effect on either Sm or Em in hypertensive subjects with 
or without left ventricular hypertrophy (154).   In heart failure subjects, Andersson et 
al. found that treatment with Metoprolol CR/XL led to an increase in atrioventricular 
plane displacement (or long axis longitudinal function) after six weeks (157).  In 
patients with HFNEF, diuretics combined with Irbesartan or Ramipril led to a small 
but significant improvement in longitudinal myocardial velocities (135).   It is unlikely 
therefore that the depression in longitudinal velocities seen in this study is due to the 
drug therapies per se.  There does not appear to be any significant previous work on 
the effect of anti-hypertensive drug therapy on ventricular twist mechanics. 
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8.7 LIMITATIONS  
Similar to the limitations in previous chapters, exercise was submaximal but this was 
dictated by the frame-rate limitations of speckle tracking.  However, this level of 
exercise is more appropriate for this age group and probably reflects more 
realistically the level of daily activities.  Also, speckle tracking imaging on exercise is 
technically demanding and this study only reported apical rotation given that the left 
ventricular apex is relatively fixed in position and allows very reliable speckle tracking 
analysis even on exercise.  In addition, apical rotation has been shown to represent 
the dominant component of the overall left ventricular torsion as discussed in 
previous chapters.  
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8.8 CONCLUSION 
In conclusion, this study showed that treated hypertensive subjects, without evidence 
of left ventricular hypertrophy and normal standard echocardiography, have 
abnormalities of the longitudinal function, twist, strain and ventricular suction which 
worsen on exercise.  It is likely that these abnormalities are relevant to the symptom 
of breathlessness that they experienced despite optimal blood pressure control. It 
remains unknown if this group of patients would progress to develop HFNEF.  Figure 
8.5 provides an illustrated synopsis of the probable pathophysiology. 
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Figure 8.5 Schema illustrating the pathophysiology of breathlessness in 
hypertensive patients without left ventricular hypertrophy 
 
 
LV, left ventricular. 
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CHAPTER 9: 
MITRAL ANNULAR PEAK SYSTOLIC 
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annular plane systolic excursion on exercise: a simple diagnostic tool for heart failure 
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9. MITRAL ANNULAR PEAK SYSTOLIC EXCURSION ON 
EXERCISE - A SIMPLE TEST FOR THE DIAGNOSIS OF 
HFNEF? 
9.1 SUMMARY 
Patients with HFNEF mainly present with exertional symptoms.  It is not surprising 
that left ventricular dysfunction is more apparent on exercise and often undetected at 
rest.  Current guidelines for the diagnosis of HFNEF are predominantly based on 
measurements at rest.  Imaging and analysis performed on exercise is challenging 
and is not readily available.  A simple and reliable test which can be performed on 
exercise would be a useful diagnostic tool.  This study tests the hypothesis that mitral 
annular plane systolic excursion (MAPSE) which is easy to acquire and measure on 
exercise could be used to detect occult left ventricular impairment and to distinguish 
patients with HFNEF.  
 
Sixty two patients with HFNEF and 36 control subjects were studied.  MAPSE at rest 
which was significantly lower in patients became even more pronounced on exercise.  
At rest MAPSE correlated with longitudinal strain (r= 0.432, p=0.001), peak systolic 
myocardial velocity (r= 0.545, p<0.001), and early diastolic myocardial velocity 
(r=0.322, p=0.02).  On exercise, MAPSE correlated with left ventricular apical rotation 
(r=0.582, p<0.001), longitudinal strain (r=0.589, p<0.001) and myocardial tissue 
velocities (r=0.730, p<0.001).  The area under the ROC curve for MAPSE was 0.66 
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(confidence interval 0.54-0.77) at rest and 0.90 (confidence interval 0.84-0.97) on 
exercise to differentiate between patients and controls.  
 
MAPSE at rest and on exercise correlated well with more sophisticated 
measurements of left ventricular function in HFNEF patients.  It is easy to acquire 
and measure, particularly on exercise, therefore it is a potentially useful test for 
diagnosing HFNEF.  
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9.2 INTRODUCTION 
As discussed in Chapter 1, the diagnosis of HFNEF is challenging and not 
straightforward.  The European Society of Cardiology (ESC) and the American 
Society of Echocardiography (ASE) published guidelines and recommendations with 
comprehensive and complex echocardiographic parameters to assess the left 
ventricular function, particularly diastolic dysfunction, to diagnose patients with 
HFNEF (31;32).  However, some of the suggested parameters might be technically 
challenging to measure particularly in obese patients such as Ard-Ad (difference 
between duration of reversed pulmonary vein atrial systolic flow (Ard) and duration of 
late diastole mitral inflow (Ad)).  Some of the parameters such as LAVI or LVMI are 
indexed to body surface area which might not be measured in routine clinical 
practice, even though increasingly applied in clinical settings.  Sophisticated 
echocardiographic techniques and subsequent analyses, such as colour tissue 
Doppler imaging or speckle tracking imaging, applied and reported in Chapters 5 to 
8, are time consuming and not applicable for routine clinical practice.  More 
importantly, left ventricular dysfunction not seen at rest is more apparent on exercise 
which is when patients are most symptomatic (136).  Consequently, problems with 
accurate diagnosis make assessment of prognosis difficult (158). 
 
Therefore, a simple measurement to diagnose left ventricular impairment at rest and 
on exercise may be useful to address the issues above.  In Chapter 5, speckle 
tracking (strain) and colour TDI (Sm, Em) assessments have shown that systolic and 
diastolic longitudinal functions are significantly impaired in HFNEF patients at rest 
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and on exercise (136).  Mitral annular peak systolic excursion (MAPSE) is an easy 
way to assess longitudinal function and had been shown to be a sensitive marker of 
left ventricular impairment in many different cardiac conditions (159-161).   
This study tests the hypothesis that MAPSE correlates with more complex 
echocardiographic parameters and can be used as a simple and reliable tool to 
detect left ventricular impairment at rest , particularly on exercise, and could 
differentiate between HFNEF patients and healthy controls.  
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9.3 METHODS 
Patients and healthy controls with a comparable mean age were recruited as outlined 
in Chapter 4.  Patients were categorised according to the criteria outlined in the 
European Society of Cardiology 2007 guidelines (31).  Those who fulfilled all the 
criteria were labelled as HFNEF and those who did not were labelled as non-HFNEF.  
All subjects underwent cardiopulmonary exercise testing as described in Chapter 4. 
 
9.3.1 TWO-DIMENSIONAL AND TISSUE DOPPLER 
ECHOCARDIOGRAPHY 
Rest and exercise echocardiography was performed as outlined in Chapter 4.  Blood 
pressure was measured at rest and on peak exercise.  Image acquisitions and 
analyses including those of colour tissue Doppler imaging and speckle tracking 
imaging were performed as described in Chapter 4. 
   
Mitral annular peak systolic excursion (MAPSE) was measured by using the apical 
four chamber view focused on the left ventricle.  An M-Mode vector was placed 
through the mitral annulus close to the septal and the lateral wall, respectively.  The 
vector was adjusted to be as parallel to the walls as possible, optimised by using 
anatomical M-Mode where necessary.  MAPSE was measured in millimetres as 
previously described (159-161).  Values of both septal and lateral walls were 
averaged.   
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9.4 STATISTICS 
Statistical analyses were performed as described in Chapter 4. 
 
Comparisons between patients and controls were performed using an unpaired t-test 
for normally distributed data and the Mann-Whitney U-test for non-normally 
distributed data.  Comparisons between HFNEF patients, non-HFNEF patients and 
controls were performed using ANOVA with Tukey post-hoc analysis.  A paired t-test 
was used to compare resting and exercise data within the patients and the controls. 
 
Receiver operator curves (ROC) were plotted to examine the ability of MAPSE to 
differentiate patients and healthy controls, at rest and on exercise, and also to 
differentiate between patients fulfilling the HFNEF criteria outlined by the European 
Society of Cardiology and healthy controls at rest and on exercise.  Pearson’s 
correlation coefficient was used to examine associations between variables.  
 
Inter-observer and intra-observer agreements were performed using readings of 20 
randomly selected subjects and reported as interclass correlation coefficient (ICC) 
with 95% confidence interval.   
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9.5 RESULTS 
A total of 149 subjects (92 patients and 57 controls) were recruited into this study. 
Thirty patients were excluded due to reasons outlined in Chapters 5-7.  In summary, 
seven had respiratory limitation on cardiopulmonary exercise testing, three had no 
increase in heart rate on exercise, one was found to have evidence of ischaemia on 
cardiopulmonary exercise testing, one had normal peak VO2 on exercise, one had 
completely normal echocardiogram, and 17 were unable to exercise or had poor 
picture quality for analysis.  Data of 36 healthy controls recruited as outlined in 
Chapter 4 was used for comparison.   Demographic data of patients and healthy 
controls is presented in Table 9.1. 
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 Table 9.1 Clinical characteristics – mitral annular peak systolic excursion 
study 
 Patients Controls p-value 
Number 62 36  
Age 71±8 70±7  0.599 
Gender 41♀ / 21♂ 29♀ / 7 ♂  0.166 * 
BMI (kg/m2) 30.5±4.8 24.4±3.4  <0.001 
NYHA  class II=44 
class III=18 
n/a  
Peak VO2 (ml/min/kg) 
(percent of predicted)  
18.6±5.2 
(77±18%) 
29.4±4.8 
(133±22%) 
 <0.001 
Years of hypertension  9.0±9.6 0  <0.001 ‡ 
NT-proBNP (pg/ml) 138.2±147.2 54.3±24.8  0.012 
Diabetes mellitus 16 (26%) 0 (0%)  
Atrial fibrillation 5 (8%) 0 (0%)  
ACE-inhibitor 19 (31%) 0 (0%)  
AR1-blocker 20 (32%) 0 (0%)  
Beta-blocker 22 (35%) 0 (0%)  
Ca-channel blocker 15 (24%) 0 (0%)  
Diuretic 31 (50%) 0 (0%)  
Alpha-blocker 11 (18%) 0 (0%)  
Statin 19 (31%) 0 (0%)  
 
Data is presented as number (and %) or mean ± standard deviation. 
p-value: unpaired t-test between patients and controls except * Fisher exact test between patients and 
controls and ‡ Mann-Whitney U test between patients and controls. 
 
Annotations as per Table 5.1 
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The left ventricular ejection fraction and left ventricular dimensions were comparable 
between patients and controls.  Left ventricular mass index, left atrial volume index 
(LAVI), mitral inflow E and A waves, and E/e’ were all significantly higher in patients 
(Table 9.2).  Twenty three (23/62) patients were found to fulfil the HFNEF criteria 
outlined by the European Society of Cardiology (Figure 9.1). 
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Table 9.2 Standard echocardiographic parameters – mitral annular peak 
systolic excursion study 
 Patients Controls p-value 
LVEF (Simpson) (%) 60±7 62±7  0.187 
IVSd (mm) 11.3±3.2 9.4±1.8  0.004 
PW thickness (mm) 11.0±2.5 9.2±1.5  0.001 
LVEDD (mm) 46.6±6.4 45.6±5.1  0.440 
LVESD (mm) 28.8±5.5 28.5±4.2  0.747 
FS (%) 38.4±7.7 37.6±6.9  0.618 
LVMI (g/m2) 94.7±33.2 76.5±19.2  0.010 
LVEDVI (ml) 40.0±9.3 38.9±8.9  0.441 
LVESVI (ml) 16.3±4.8 14.9±5.1  0.265 
LAVI (ml/m2) 31.7±10.8 22.9±7.7  <0.001 
A (m/s) 0.86±0.20 0.72±0.16  0.001 
E (m/s) 0.70±0.17 0.60±0.11  0.001 
E/A 0.82±0.20 0.86±0.23  0.403 
DT (ms) 239±57 250±49  0.319 
IVRT (ms) 99±25 97±20  0.723 
E/e’ 11.3±4.2 8.2±1.9  <0.001 
 
Data is presented as mean ± standard deviation. 
p-value: unpaired t-test between patients and controls. 
 
LVEF, left ventricular ejection fraction; IVSd, interventricular septal wall thickness; PW, posterior wall; 
LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end systolic diameter; FS, 
fractional shortening; LVMI, left ventricular mass index; LVEDVI, left ventricular end-diastolic volume 
index; LVESVI, left ventricular end-systolic volume index; LAVI, left atrial volume index; A, late 
diastolic mitral inflow velocity; E, early diastolic mitral inflow velocity; E/A, ratio of E to A; DT, 
deceleration time; IVRT, isovolumic relaxation time; e’, peak early diastolic myocardial mitral annular 
velocity; E/e’, ratio of E to e’. 
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Figure 9.1 Patients fulfilling ESC HFNEF criteria 
 
ESC, European Society of Cardiology; HFNEF, heart failure with a normal ejection fraction; n, number; 
E, early diastolic mitral inflow velocity; A, late diastolic mitral inflow velocity, E/A, ratio of E to A; DT, 
deceleration time; LAVI, left atrial volume index; LVMI, left ventricular mass index;  e’, peak early 
diastolic myocardial mitral annular velocity; E/e’, ratio of E to e’;  NT-proBNP, N-terminal pro B-type 
natriuretic peptide. 
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9.5.1 HAEMODYNAMIC CHANGES  
The resting and exercise heart rates were comparable between both groups.  
Patients had a slightly increased systolic blood pressure at rest compared to healthy 
controls.  On exercise, systolic and diastolic blood pressures were comparable 
between the groups.  Patients had a higher stroke volume at rest but they were 
unable to increase their stroke volume on exercise as much as healthy controls 
(Table 9.3). 
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Table 9.3 Haemodynamic data – mitral annular peak systolic excursion 
study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
HR (bpm) 69±12 91±10 <0.001 69±11 93±9 <0.001  0.985 * 
 0.368 # 
BP 
(mmHg) 
146±14 / 
 
79±11 
167±16 
 
88±11 
<0.001 
 
<0.001 
 
138±12 / 
 
79±8 
162±14 / 
 
86±8 
<0.001  
 
<0.001 
 
 0.045 * 
 0.133 # 
 0.905 * 
 0.044 # 
SV 
(ml/min) 
73±25 76±24 0.375 
 
65±15 80±24 0.006  0.070 * 
 0.514 # 
CO 
(l/min) 
5.3±2.2 6.7±2.2  <0.001 
 
4.5±1.2 7.5±2.6  <0.001  0.056 * 
 0.150 # 
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test for patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
# unpaired t-test between patients and controls on exercise. 
HR, heart rate; BP, blood pressure; SV, stroke volume; CO, cardiac output. 
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9.5.2 LONGITUDINAL FUNCTION AND MITRAL FLOW PROPAGATION 
VELOCITY 
Similar to the results in Chapter 5, the mitral annular velocities in systole and early 
diastole (Sm and Em), longitudinal strain, radial strain and apical rotation at rest were 
significantly lower in patients compared to controls and these differences were more 
pronounced on exercise.  Mitral flow propagation velocity (Vp) was comparable 
between patients and controls at rest, but became significantly different  on exercise 
as previously described in Chapter 5 (136) (Table 9.4).  
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Table 9.4 Doppler and speckle tracking data – mitral annular peak systolic 
excursion study 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
Sm (cm/s) 5.0±0.9 6.0±1.2 <0.001 5.9±1.4 7.7±1.4 <0.001  0.001 * 
 <0.001 # 
Em (cm/s) 4.6±1.6 6.5±1.8 <0.001 5.6±1.3 8.3±1.8 <0.001  0.003 * 
 <0.001 # 
GlobLong 
Strain (%) 
-18.3±3.3 -19.9±4.0 <0.001 
 
-21.1±3.0 -23.9±2.5 <0.001 
 
 0.002 * 
 <0.001 # 
Rad strain 
(%) 
41.8±14.5 48.9±16.0 0.039 49.2±13.6 58.9±13.1 0.002  0.046 * 
 0.021 # 
Apical Rot 
(º) 
10.9±4.3 13.6±4.6 0.001 13.0±3.1 18.0±3.8 <0.001  0.030 * 
 <0.001 # 
Vp (m/s) 39.7±8.5 52.8±13.0 <0.001 39.8±7.9 67.0±17.9 <0.001  0.990 * 
 <0.001 # 
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test for patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
Sm, peak systolic myocardial mitral annular velocity; Em peak early diastolic myocardial mitral annular 
velocity; GlobLong, global longitudinal; Rad, radial; Rot, rotation; Vp, mitral flow propagation velocity; 
Δ, (delta) change in. 
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9.5.3 MITRAL ANNULAR PEAK SYSTOLIC EXCURSION (MAPSE) 
In patients, MAPSE was significantly reduced at rest and even more so on exercise 
(Table 9.5, Figure 9.2).  Patients had a smaller increase in MAPSE compared to 
controls (∆ MAPSE 1.2 ± 1.2 mm versus 4.0 ± 2.4 mm, p<0.001).   
 
HFNEF patients had a comparable MAPSE at rest compared to non-HFNEF patients 
(10.6 ± 2.6 mm versus 11.0 ± 1.7 mm, p=0.737).  On exercise there was only a slight 
but not significant difference in MAPSE between the two patient groups (11.2 ± 1.8 
mm versus 12.4 ± 2.3mm, p=0.147).  ANOVA analysis for all three groups (HFNEF 
patients, non-HFNEF patients and healthy controls) showed a significant difference in 
MAPSE at rest (p=0.023) and on exercise (p<0.001). 
 
Table 9.5 Mitral annular peak systolic excursion 
 Patients 
rest 
Patients 
exercise 
Patients 
p-value 
(paired  
t-test) 
Controls 
rest 
Controls 
exercise 
Controls  
p-value 
(paired  
t-test) 
Patients / 
controls  
p-value 
(unpaired 
t-test) 
MAPSE 
(mm) 
10.9±2.1 12.0±2.2 <0.001 12.1±2.2 16.2±2.7 <0.001  0.008 * 
 <0.001 # 
Δ MAPSE 
(mm) 
 1.2±1.2   4.0±2.4   <0.001  
 
Data is presented as mean ± standard deviation. 
p-value (paired t-test): paired t-test for patients (or controls) at rest and on exercise. 
p-value (unpaired t-test): * unpaired t-test between patients and controls at rest and  
 # unpaired t-test between patients and controls on exercise. 
MAPSE, mitral annular peak systolic excursion; Δ, (delta) change in. 
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Figure 9.2 Examples of mitral annular peak systolic excursion at rest and on 
exercise for HFNEF patient and control 
 
 
HFNEF, heart failure with a normal ejection fraction; MAPSE, mitral annular peak systolic excursion. 
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Correlations and receiver operator curves (ROC) 
MAPSE at rest correlated well with many echocardiographic parameters which were 
reduced in HFNEF patients as shown in Chapter 5.  It correlated with measurements 
used for the diagnosis of HFNEF as suggested by the European Society of 
Cardiology guidelines, such as the left atrial volume index (LAVI) and E/e’.  More 
importantly, these parameters correlated even more significantly with MAPSE on 
exercise.  In addition, peak VO2 also correlated with MAPSE on exercise (Table 9.6). 
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Table 9.6 Correlations with mitral annular peak systolic excursion at rest 
and on exercise 
 MAPSE at Rest MAPSE on Exercise 
Pearson 
correlation 
Significance 
(p-value) 
Pearson 
correlation 
Significance 
(p-value) 
LVMI 0.176 0.128 0.204 0.086 
LAVI 0.220 0.038 0.279 0.009 
CO 0.156 0.148 0.303 0.011 
Sm 0.545 <0.001 0.730 <0.001 
Em 0.322 0.002 0.357 0.001 
E/e’ 0.331 0.001 0.359 0.001 
Longitudinal strain 0.432 0.001 0.589 <0.001 
Radial strain 0.196 0.133 0.338 0.017 
Apical rotation 0.283 0.019 0.582 <0.001 
Vp 0.105 0.319 0.519 <0.001 
Peak VO2 0.197 0.097 0.512 <0.001 
LVEF 0.282 0.014 0.326 0.013 
 
MAPSE, mitral annular peak systolic excursion; LVMI, left ventricular mass index; LAVI, left atrial 
volume index; CO, cardiac output; Sm, peak systolic myocardial mitral annular velocity; Em, peak 
early diastolic myocardial mitral annular velocity; E, early diastolic mitral inflow velocity; e’, peak early 
diastolic myocardial mitral annular velocity; E/e’, ratio of E to e’; Vp,mitral flow propagation velocity; 
VO2, oxygen consumption; LVEF, left ventricular ejection fraction. 
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The receiver operator curve for MAPSE at rest showed an area under the curve 
(AUC) of 0.665 (CI = 0.540-0.770) and for MAPSE on exercise it showed an area 
under the curve of 0.901 (CI = 0.835-0.967) (Figure 9.3) to differentiate between 
patients and controls.  Using MAPSE on exercise of < 14.5 mm as a cut off to identify 
patients, the sensitivity was 91% and the specificity 76%.  The receiver operator 
curves to differentiate between patients fulfilling the European Society of Cardiology 
criteria for HFNEF and controls showed an AUC of 0.707 (CI = 0.539-0.875) for 
MAPSE at rest and an AUC of 0.964 (CI = 0.914-1.014) for MAPSE on exercise  
(Figure 9.4). Using MAPSE on exercise < 13.5mm as a cut off to identify patients 
fulfilling the European Society of Cardiology criteria for HFNEF, sensitivity was 95% 
and specificity was 85%. 
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Figure 9.3 Receiver operator curve of mitral annular peak systolic excursion 
at rest and on exercise to differentiate patients from healthy 
controls 
 
MAPSE, mitral annular peak systolic excursion. 
 
Area under the curve of 0.665 (confidence interval = 0.540-0.770) for MAPSE at rest 
and area under the curve of 0.901 (confidence interval = 0.835-0.967) for MAPSE on 
exercise to differentiate all patients (HFNEF and non-HFNEF) from controls. 
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Figure 9.4 Receiver operator curve of mitral annular peak systolic excursion 
at rest and on exercise to differentiate patients with HFNEF from 
healthy controls 
 
MAPSE, mitral annular peak systolic excursion. 
Area under the curve of 0.707 (confidence interval = 0.539-0.875) for MAPSE at rest 
and area under the curve of 0.964 (confidence interval = 0.914-1.014) for MAPSE on 
exercise to differentiate patients fulfilling the European Society of Cardiology criteria 
for HFNEF from controls. 
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9.5.4 INTER-OBSEVER AND INTRA-OBSERVER VARIABILITY 
The interclass correlation coefficient (ICC) for inter-observer variability at rest was 
between 0.82 and 0.96 and on exercise, the ICC varied from 0.67 to 0.99 as reported 
in Chapter 5 (for tissue Doppler, speckle tracking and colour M-mode Doppler 
measurements).  In addition, the ICC for MAPSE at rest was 0.82, 95% confidence 
interval (CI =0.52-0.92)and on exercise it was 0.83, 95% confidence interval (CI 
=0.40-0.91). 
 
The interclass correlation coefficient (ICC) for intra-observer variability at rest varied 
from 0.88 to 0.98 and on exercise from 0.66 to 0.98 as reported in Chapter 5 (for 
tissue Doppler, speckle tracking and colour M-mode Doppler measurements).  The 
ICC for MAPSE at rest was 0.83, 95% confidence interval (CI =0.60-0.92) and on 
exercise it was 0.88, 95% confidence interval (CI =0.70-0.95). 
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9.6 DISCUSSION 
This study demonstrated that MAPSE measured at rest and on exercise is a 
potentially useful measurement  to identify patients with HFNEF.  It is a simple way to 
assess left ventricular function, particularly the long axis function, and it is reduced 
even when the left ventricular ejection fraction is still normal.  It correlates with 
parameters such as E/e’ and left atrial volume index which are considered markers of 
diastolic dysfunction essential in the diagnosis of HFNEF as outlined by recent 
guidelines (31;32).  More importantly, MAPSE correlates with more sophisticated and 
time consuming measurements of systolic left ventricular function (longitudinal strain, 
apical rotation and Sm) as well as diastolic parameters (Em and mitral flow 
propagation velocity).  Furthermore, MAPSE on exercise correlates with exercise 
capacity as measured by peak VO2.   
 
MAPSE is potentially a very useful tool for the diagnosis of HFNEF in view of its ease 
to obtain and measure during exercise, even in obese patients which constitute 50% 
of the patient group in this study.  Many patients with significant exercise intolerance 
may have normal physical examination, echocardiography and haemodynamics at 
rest.  Borlaug et al. showed that many of these patients had elevated left ventricular 
filling pressures on exercise (162).  Based on the findings reported in Chapters 5 to 
8,  left ventricular assessments performed on exercise give a more complete 
evaluation and are key to evaluate patients with exertional symptoms such as those 
with HFNEF. 
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MAPSE was used in early studies as a marker of left ventricular function but was 
shortly replaced by more advanced imaging modalities such as tissue Doppler 
imaging and speckle tracking imaging.  Willenheimer et al. showed that MAPSE, as a 
measure of long axis function or atrioventricular displacement, was strongly related to 
one year mortality in heart failure patients.  They showed a 36% one year mortality in 
those with MAPSE of < 6.4 mm and no deaths in those with MAPSE > 10 mm (163).  
More recently, a 10-year follow-up study found that MAPSE was a strong 
independent risk predictor of long-term survival after adjusting for age, gender, heart 
rate, systolic blood pressure and short axis fractional shortening (164).     
 
These results emphasise the importance of left ventricular longitudinal function and 
the contribution of the mitral annulus or atrioventricular displacement in the overall 
function and mechanics of the left ventricle.  As discussed in earlier chapters, the 
movement of the mitral annulus away from the base during systole is also a reflection 
of left ventricular twist or torsion, which helps to pull the annulus towards the apex.  
Interestingly, this study also found a good correlation between MAPSE and apical 
rotation in addition to measurements of longitudinal function such as Sm and 
longitudinal strain.  Carlsson et al. estimated that left ventricular longitudinal 
shortening contributed 60% of normal stroke volume (165).  Furthermore, the recoil 
of the atrioventricular plane in diastole is very important to aid early left ventricular 
filling.  Hence, the loss of longitudinal or atrioventricular plane motion will have a 
significant impact on the overall left ventricular function, and may explain why 
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longitudinal function is one of the earliest markers of overall left ventricular 
mechanical dysfunction. 
 
E/e’ is an indirect marker of left ventricular end-diastolic pressure and its 
measurement at rest is an essential non-invasive marker for diastolic dysfunction 
used in the European Society of Cardiology guidelines for the diagnosis of HFNEF 
(31).  Burgess et al. found that E/e’ > 13 on exercise could accurately identify a 
raised left ventricular end-diastolic pressure of  > 15 mmHg (166).  However, E/e’ did 
not rise consistently in patients with HFNEF on exercise in the results reported in this 
thesis.  Recently, doubts have been raised about the validity of E/e’ as a non-
invasive measurement of left ventricular end diastolic pressure in conditions such as 
decompensated heart failure (167).  In addition, fusion of the mitral inflow E and A 
waves seen in higher heart rates makes precise measurement of E/e’ difficult.  In 
contrast, MAPSE which is relatively easy and quick to obtain, particularly on exercise, 
appears to be a robust measurement which also correlates with E/e’.     
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9.7 LIMITATIONS  
Sm and Em may be after-load dependent (168), and this is likely to apply in the 
measurement of MAPSE.  The arterial blood pressure was similar in patients and 
controls both at rest and on exercise to minimise the effects of after-load difference.  
Yip et al.  showed that diuretics reduce symptoms of breathlessness in patients with 
HFNEF and there has been suggestion that angiotensin converting enzyme inhibitors 
or receptor antagonists may improve longitudinal function (135).   It is probable that 
the effect of treatment would be to improve longitudinal function and therefore reduce 
the differences in MAPSE seen between patients and controls.  In addition, it would 
have been difficult to account for a resulting increase in arterial blood pressure on 
exercise if treatment was stopped in these patients.  
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9.8 CONCLUSION  
MAPSE is a simple and technically easy measurement to obtain at rest and on 
exercise and it reflects more sophisticated indices of left ventricular function.  Left 
ventricular atrioventricular motion is a fundamental property of the left ventricular 
function and a simple M-mode measurement such as MAPSE appears to be a robust 
and good discriminator especially when applied on exercise. 
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10. CONCLUSION AND DISCUSSION 
10.1 DISCUSSION 
It remains unclear whether HFNEF and HFREF are part of a spectrum of heart failure 
or whether they are distinct diagnosis.  The unimodal distribution of left ventricular 
ejection fraction in large studies suggests a single syndrome with increasing degrees 
of left ventricular remodelling.  However, the different structural and biomolecular 
aspects which might be associated with neutral outcomes in drug trials with 
angiotensin converting enzyme inhibitor (169), angiotensin receptor blocker (170) 
and beta blocker (171) compared to HFREF might support that clinical heart failure 
presents and evolves not as a single, but as two syndromes each with specific 
mechanisms responsible for left ventricular diastolic dysfunction seen in heart failure, 
regardless of whether the left ventricular ejection fraction is reduced or preserved.  
The exact progression of HFNEF is not clear.  Long term follow up study would be 
the only way to demonstrate if patients evolve from HFNEF to HFREF, and 
understand the natural progression of the condition.   
 
The diagnosis of HFNEF remains challenging and not at all straightforward given that 
the symptom of exercise intolerance or dyspnoea are both non-specific, difficult to 
quantify, and are common presentations in many other medical conditions.  In 
addition, many patients with such symptoms have multiple comorbidities.  HFNEF 
constitutes 50% of the heart failure population and its rising prevalence threatens to 
make it the most common form of heart failure in the near future.  It is unclear if the 
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increasing prevalence of HFNEF is a reflection of the increase in obesity and 
metabolic syndrome, both of which are commonly seen in patient with HFNEF, or 
over-diagnosis because of inexact diagnostic criteria and difficulties in precisely 
assessing diastolic dysfunction which is not exclusive to the pathophysiology of 
HFNEF.   
 
The body mass index (BMI) of HFNEF patients in many studies is more then 25 and 
commonly more than 30.  In this project, 73% of HFNEF patients had a BMI > 
25kg/m2, and 53% had a BMI > 30kg/m2.  This could be due to a regional difference 
in population, but the mean BMI was not dissimilar to many other HFNEF studies 
(23).  It is difficult to determine the effects of increase loading due to obesity alone on 
the overall cardiovascular function given that, diabetes and hypertension are 
commonly found in obesity.  Diastolic dysfunction is found to be associated with 
obesity (172) and could precede systolic dysfunction.  Even though many parameters 
used to study the pathophysiology of HFNEF are corrected to either body mass index 
or body surface area, the true impact of body weight on cardiac function remains 
unknown.  Therefore, a future study to compare the pathophysiology between obese 
HFNEF patients and non-obese HFNEF patients might shed some light.  Metabolic 
syndrome is very common in developing countries.  The question is whether HFNEF 
is a diagnosis of metabolic syndrome in older people. 
 
The main aim to study the pathophysiological mechanism underlying HFNEF is to 
diagnose and treat the condition.  To date, the pathophysiology of HFNEF remains 
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uncertain given the complexity of the condition.  Patients with HFNEF are likely to 
display a mixture of abnormalities as shown in the extensive research over the past 
two decades.  Fundamentally, HFNEF is a condition of cardiovascular reserve 
disorder encompassing systolic, diastolic, chronotropic, energetics and vascular 
abnormalities.  The root of all these problems could be a degenerative signalling 
compound which is responsible in triggering a cascade of changes in the 
extracellular matrix or myocytes, interfering with the normal structure and function of 
the myocardium.  The presence of conditions such as hypertension, diabetes and 
obesity might have accelerated or contributed towards its degeneration.  Future 
research focus should be to identify and interfere with such myocardial signalling 
pathway.   
 
In order to carry out appropriate research specific to the condition, accurate 
identification of patients is crucial.  Therefore, improvement in the diagnosis of 
HFNEF using non-invasive methods is important.  The current diagnosis guidelines 
for HFNEF are complex and not without flaws.  The guidelines identify a proportion of 
patients with signs of congestion associated with high filling pressures at rest, 
detected using a selection of echocardiographic parameters.  However, HFNEF 
patients can present at different stages of the condition.  In early stages, these 
patients commonly have normal resting haemodynamical and echocardiographical 
findings and would not meet the criteria for diagnosis of HFNEF.  The majority of 
HFNEF patients are symptomatic on exertion and therefore, it is not surprising that 
tests performed at rest are frequently negative.  The studies in this thesis identified 
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complex left ventricular systolic and diastolic dysfunction which became apparent on 
exercise in a group of HFNEF patients, some of whom do not fulfil the criteria of the 
current European Society of Cardiology guidelines.  Furthermore, left ventricular 
function abnormalities were found in a group of well controlled hypertensive patients 
implying that these patients could be in the early stage of HFNEF, and with time 
could progress to developing signs and symptoms meeting the criteria for diagnosis 
of HFNEF.  Of note, these findings also suggest that controlling blood pressure might 
not entirely stop the progression of disease and that changes at the molecular level 
have taken place much earlier than the presentation of disease.  Failing to diagnose 
the condition early could explain the high morbidity and mortality of the condition.  
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10.2 FINAL CONCLUSION 
“Diastolic Heart Failure” is an obsolete term as diastolic dysfunction rarely if at all 
occurs in isolation.  The findings of this thesis showed that patients who previously 
would have been labelled as diastolic heart failure have left ventricular systolic 
dysfunction which is not apparent at rest given that they only become symptomatic 
on exercise.  Therefore, using exercise echocardiography, complex abnormalities of 
left ventricular systolic and diastolic function at rest and on exercise were found using 
a combination of tissue Doppler and speckle tracking imaging.  The findings of this 
thesis confirmed that left ventricular systolic function is impaired due to longitudinal 
dysfunction, including reduced longitudinal strain, impaired left ventricular twist 
(Chapter 5) (136) and left ventricular dyssynchrony(173).  These systolic 
abnormalities affect left ventricular diastolic function and delay left ventricular 
relaxation which lead to reduced and delayed untwisting (136).   
 
The release of potential energy stored in systole for left ventricular recoil during 
untwisting in diastole generates sufficient intraventricular pressure gradient to create 
a suction effect for rapid filling of the left ventricle, particularly during exercise when 
diastolic filling time is shortened as heart rate increases.  In HFNEF, left ventricular 
untwisting is impaired, leading to reduced left ventricular suction and hence early left 
ventricular filling which is not compensated by late diastolic filling during atrial 
contraction, secondary to diminished left atrial functional reserve (Chapter 6) (145). 
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Furthermore, this project confirmed that exercise induces torsional dyssynchrony due 
to the uncoupling of left ventricular longitudinal and twist mechanics, which are the 
two main components responsible for the overall atrioventricular plane motion.  The 
disco-ordination of these two motions contributes to the reduction of exercise 
capacity (Chapter 7)(173).  
 
In addition, there is a significantly reduced systolic and diastolic functional reserve, 
as seen in patients with HFNEF,  in a group of treated hypertensive patients with 
normal resting echocardiography examination (Chapter 8) (174).  This showed that 
normal resting echocardiography does not preclude the presence of significant 
functional abnormalities on exercise that contribute to symptoms, and suggests that 
subclinical level of left ventricular mass increase might be associated with impaired 
left ventricular function which could represent the early stage of HFNEF. 
 
Left ventricular systolic and diastolic dysfunction can be detected using 
echocardiography at rest.  But, more importantly these abnormalities become more 
apparent on exercise which is when the patients are symptomatic.  The additional 
information from exercise studies could identify HFNEF patients at an early stage 
when they do not meet the current criteria of diagnosis and hence exercise 
parameters should be included as part of the HFNEF diagnostic pathway. 
 
Current guidelines for diagnosing HFNEF involve multiple echocardiographical and 
invasive haemodynamic measurements (31) which might not be applicable in daily 
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clinical settings.  The current guidelines do not include any exercise assessments.  
Admittedly, multiple echocardiographical measurements during exercise is time 
consuming, requires certain expertise and accurate data analyses require training 
and experience.  A simple and technically easy measurement at rest and on exercise 
which reflects more complicated left ventricular function indices might ease the 
diagnosis of HFNEF.   
 
The measurement of MAPSE is easily obtainable on exercise even in technically 
challenging imaging subjects.  Furthermore, MAPSE was shown to reflect more 
sophisticated indices of left ventricular function, particularly indices which relate to 
diastolic dysfunction and appears to be a robust and good discriminator for HFNEF, 
making it a potential diagnostic measurement (Chapter 9) (175). 
 
The pathophysiology of HFNEF is unlikely to be explained by a single causal 
mechanism.  Research has provided, and continues to provide, crucial information 
about the molecular, structural and physiological mechanisms involved in HFNEF but 
no novel target for precise therapy has been found yet.  Nevertheless, the 
understanding of the pathophysiology of HFNEF would aid the establishment of an 
accurate investigation pathway which could increase diagnostic yield in this group of 
patients.  This would enable more accurate recruitment of HFNEF patients in medical 
trials in search for treatment for this condition.  
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To date, the management of HFNEF involves risk modification by treating 
contributory conditions such as hypertension, diabetes and obesity, and preventing 
subendocardial ischaemia, development of left ventricular hypertrophy and 
myocardial fibrosis, in the hope that these patients who are at risk do not progress to 
develop HFNEF.  In those presenting with symptoms of heart failure, the search for 
therapeutic targets which improve morbidity and mortality continues.  The findings in 
this thesis are suggestive that the primary abnormality more likely resides in the 
extracellular matrix, a common pathway involved in all the comorbidities of HFNEF, 
and this may be a potential therapeutic target (Figure 10.1). 
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Figure 10.1 Flow chart illustrating unifying hypothesis 
 
 
LV, left ventricular; IVPG, intraventricular pressure gradient; LA, left atrial; AF, atrial fibrillation; 
LVEDP, left ventricular end diastolic pressure; VO2,oxygen consumption. 
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APPENDIX 1  LIST OF ABBREVIATIONS 
2D two-dimensional 
A late diastolic mitral inflow velocity 
A' peak late diastolic myocardial mitral annular velocity by pulse 
wave Doppler imaging 
ACE angiotensin converting enzyme 
Ad duration of late diastole mitral inflow 
AF atrial fibrillation 
AFRI atrial functional reserve index 
Am peak late diastolic myocardial mitral annular velocity by colour 
tissue Doppler imaging 
ANOVA / 
Anova 
analysis of variance analysis 
ARB angiotensin receptor blocker 
Ard - Ad difference between duration of reversed pulmonary vein atrial 
systolic flow (Ard) and duration of late diastole mitral inflow 
(Ad) 
ARP abnormal relaxation pattern 
AVC aortic valve closure 
BMI body mass index 
BNP B-type natriuretic peptide 
BP blood pressure 
bpm beats per minute 
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BSA body surface area 
CO cardiac output 
CPET cardiopulmonary exercise testing 
DHF diastolic heart failure 
DLFRI diastolic longitudinal function reserve index 
dP/dt  left ventricular pressure change 
DT deceleration time of early mitral inflow velocity 
E early diastolic mitral inflow velocity 
E’ or e' early diastolic myocardial mitral annular velocity by pulse wave 
Doppler imaging 
E/A ratio of early to late diastolic mitral inflow velocity 
E/e' ratio of early mitral diastolic inflow velocity to early diastolic 
mitral annular velocity 
Ea arterial elastance 
ECG electrocardiogram  
EDP end diastolic pressure 
EDPVR end diastolic pressure-volume relationship 
EDV end diastolic volume 
Ees end systolic elastance 
EF  ejection fraction 
Em peak early diastolic myocardial mitral annular velocity by 
colour tissue Doppler imaging 
ESC European Society of Cardiology  
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ESPVR end systolic pressure-volume relationship 
FS fractional shortening 
HFNEF heart failure with a normal ejection fraction 
HFPEF heart failure with a preserved ejection fraction (same as 
HFNEF) 
HFREF heart failure with a reduced ejection fraction 
ICC interclass correlation coefficient 
IVPG intraventricular pressure gradient 
IVRT isovolumic relaxation time 
IVSd interventricular septal thickness in diastole 
K chamber stiffness 
LA  left atrium / left atrial 
LAFRI left atrial functional reserve index 
LAVI left atrial volume index 
LE longitudinal extension 
LV left ventricle / left ventricular 
LVEDD left ventricular end diastolic dimension 
LVEDP left ventricular end diastolic pressure 
LVEDVI left ventricular end diastolic volume index  
LVEDSI left ventricular end systolic volume index 
LVEF left ventricular ejection fraction 
LVH left ventricular hypertrophy 
LVMI left ventricular mass index 
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LVOT left ventricular outflow tract 
LVPVR left ventricular pressure-volume relationship 
MAPSE mitral annular peak systolic excursion 
MRI magnetic resonance imaging 
NT-proBNP N-terminal pro B-type natriuretic peptide 
NYHA New York Heart Association 
p probability 
PCWP pulmonary capillary wedge pressure 
Peak VO2 peak oxygen consumption 
PPI peak power index 
PW posterior wall 
PWD pulse wave Doppler 
r correlation 
RER respiratory exchange ratio 
RFP restrictive filling pattern 
ROC receiver operator curve 
ROI region of interest 
S' peak systolic myocardial mitral annular velocity by pulse wave 
Doppler imaging 
SD standard deviation 
SDSM standard deviation systolic motion  
SHF systolic heart failure 
SLFRI systolic longitudinal function reserve index 
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Sm peak systolic myocardial mitral annular velocity by colour 
tissue Doppler 
STI speckle tracking imaging 
SV stroke volume 
SWI stroke work index 
TDI tissue Doppler imaging 
TLMD twist-longitudinal motion delay 
UT untwist 
UT:LE ratio of untwist to longitudinal extension 
UTR untwisting rate 
VO2  oxygen consumption 
Vp mitral flow propagation velocity 
VTI velocity time integral 
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